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1 In the past decades  MRI of the pelvis and pelvic floor has gained a lot of attention and 
development. For benign conditions and diseases dedicated MRI has demonstrated value 
for diagnosis and guiding appropriate treatment (1-5). In  oncology multiparametric MRI 
has been the established method for detection and local staging of rectal cancer, prostate 
cancer and cervical cancer (6-9). It is of paramount importance to adapt imaging technique 
and MRI protocols to the clinical indication for imaging. Advances in medical technology 
and clinical insight enables to apply dedicated imaging tailored to the specific clinical prob-
lem. This leads not only to gain in diagnostic accuracy but has become an integral part of 
patient management. Our center, a tertiary referral center for diseases in both, the ventral 
and dorsal compartments of the pelvis, including the pelvic floor, has extensive experience 
with the application of pelvic phased array multicoils and endoluminal surface coils for 
the preoperative evaluation of perianal and female urethral and periurethral diseases. The 
endoluminal coils are of a rigid design and can be used repeatedly. They are custom built in 
collaboration with our technical staff and are regularly upgraded technically. 
The purpose of this thesis was to investigate the value of dedicated MRI of the pelvis and 
pelvic floor in clinical patients referred to the radiology department with diseases in this 
anatomic region. 
enDoLuMInaL coIL veRsus PeLvIc  
PhaseD aRRay IMagIng
The value of endoluminal receiver coils for application in the pelvic area has been estab-
lished with proven clinical value especially for perianal fistula imaging and prostate imaging. 
Recent studies have demonstrated valuable clinical potential for endovaginal application 
with visualization of urethral and periurethral pathology in woman. Our center, a tertiary 
referral center for diseases of the pelvis and pelvic floor, has solid experience with the use of 
rigid endoluminal receiver coils for endoanal,  and endovaginal application on 1.5 T and 3.0 
T MRI systems. With endoluminal MRI we aim to aquire accurate morphologic images. The 
endoluminal coil has been technically improved with the dualloop design with an increase 
in SNR and spatial resolution over the previous generation single loop coils. The dual loop 
endoluminal receiver coil may allow for better diagnosis through improved spatial resolu-
tion without increase in imaging time compared with the single loop coil. Practically, there 
are 2 main types of endocavitary receiver coils for use in the pelvic region: the inflatable and 
rigid design. The inflatable design has been more widely used especially for endorectal ap-
plication with focus on  prostate imaging. An adapted version has been used for intravagi-
nal application. This inflatable version is of a disposable design with 1 coil application per 
examination. The rigid endocavitary coil has been initially designed for endoanal applica-
tion. The same coil has also been used for endovaginal placement with satisfactory results 
(3, 5). This rigid type is reusable and provides unequaled image quality and conspicuity of 
numerous diseases of the ano-vaginal region and pelvic floor. Previous studies found the 
endoluminal coil to be superior to the phased array coil for demonstration of anal sphincter 
anatomy and perianal fistula disease (10, 11). Endoanal MRI is especially valuable for clas-
sification of the primary tract and identification of the internal ostium  in cryptoglandular 
fistula’s (11-14). Because of the limited field of view, the phased array was especially superior 
for demonstration of distant fistula extensions (15, 16). 
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Endoanal MRI is highly accurate in demonstrating lesions of the sphincter complex  (17-19). 
Sphincter damage is especially seen in patients with chronic fistula and previous surgery 
and is important for surgical planning. For prostate cancer imaging, studies have shown su-
perior image quality and improved reader confidence using an ERC in staging performance 
for prostate cancer at 3T when compared with pelvic phased array coil at 3T (20, 21). For 
female urethral diverticula, endoluminal coil demonstrated better subjective image quality 
with endovaginal  placement when compared with endoanal placement or phased array 
coil imaging (3). All these studies were based on imaging with the single loop coil design. In 
addition, vaginal endoluminal coil imaging proved valuable for diagnosis and preoperative 
assessment of periurethral disease (5).     
PeRIanaL FIstuLa DIsease
Fistula-in-ano is an abnormal communication between the anal canal and the perianal skin. 
Perianal abscess is an acute manifestation of fistula-in-ano.  (22). In the surgical literature, 
cryptoglandular fistulas and abscesses are distinguished from fistulas and abscesses due to 
an underlying disease such as Crohn’s disease (14, 23). Fistulas resulting from an underly-
ing disease are termed specific. Most cases of fistula-in-ano are nonspecific and result from 
inflammation of anal glands and crypts (cryptoglandular) (14, 24). The prevalence of this 
type of fistula is said to be approximately 10 per 100,000 of the general population. Peri-
anal fistulas and abscesses are often diagnosed clinically, based on typical symptomatology 
and physical examination. The exact relationship between the fistula and the anorectum, 
in particular the anal sphincter complex, is often not evident at physical examination. The 
classification of cryptoglandular fistulas depends on the degree of involvement of the anal 
sphincter complex and determines the type of surgical treatment. MR imaging has become 
the standard imaging technique for demonstration and classification of perianal fistulas 
and abscesses (14). This modality provides multiplanar images with high inherent contrast 
resolution and high spatial resolution of the anal canal, rectum, rectovaginal septum, and 
vagina (1-5). At MR imaging, the identification and localization of the entire  fistula, includ-
ing the external opening, the primary tract, secondary tracts, abscesses, and the internal 
opening, are essential for fistula classification and treatment. Fistulas with unrecognized 
components may cause problems during surgery and are more likely to recur (14, 25, 26). 
Studies have shown that preoperative MR imaging revealed important additional informa-
tion compared with surgery alone and better predicts clinical outcome of patients with 
fistula-in ano than initial surgical exploration (6, 27). 
Anovaginal fistula is considered a special type of perianal fistula with typical symptoms 
of recurrent vaginal infections with vaginal flatus and vaginal defecation and can clearly 
be depicted with MR imaging using an endoanal coil (1). At our institution, endoanal MR 
imaging is routinely performed in the assessment of perianal fistulas, including anovaginal 
fistula. In particular, T2weighted MR imaging sequences can demonstrate fistulas and ab-
scesses, as high signal intensity lesions.
The treatment of these fistulas is mainly surgical, with a number of options. For low trans-
sphincteric andintersphincteric fistulas fistulotomy is the treatment of choice. 
Transanal advancement flap repair has been advocated as the treatment of choice for trans-
sphincteric fistulas passing through the upper and middle third of the external anal sphinc-
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1 ter. This procedure enables healing of the fistula in 2 out of  3 patients without consequent 
sphincter damage. 
chRonIc anaL PaIn
Chronic anal and perianal pain (CAP) is a common problem in the gastroenterological prac-
tice (28, 29). CAP is defined as recurrent or persistent pain in the anal canal, usually deep and 
severe, with a variable radiation and of more than 3 months duration (29). CAP is thought 
to be present as a major symptom in up to 6% of U.S. citizens (28). Patients generally pres-
ent with a combination of symptoms, including pain, soiling, loss of blood or pus from the 
anus, faecal incontinence or a palpable mass in and around the anus. A combination of 
symptoms may lead to clinically suspected disease and a clinical examination will assess 
local anal pathology including complicated hemorrhoids, hypertrophied anal papillas, anal 
fissure and perianal suppurative conditions. When the only presentation is pain in the anal 
region and no local pathology is found at initial clinical evaluation, the clinician is faced 
with a major challenge. It has been speculated that patients without a clinically confirmed 
physical explanation may have an underlying functional disorder or that CAP may result 
from a significant psychological overlay (19, 20). The aim of further investigations, including 
imaging, must be to identify causes of pain not initially detected at clinical evaluation. Only 
few ultrasoundbased studies were published in a patient cohort with CAP (30). 
MRI In chRonIc LoweR uRInaRy tRact syMPtoMs In 
woMen
Chronic lower urinary tract symptoms are common in women. Lower urinary tract symp-
toms are a group of symptoms with abnormalities that may be categorized into seven 
groups: storage problems, voiding problems, postmicturition symptoms, symptoms associ-
ated with sexual intercourse or pelvic organ prolapse, lower urinary tract pain, and lower 
urinary tract dysfunction syndrome (31). New insights suggest that lower urinary tract 
symptoms are a non-organ-specific group of symptoms, which are sometimes age related 
and progressive, affecting up to 26% of women 40 years and older (32, 33). The presentation 
of symptoms can be diverse and the differential diagnoses extensive. It is of importance 
to differentiate morphologic abnormalities from dysfunctional conditions that are respon-
sible for a patient’s complaints. Dedicated MRI and urodynamic studies are important tools 
in this respect (3). With its excellent soft-tissue contrast and multiplanar acquisition, MRI 
has become the imaging modality of choice for diagnosis and preoperative evaluation in 
female patients with urethral and periurethral disease. Previously, pelvic phasedarray coils 
were applied for female pelvic imaging, including imaging of the urethra and periurethral 
region. Subsequently, intracavitary MRI coil design (for endovaginal and endorectal place-
ment) made imaging with increased spatial resolution and high signal-to-noise ratio of this 
anatomic region possible (3, 34, 35).
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MRI oF FeMaLe uRethRaL DIveRtIcuLa
Female urethral diverticulum is often overlooked and frequently misdiagnosed because 
of unawareness of the condition. Urethral diverticula are estimated to occur in 1–6% of 
women. Although usually diagnosed between the third and fifth decade of life, it can affect 
all age groups (36-38). Usually, an array of nonspecific genitourinary symptoms predomi-
nate. This condition should always be considered in women with unexplained lower urinary 
tract symptoms. In addition to interstitial cystitis, urethral syndrome, and urgencyfrequency 
syndrome, the clinician should include urethral diverticula in the differential diagnosis (39). 
Appropriate investigations play an important role in the diagnosis of urethral diverticula 
and ideally should provide the surgeon with information regarding location, number, size, 
configuration, and communication of the urethral diverticula (40). MRI has now become the 
imaging study of choice (40). 
MRI oF LocaLLy RecuRRent RectaL canceR (LRRc)
Colorectal cancer  is a common malignancy and rectal cancer accounts for approximately 
one third of the colorectal malignancies (41). Developments in the treatment of rectal can-
cer, such as neo-adjuvant (chemo) radiotherapy and total mesorectal excision, have signifi-
cantly reduced  local recurrence rate over the last decades. Currently, the local recurrence 
rate after rectal surgery amounts 5-10 % (42). Locally recurrent rectal cancer (LRRC) often 
occurs within the first 2 years after treatment of the primary tumor and has often disabling 
and difficult to treat symptoms, such as severe pain, fistulating and bleeding tumors (43, 
44). Radical surgical resection of the local recurrence offers the highest chance of cure and 
leads to survival rates ranging between 14 % and 30 % (45, 46). On the contrary, without 
surgical intervention LRRC is associated with a dismal 5-year survival rate of less than 4% 
(4). Early detection of LRRC may facilitate radical resection and thus achieve a better sur-
vival (46, 47). Magnetic Resonance imaging (MRI) is widely used for diagnosis and surgical 
planning of LRRC (48). The diagnosis is challenging due to difficulty of differentiating actual 
recurrent disease from fibrosis and scarring (44, 47, 48). This hinders the detection of local 
recurrences and also poses a problem in defining the exact tumor extent (48). In addition to 
conventional MRI sequences (T1and T2weighted MRI), contrast enhanced (CE) MRI has the 
potential to increase lesion visibility and conspicuity and thus may be of additional value in 
distinguishing malignant from non-malignant tissue. (47, 49, 50). 
PRIMaRy cystIc LesIons oF the RetRoRectaL sPace
The retrorectal space, which is also known as the presacral space, is a space bounded by 
the rectum anteriorly, presacral fascia posteriorly, and the endopelvic fascia  laterally. The 
superior border is formed by the posterior peritoneal reflection of the rectum with the infe-
rior border being the superior fascia of the pelvic diaphragm. This space contains remnants 
derived from embryonic neuroectoderm, notochord, and hindgut, and hence may result 
in a wide variety of congenital lesions herein. Malignancy is more common in the pediatric 
population, and solid lesions are more likely to be malignant than are cystic lesions (51).
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1 Retrorectal cystic lesions (RRCL) in adults are rare with little literature available and an un-
known prevalence. Often the basic clinical problem is whether a RCL lesion should be con-
sidered a malignant lesion. 
aIM oF thIs thesIs
The aim of this thesis was to determine the value of dedicated MRI with high spatial and 
contrast resolution in different diseases of the lower pelvis and pelvic floor.  
outLIne oF thIs thesIs 
Chapter 2 focuses on applied physics and design of the current rigid endoluminal surface 
coils for pelvic imaging, including translation to state of the art imaging of the perianal 
and periurethral (female) anatomic regions. These coils were applied in some of the studies 
described in this thesis. 
In Chapter 3, the focus is on MRI of perianal fistula disease and chronic anal pain. Chapter 
3.1 relate to a review study on MRI of perianal fistula disease. In Chapter 3.2, I present the 
results of a study with endoanal MRI of anovaginal fistulas. In many institutions, the clinical 
diagnosis or suspicion of an anovaginal fistula is confirmed with imaging studies especially 
conventional fistulography and and anal endosonography. Conventional fistulography may 
not be possible in many patients because the internal openings of the fistulas may not be 
visible at physical examination. Endoanal ultrasonography (US) is often inaccurate in the 
depiction of anovaginal fistulas, mainly because endoanal US has inherent low soft-tissue 
contrast. We evaluated  the role of endoanal MR imaging in the assessment of anovaginal 
fistulas and associated findings. In Chapter 3.3, a clinical study on surgical outcome of 
complex high transshpincteric fistulas is described. Transanal advancement flap repair for 
the treatment of high transsphincteric fistulas fails in 1 out of  3 patients. The present study 
was conducted to determine the prevalence of horseshoe extensions in posterior and an-
terior high transsphincteric fistulas with the use of endoanal MR imaging and to investigate 
whether the more complex fistulas, such as those with horseshoe extensions and associ-
ated abscesses, have a less favorable outcome. In Chapter 3.4,  a study is presented on 
dedicated MRI in patients with clinical occult chronic analand perianal pain (CAP). Although 
CAP is a relatively common problem in the general population, few studies have focused on 
this problem. These ultrasound-based studies showed a common weakness in that a clear 
clinical reference standard for the reported ultrasound findings was lacking. In addition, the 
nature of ultrasound as an operator-dependent imaging modality leads to limitations in the 
reproducibility of findings. Our study is the first with use of MRI in a cohort of patients with 
CAP. Imaging findings were correlated with surgery and clinical follow up data. 
Chapter 4 focuses on the value of dedicated MRI in female patients with chronic lower uri-
nary tract symptoms (LUTS). In Chapter 4.1, I describe and illustrate our experiences with 
state of the art MRI of female patients with chronic lower urinary tract symptoms (LUTS) 
in a clinical perspective paper. The presentation of LUTS  can be diverse and the differen-
tial diagnoses extensive. This article presents a classification of morphologic or functional 
abnormalities that can be considered in the differential diagnoses of women with LUTS. 
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This classification is based on common and less-common causes for lower urinary tract 
symptoms according to the literature and our experience at a tertiary referral center for fe-
male genitourinary symptoms and dedicated MRI of the pelvis and pelvic floor. In Chapter 
4.2, I investigate a cohort of female patients referred for MRI with clinical suspicion of ure-
thral diverticula. Accurate imaging plays an important role in the diagnosis and differential 
diagnosis of urethral diverticula and ideally should provide the surgeon with information 
regarding location, number, size, configuration, and communication of the urethral diver-
ticulum. 
Chapter 5 focuses on the value of dedicated MRI for diagnosis and local staging of ma-
lignancies in the dorsal compartment of the pelvis. In Chapter 5.1, I present a study on 
staging of locally recurrent rectal cancer (LRRC) with MRI, with focus on the added value of 
contrast enhanced MRI, to predict accuracy of tumor size and  surgical resection margins 
(radical or incomplete). The diagnosis of LRRC is challenging due to difficulty of differenti-
ating actual recurrent disease from fibrosis and scarring. In addition to conventional MRI 
sequences (T1and T2weighted MRI), contrast enhancement (CE) MRI has the potential to in-
crease lesion visibility and conspicuity and thus may be of additional value in distinguishing 
malignant from non-malignant tissue. In Chapter 5.2, I describe the retrorectal space (RRS) 
and present a study of primary cystic lesions of the RRS, using MRI to assess malignancy. 
Often the basic clinical problem is whether a retrorectal cystic lesion should be considered 
a malignant lesion. Based on our analysis, we assessed the a priori chance that a RRCL is 
malignant and we tried  to identify MR imaging characteristics which may be indicative of 
malignancy. 
Chapter 6, Interlude. These images were captured during one of my favourite activities, 
travel. Finally, in Chapter 7, I conclude with a review of my main findings in the context of 
present knowledge and indicate the importance for patient management. 
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abstRact 
There are two main types of endocavitary  MRI coils (eCoils) for use in the pelvic region: 
the inflatable and rigid type. The inflatable type has been more widely used especially for 
prostate imaging with endorectal application. This inflatable version is meant for use of one 
disposable coil per examination.  The rigid eCoil has been designed initially for endoanal 
application with proved value for classification of the primary tract and identification of 
the internal ostium in cryptoglandular fistulas. The same coil has also been used for endo-
vaginal assessment of female urethral diverticula and periurethral disease. This rigid coil 
is reusable. Both coil types were technically improved recently with the dual loop design, 
including an  increase in SNR and improved image quality. The dual loop eCoil may allow 
for better diagnosis through improved spatial resolution without increase in imaging time 
when compared with the single loop coil. In this article we describe and illustrate our expe-
riences with the use of the rigid eCoils for endoanal and endovaginal application, including 
added value over the pelvic phased array multicoils as well as pitfalls in using these coils.
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IntRoDuctIon
The value of endoluminal receiver coils (eCoils) for application in the pelvic area has been 
established with proven clinical value especially for perianal fistula imaging and prostate 
imaging (1-3). Recent studies have proven valuable clinical potential for endovaginal ap-
plication with demonstration of urethral and periurethral pathology. Our center, a tertiary 
referral center for diseases of the pelvis and pelvic floor, has solid experience with the use of 
rigid eCoils for endoanal  and endovaginal application on both, 1.5 T and 3.0 T MRI systems. 
In this article we describe our experience with the use of these coils, including added value 
over the pelvic phased array multicoils as well as pitfalls in using these coils.  
Endoluminal receiver coils for use in the pelvic region
There are 2 main types of eCoils for use in the pelvic region: the inflatable and rigid type. 
The inflatable design has been more widely used especially for endorectal application with 
focus on prostate imaging. This inflatable version is meant for use of one disposable coil 
per examination. The rigid eCoil has been initially designed for endoanal application. The 
same coil has also been used for endovaginal placement with satisfactory results (4, 5). This 
rigid coil type is reusable. Due to its versatile use, this paper will further focus on the rigid 
eCoils.
Design of a rigid MRI coil with a cylindrical reception field profile
Given the anatomy of the anal canal, a homogeneous cylindrical radiofrequency (rf ) field 
profile of the receiving coil is required. A single loop coil generates a dipole H
1
 field that can 
be described by using Biot Savart’ s law for a quasi- static H
1
 field. Calculation of the H
1
 field 
demonstrates the rf field in the axial plane around two wires separated by 12 mm (Fig 1). 
Note that the field has an elliptic profile close to the coil. To correct for this a second loop 
coil, placed orthogonally to the first loop, was introduced.
a b
Figure 1. Calculations of the H
1
field profile of two wires separated by 12 mm in vertical A) and horizontal (B) ori-
entation. Calculations were performed using  the mathematical program MatLab®. 
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By combining the signals of  both coils in an array a cylindrical field  is expected. The sensi-
tivity of both coils combined can be described by the following equation: 
where a is the radius of the coil, r is the distance between a voxel and the center of the coil 
and  is the voxel orientation with respect to the four wires. Based on above equation, follow-
ing H1 field was expected for the dual loop design (Fig 2). 
Differences in SNR data derived from the single loop- and dual loop coils are displayed in 
Table I. Signal intensities were measured over an area of 14 mm2 radially to a length of 50 
mm from the coil center in two orthogonal directions.
table I. snR measured from the single- and dual loop design rigid endoluminal coil on 3t MR system.    
r (mm) SNR single loop at  00 SNR single loop at  900 SNR dual loop  at  00 SNR dual loop at  900
11 414 370 587 569
15 257 206 334 348
19 167 118 244 242
23 119 76 161 156
27 90 42 98 98
31 70 39 72 87
35 53 31 55 56
39 42 27 44 53
43 34 23 36 42
47 26 20 32 29
r (mm): distance from the center of the coil measured in mm. 
SNR single loop: measurements in two orthogonal directions.
SNR dual loop: measurements in two orthogonal directions.
a b c
Figure 2. Dual loop design: Calculations of the H1 field profile (A), axial MRI image on phantom containing 0.9% 
NaCl and 20mMol CuSO4 (B) and associated  iso- contour plot (C) show the circular field profile which is in accor-
dance to the calculated profile. Calculations were performed using  the mathematical program MatLab®. 
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The SNR of the dual coil array exceeds that of the single loop coil at any distance, with an 
average increase of  35 % at 20 mm. 
Coil construction and specifications
Coil specifications
Coil former : Delrin®
Coil former  : Length 70 mm; diameter 15 mm.
Coil housing : Length  20 mm, diameter: 18 mm
Preamplifier : MWT®, MSM128281C
All capacitors  : ATC®
RF inductors : Coilcraft®
All diodes : Macom®
To ensure mechanical stability in the dual loop design, both coils were winded on a cylindri-
cal former with groves to secure the loop coils. Circuitry was built on pcb which connect 
directly to the coils. To minimize transmission losses, the preamplifiers were integrated on 
the PCB, which holds the tuning and matching circuits. The crosstalk between the coils is 
reduced to -30 dB by proper mechanical adjustment of the orthogonal position. The loop 
wires are isolated from each other by using classical decoupling with preamplifiers built 
directly onto the coils. The isolation resulting from the preamplifier decoupling is 17dB. The 
T/R  (coil decoupling during transmit) switch is built in a classical way by inserting an induc-
tor in a parallel fashion over one of the coil capacitors. Decoupling is realized by enabling a 
PIN diode (MA4P7461F). The off-gating detunes the coil by another 23 dB. Figure 3 shows 
the pcb assembly (A) and coil complete with housing (B).  
According to Faraday’s law, rf electromagnetic fields may result in induced currents in the 
transmission line of the coil, which may interfere with the local excitation field and cause 
artifacts (Fig 4A). To minimize these braiding currents rf- traps have been installed at every 
1/8  λ (=23 cm) with a high impedance factor and an attenuation of 20 dB per trap (Fig 4B). 
The final result is a homogenous cylindrical H
1
 field over the total length of the coil (Fig 5). 
Figure 3. The current rigid endoluminal coil on 3T. A) PCB assembly, B) Complete with housing.
a b
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cLInIcaL aPPLIcatIon
Preparation for use in patients
The coil should be cleaned conform procedures for Ultrasound endocavitary probes. Clean-
ing the coil with 70% medical alcohol is sufficient. The device is  covered with a condom 
before application. For each patient a new condom must be used. In case of rupture or 
damage of the condom above cleaning procedure is not sufficient and sterilization is man-
datory. Patient needs to be positioned head-first in the MRI scanner. Before insertion a lu-
bricant over the condom is applied. We use a thin layer of hydrophile ultrasound gel for 
this purpose. For endoanal insertion the patients is positioned in the left lateral decubitus 
position after which the patient needs to be carefully positioned in the prone position. For 
endovaginal insertion, the patient is asked to insert the device herself. On coronal and sagit-
tal survey images, the right postion of the coil is confirmed or adjusted and scan planes are 
planned. 
a b
Figure 4. A) Phantom image acquired with the endoluminal coil showing an artefact caused by standing waves 
on the transmission line. B) Schematic display of rf- traps installed along the transmission line to minimize braid-
ing currents.
Figure 5. Test MR images (3T) on phantom (containing an aqueous solution of 0.9% NaCl and 20mMol CuSO4) on 
3T with a homogenous H
1
field on consecutive axial slices resulting in an almost perfect cylindrical field produced 
by the dual coil array.
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Endoluminal coil versus pelvic phased array imaging
Previous studies found the eCoil to be superior to the phased array coil for demonstration 
of anal sphincter anatomy and perianal fistula disease (6, 7). Endoanal MRI is especially valu-
able for classification of the primary tract and identification of the internal ostium (Fig. 6) 
in cryptoglandular fistula’s (7-10). Because of the limited field of view, the phased array was 
especially superior for demonstration of distant fistula extensions (11, 12). 
Endoanal MRI is highly accurate in demonstrating lesions of the sphincter complex (Fig. 7) 
(13-15). Sphincter damage is especially seen in patients with chronic fistula and previous 
surgery and is important for surgical planning (Fig. 8). For prostate cancer imaging, studies 
have shown superior image quality and improved reader confidence using an ERC in stag-
ing performance for prostate cancer at 3T when compared with pelvic phased array coil at 
3T (2, 3). For female urethral diverticula, endoluminal coil demonstrated better subjective 
image quality with endovaginal  placement when compared with endoanal placement or 
Pelvic phased array versus endoanal coil imaging
Figure 6. 48-year-old woman with MRI after surgery 
(incision and drainage perianal abcess, including 
seton drain placement in fistula). On the external 
phased array image (A) no obvious lesions are seen; 
conversion with the endoanal coil (1.5 T) demon-
strates a subsphincteric fistula with drain in situ 
(arrow) (B), including the patent ostia of two fistula 
tracks (12 and 1 o’clock position). Arrowheads indi-
cate scar tissue. Axial T2W TSE with fat saturation (A) 
and without (B,C). 
a b
c
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phased array coil imaging (Fig. 9)(4). All these studies were based on imaging with the 
single loop coil design. In addition, vaginal endocoil imaging proved valuable for diagnosis 
and preoperative assessment of periurethral disease (Fig. 10)(5).
Dedicated endoanal imaging correlated with symptoms
Figure 7. a) 47- year-old woman with active transsphincteric fistula (arrow) in 2007. B) Post- surgery  MRI in 2009 
because of persistent anal pain demonstrates fibrosis in the old fistula tract (dashed arrow) and no evidence of 
active disease. C) Repeat MRI in 2013 because of increased pain, soiling, including bloody content, and no obvious 
abnormalities found at initial clinical examination. Small submucosal abscess is noted at the level of the original 
internal ostium. All images: axial: T2W TSE  on 1.5 T. D) Axial reconstructed sagittal T2W cube image affirms the 
small submucosal abscess which was surgically confirmed.
a b
c D
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Dual loop versus single loop design 
We found two clinical publications on the dual loop design of an endoluminal pelvic coil; 
both were applied for prostate imaging. An investigational dual-channel next-generation 
endorectal coil (NG-ERC) was compared with the current clinically available single-loop en-
dorectal coil (ERC) at both 1.5 and 3 T (16). The authors found that the SNR was higher for 
the NG-ERC compared with the ECR. Overall, T2-weighted image quality was considered 
better for NG-ERC at both field strengths. In addition,  a  two-channel solid reusable phased 
array endorectal receiver coil (SPAC) was compared with a single-channel inflatable en-
dorectal balloon coil on 1.5 T MRI (17). SNR of the SPAC was significantly better compared 
sphincter damage with focal fat versus active fistula 
Figure 8. 34-year-old man with chronic perianal fistula, including sphincter damage. A) Axial T2W TSE image 
with a local defect of the external sphincter, including fatty tissue deposition on the right which is evident on 
the T2W image with fat saturation in B) depressed signal intensity (SI). At the level of the puborectalis muscle an 
active fistula (arrow) is seen with high SI on both, the axial T2W TSE image without (C) and with  fat saturation (D).
a b
c D
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with that of the balloon coil. Both SNR and image quality were significantly improved with 
use of the SPAC at 1.5 T compared with the single-channel inflatable endorectal balloon 
coil. In addition, both studies showed that the dual loop design can reduce patient imag-
ing time without loss in image quality compared with that of a single-channel balloon 
endorectal coil. The increase in SNR can be used to increase the spatial resolution (Fig. 11). 
To our knowledge, no studies were performed that directly compare image quality in the 
same patient cohort with similar setups at the two field strengths. Because of the increase 
in spatial resolution at 3 T it is expected that images will be of higher quality when com-
pared with 1.5 T (Fig. 12).
Female urethral diverticulum
Figure 9. 53-year-old woman with an uncertain 
periurethral lesion (arrow) on screening CT for per-
sistent retropubic pain. A) Subsequent  MRI with the 
endoluminal coil in de vagina on 3T demonstrates a 
semicircular urethral diverticulum, including level of 
the internal ostium (arrow) in B) and diverticular neck 
(arrow) in C. B,C: Axial T2W TSE images.
a b
c
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Patient tolerance of the endoluminal coil
The use of endoluminal coils may be impossible in case of anal stenosis or severe local pain 
. Studies found that the endoanal coil could not be inserted in 3-17 % of  patients respec-
tively (8, 18). In a study of MRI in patients with clinical occult anal and perianal pain  7% of 
cases the endoluminal coil could not be used because of severe pain or patient preferance 
for the phased array pelvic coil (19). A prospective comparison of an inflatable endorectal 
coil with a rigid endorectal coil for prostate imaging proved significant increased patient 
discomfort with the inflatable design (20).  
cyst of skene, pelvic phased array versus endoluminal coil imaging 
Figure 10.  23- year-old woman with dysuria and palpable periurethral mass. A, B) On initial MRI with the phased 
array coil on 3T, the lesion  is hard to discern on axial (A) and sagittal (B) T2WTSE image. C, D) Repeat examination 
with the endovaginal coil on 3T demonstrates a cyst (arrow) in the left periurethral region which is consistent 
with a cyst of Skene (surgery and pathology confirmed). The displaced urethra can be identified on the right (D). 
a b
c D
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MRI protocol 
With endoluminal MRI we aim to aquire accurate morphologic images. Image volume en-
compasses the entire sensitive region of the coil with recommended field of view of 120 
single loop versus dual loop endoluminal coil design on 1.5 t 
Figure 11. A) 68-year-old man with low transshpincteric fistula (arrow) after insertion of a seton drain in 2005. 
B) Repeat MRI in 2013 after successful treatment with a fistula plug. Note the better detailed image including, 
homogeneous signal intensity with no signal voids with the current endoluminal coil (dual loop design) on 1.5 T 
when compared with the old single loop design in (A). 
a b
Improved sRn on 3t versus 1.5 t
Figure 12. 43-year-old woman A) 1.5 T in 2009, B) 3.0 T in 2011. Patient underwent  MRI for evaluation of urethra 
diverticulum (not shown) in 2009 and follow up MRI after surgery in 2011. Endoluminal coil in the vagina. Better 
image quality due to increase in SNR and larger field of view can be noted on 3T. Both, axial T2W TSE images. Ar-
rows demonstrate the periurethral ligaments which are more clearly observed in B.
a b
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mm, matrix: 256x256 – 256x384, slice thickness/gap 2/0.2- 2.5/0.3 mm. For perianal fistula 
imaging T2-weighted (T2W) turbo spin-echo (TSE) sequences in three planes (axial, coronal, 
and sagittal), including  axial T2W with fat saturation (fat sat) imaging is recommended. For 
female urethral and periurethral imaging: T2W TSE in three planes (axial, coronal, and sagit-
tal), including axial T2W fat sat and T1W is recommended. With this concise protocol, scan 
times may be limited to an average of 20 minutes per patient.
Pitfall: technical artefact 
Figure 13. 32-year-old man with active intersphinc-
teric fistula on the left (arrow) on axial T2W TSE 
image. Two regions of signal voids are noted on 
the right. These are technical artifact because of a 
dysfunctional rf- traps and  may be misinterpreted 
as focal fibrosis. The blooming nature suggests an 
artefact.
Pitfall: MR imaging of perianal pain.
Figure 14. 40-year-old man, seventeen years after surgical drainage of perianal abscess with persistent and in-
creasing anal and perianal pain for almost a year. A, Endoanal MRI revealed only a thickened anococcygeus  liga-
ment. B, Whole pelvic imaging with the pelvic coil (axial T2W TSE) demonstrates a tumor at the sacrococcygeus 
joint (arrow) which was confirmed as an adenocarcinoma of unknown primary. For screening studies in patients 
with pelvic pain whole field imaging of the pelvis is recommended.
a b
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For extensive fistula disease (e.g. Crohn’s disease), perianal or periurethral pain, evaluation 
of prolapse or malignancy, imaging of the entire pelvis with the phased array multicoils is 
needed. To evaluate for prolapse, a dynamic true fast imaging with steady-state free preces-
sion (true FISP) or HASTE sequence in the midsagittal plane may be performed. When ma-
lignancy is suspected, lesion detection and characterization may be enhanced with diffu-
sion-weighted imaging and dynamic contrast enhanced series after iv Gadolinium chelates. 
Pitfalls in endoluminal coil MR imaging 
Pitfalls in imaging using the endoluminal coil can be categorized in technical artefacts (Fig. 
13) which may be confused for pathology and the limited field of view of the coil with 
failure to capture lesions outside the sensitive region of the coil (Fig. 14, 15). Especially in 
obese patients upper anal canal and anorectal region may fall outside the field of view.  In 
these cases endoluminal coil imaging is not sufficient and application of the pelvic phased 
array coil is advised. It is therefore recommended to view the examination for completeness 
before the patient is dismissed. 
Future perspective
Theoretically, an increase in SNR may be achieved by applying four loops rather than two 
like in the current approach. By arranging the four elements two by two in series the SNR 
could be increased without suffering loss of field homogeneity in the radial direction. Less 
decrease in SNR at increasing distance from the coil could also be expected when com-
pared to the dual loop configuration. An obstacle though, will be the limited space for 
Pitfall: MR imaging of superficial extended fistulas 
Figure 15. 69-year-old man with extensive superficial fistulas in the left nates. In A) the lesion is hard to discern on 
the lower slice (T2W image with fat saturation) with the endoluminal coil. B) Conversion with the pelvic phased 
array coil demonstrates the fistula (arrow) on the left in full extent from buttocks to scrotum. In addition, a small 
fistula is seen on the right  (Axial T2WTSE with fat saturation)  It is recommended to confirm that the field of view 
is sufficient before regarding the examination as complete. 
a b
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installation of all components  within current coil housing. Currently a version is being stud-
ied for endorectal application, including use of flexible material to adjust for  the anorectal 
angle. Coupling of the endoluminal coil to an external receiver coil array may further in-
crease the volume to be imaged. For this configuration proper matching and tuning of all 
components (endoluminal-, external coil  and MR system) is required. For prostate imaging 
this configuration, using a single loop coil, resulted in significant improvement of anatomic 
details, extracapsular extension accuracy and specificity (2). We believe that stepwise tech-
nical improvements should be pursued  based on clinical need.
concLusIon 
The endoluminal coil has been technically improved with the dual- loop design, including 
an increase in SNR over the previous generation single loop coils. The dual loop endolumi-
nal receiver coil may allow for better diagnosis through improved spatial resolution without 
increase in imaging time compared with the single loop coil. 
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abstRact
Most cases of fistula-in-ano are nonspecific and result from inflammation of anal glands and 
crypts (cryptoglandular). The classification of cryptoglandular fistulas depends on the de-
gree of involvement of the anal sphincter complex and determines the type of treatment. 
Studies have shown that preoperative MR imaging revealed important additional informa-
tion compared with surgery alone and better predicts clinical outcome of patients with 
fistula-in-ano than initial surgical exploration. With the emergence of novel surgical treat-
ments like MRI-guided surgery, laser, and adhesive treatments, MR imaging is a mainstay 
for pre-procedural and intra-operative evaluation to ensure the adequacy of the procedure. 
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IntRoDuctIon
Fistula-in-ano is an abnormal communication between the anal canal and the perianal 
skin. Perianal abscess is an acute manifestation and fistula-in-ano a chronic condition of 
the same disease (1). In the surgical literature, cryptoglandular fistulas and abscesses are 
distinguished from fistulas and abscesses due to an underlying disease such as Crohn’s 
disease (2). Fistulas resulting from an underlying disease are termed specific. Most cases 
of fistula-in-ano are nonspecific and result from inflammation of anal glands and crypts 
(cryptoglandular) (3,4). Anal glands, slightly more numerous in men than in women, are 
located at the level of the dentate line of the anal canal and sometimes penetrate through 
the internal anal sphincter and intersphincteric space into the ischioanal space (3). Infection 
of these glands due to predisposing factors such as an acute episode of diarrhea or trauma 
plays an essential role in the development of cryptoglandular fistulas (5,6) (Fig 1). The preva-
lence of this type of fistula is said to be approximately 10 per 100,000 of the general popula-
tion (5). Specific or Crohn’s fistulas and abscesses result from transmural spread of chronic 
granulomatous inflammation (3,6). The prevalence of Crohn’s disease varies between 3 and 
7 per 100,000 of the general population (3,6). Approximately 36% of Crohn’s patients have 
perirectal disease, which results in the specific type of pelvic fistulas and abscesses (3,6). 
Perianal fistulas may also be caused by other conditions and events, including tuberculosis, 
trauma during childbirth, pelvic infection, pelvic malignancy, and radiation therapy.
This report describes the current views on diagnosis and treatment of perianal fistula dis-
ease. Recent developments in preoperative imaging with emphasis on magnetic resonance 
imaging (MRI) and pitfalls on MRI will be described and illustrated.
Figure 1. Anal sinus (pre-fistula stage). An anal sinus is a localized infection of the anal glands and crypts. (A) Axial 
T2-weighted fast spin-echo (FSE) endoanal MR image ( TR/TE = 2000/150 ms). (B) Coronal T2-weighted FSE image 
( TR/TE = 2136/120 ms). A well-circumscribed lesion with high signal intensity on T2W images (arrow) can be seen 
submucosally. There are no additional fistula tracts. An anal sinus can heal completely or progress into a fistula. This 
patient had complaints of perianal pain in the last month, especially during defecation, without perianal discharge. 
E, external anal sphincter; I, internal anal sphincter; P, puborectalis muscle; L, levator ani muscle; Endoanal coil (*).
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DIagnosIs anD cLassIFIcatIon
Perianal fistulas and abscesses are often diagnosed clinically, based on typical symptom-
atology and physical examination (5). The exact relationship between the fistula and the 
anorectum, in particular the anal sphincter complex, is often not evident at physical exami-
nation. The classification of cryptoglandular fistulas depends on the degree of involvement 
of the anal sphincter complex and determines the type of surgical treatment. In addition 
to digital examination, rectosigmoidoscopy with or without mucosal biopsies and care-
ful cannulation of the external opening with fistulography are traditional techniques for 
fistula evaluation. Fistulography, however, is an unreliable technique because the sphincter 
complex is not directly visualized, and the level of the internal opening in the anal canal 
is difficult to visualize because of the absence of precise anatomic landmarks. In addition, 
secondary fistulous tracks often fail to fill with contrast material (7,8). Cross-sectional imag-
ing modalities, such as computed tomography, ultrasound, and MR imaging, have become 
standard imaging techniques for classification of perianal fistulas and abscesses. Comput-
ed tomography, performed with rectally and intravenously administered contrast media, 
Figure 2. Classification of perianal fistulas according to Parks et al.14 (A) Intersphincteric fistula located between 
the internal (1) and external anal sphincter (3). (B) Trans-sphincteric fistulas (arrow) cross these muscles and run 
in the ischioanal space. (C) Suprasphincteric and (D) extrasphincteric fistulas are rare and show a complex course. 
Puborectalis muscle (4) and levator ani muscle (5). (Modified from Parks et al. (14))
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showed some early promise (9,10). However, the attenuation values for the sphincters, leva-
tor ani, fibrotic fistulous tracks, and active fistulas are so similar that it is difficult to charac-
terize these structures accurately, unless the track contains gas or leaked contrast material. 
Anal endosonography (AES), though also promising, has proved inferior to expert clinical 
assessment (11). The external sphincter can be difficult to assess in some individuals. In ad-
dition, infection cannot be distinguished from fibrosis with this technique, and insufficient 
depth penetration results in a failure to identify secondary fistulous extensions in some 
cases (4,11). 
Contrast-enhanced (with hydrogen peroxide) AES appears to be superior to non-contrast 
AES in the preoperative assessment of anal and anovaginal fistulas and in demonstrating 
and locating their internal openings (12). West et al. showed good agreement between 
hydrogen peroxide-enhanced three-dimensional AES and endoanal magnetic resonance 
imaging especially for classification of the primary fistula track and location of the internal 
opening compared with surgical findings in patients with a visible external opening of peri-
anal fistulas. However, there is no place for contrast enhanced EAS when an external open-
ing is not visible or cannulation of the external opening is not possible (13). 
Due to the multiplanar capability and high inherent soft tissue contrast, MR imaging has 
been suggested as the modality of choice for classification of perianal fistulas and abscesses 
(4,5). Cryptoglandular fistulas, predominantly located at the level of the anal canal and direct 
surroundings, can be classified according to the classification by Parks et al (14) (Figs 1 and 
2). This classification is used most often. Recently Morris et al presented a classification of 
five MR imaging- based grades. If the ischioanal and ischiorectal fossae are unaffected, dis-
ease is likely confined to the sphincter complex (Grade 1, simple linear intersphincteric fis-
tula; Grade 2, intersphincteric fistula with abscess or secondary track), and outcome follow-
ing simple surgical management is favorable. Involvement of the ischioanal or ischiorectal 
fossa by a fistulous track or abscess indicates complex disease related to trans-sphincteric or 
suprasphincteric disease (Grade 3, trans-sphincteric fistula; Grade 4, trans-sphincteric fistula 
with abscess or secondary track within the ischiorectal fossa) (15). Correspondingly, more 
complex surgery may be required that may threaten continence or may require colosto-
my to allow healing. If the track traverses the levator plate, a translevator fistula is present 
(Grade 5, supralevator and translevator disease), and a source of pelvic sepsis should be 
sought. Studies have shown that preoperative MR imaging revealed important additional 
information compared with surgery alone and better predicts clinical outcome of patients 
with fistula-in-ano than initial surgical exploration (16,17).
tReatMent
The treatment of cryptoglandular fistulas is mainly surgical, with a number of options. To 
understand the surgical options for treating fistulous disease, one must first consider the 
anatomy and function of the anal sphincters and the causes of perianal fistulas. The internal 
sphincter is involuntary and is composed of smooth muscle continuous with the circular 
smooth muscle of the rectum. It is responsible for 85% of resting anal tone. In most individ-
uals, it can be divided without causing a loss of continence. The external sphincter is com-
posed of striated muscle and is continuous superiorly with the puborectalis and levator ani 
muscles. It contributes only 15% of resting anal tone, but its strong voluntary contractions 
resist defecation (15). A division of the external sphincter can lead to incontinence. Preser-
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vation of fecal continence is a paramount consideration, and treatment strategies aim to 
preserve the integrity of the external sphincter. Fistulotomy, fistulectomy, drain placement, 
advancement flap closure, and fecal deviating colostomy are traditional techniques for fis-
tula surgery (2,6). Fistulotomy, which denotes only the unroofing of a fistula, is preferred 
to fistulectomy, which involves the unroofing and coring out of a fistula in combination 
with excision of the sphincter muscle below the level of the internal opening. In general, 
intersphincteric and low trans-sphincteric fistulas are preferably treated with fistulotomy, 
whereas other types of fistulas require stepwise or modified procedures. The treatment of 
perianal abscesses, due either to cryptoglandular disease or Crohn’s disease, is incision and 
drainage (2,6,18). Fecal deviating colostomy is reserved for patients with uncontrollable ex-
tensive perianal fistulous disease and severe clinical symptoms, which usually is associated 
with Crohn’s proctitis (6). Novel surgical treatments include laser and adhesive treatments. 
The use of laser ablation or fibrin glue to treat fistula seems attractive, especially in more 
complex fistulas (19,20). There are promising reports of human granulocyte colony stimu-
lating factor, as an alternative to fibrin glue in the treatment of perianal Crohn’s fistula (21). 
MRI-guided surgery for anal fistula is feasible. Pre-procedural and intraoperative MRI tech-
niques can be used to identify the extent of the fistula tracts and septic foci and to ensure 
the adequacy of the surgical procedure. It can thus prevent an incomplete procedure and 
the potential requirement for a second operation. It may become particularly useful in sur-
gery for recurrent and complex anal fistulas and may lead to fewer recurrences (22).
MRI oF PeRIanaL FIstuLa DIsease
Cryptoglandular Fistulas
A typical cryptoglandular fistula has an internal opening at the level of the anal canal, a 
primary tract, and an external opening (5). Occasionally, cryptoglandular fistulas have a sec-
ondary tract, a horseshoe shaped spread, an abscess, and more than one external opening.
At T2-weighted MR images, fistulas have a distinct appearance, with a central high signal 
intensity tract that is surrounded by a relatively low signal intensity wall (5). Presumably, the 
inner high signal intensity region of fistulas consists of the true lumen and granulation tis-
sue, and the outer part of fistulas with lower signal intensity is comprised of fibrotic tissue. 
The ratio of high and low signal intensity areas is expected to decrease as a fistula becomes 
more chronic, which is consistent with the development of an increasing amount of fibrotic 
tissue (4,5). Most of the MR images of cryptoglandular fistulas shown in the present review 
were acquired by using an endoanal coil at a 1.5 T MR imager (Gyroscan NT Intera 1.5; Philips 
Medical Systems, Best, the Netherlands). The endoanal coil is commercially available (Philips 
Medical Systems) and consists of a fixed, rectangular, 60 mm long rigid receiver with a width 
of 16 mm. The coil is contained within an 80 mm long cylindrical coil holder with a diam-
eter of 19 mm. Before the introduction of the coil into the anal canal, a condom was placed 
over the coil and ultrasound gel was used as a lubricant. The coil was introduced while the 
patient was lying in the left lateral position. After the coil was introduced, each patient care-
fully turned onto his or her back, and the position of the coil was rechecked. For MR imag-
ing sequences, the following parameters are suggested: axial three dimensional turbo spin 
echo images [repetition time ( TR) = 2000 ms, effective echo time ( TE) = 150-170 ms, field of 
view = 140 mm, matrix = 68 x 256, slice thickness = 2 mm without gaps, 60 slices], coronal, 
and sagittal two-dimensional turbo spin-echo images ( TR = 2100 ms, effective TE = 120 ms, 
field of view = 120 mm, matrix = 205 x 256, slice thickness = 4 mm/0.4 mm).
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At MR imaging, the identification and localization of the entire cryptoglandular fistula, in-
cluding the external opening, the primary tract, secondary tracts, abscesses, and the inter-
nal opening, are essential for fistula classification and treatment. Fistulas with unrecognized 
Figure 3. Intersphincteric fistula. (A) Sagittal T2-weighted fast spin-echo endoanal MR image ( TR/TE = 2443/100 
ms) with an intersphincteric fistula (arrows) displayed in full extent. (B) Sagittal slice next to (A) shows an internal 
opening (arrowhead) in the lower part of the fistula. I, internal anal sphincter; E, external anal sphincter; P, puborec-
talis muscle; endoanal coil (*). Compare with Fig. 1, which illustrates the classification of perianal fistulas according 
to Parks et al.14
Figure 4. Low trans-sphincteric fistula. (A) Axial T2-weighted fast spin-echo (FSE) endoanal MR image ( TR/TE = 
2000/170 ms). An active fistula with high signal intensity (arrow) is seen tracking through the external sphincter 
muscle (E) on the left. Endoanal coil (*). (B) Coronal T2-weighted FSE image 
( TR/TE = 2136/150 ms). The fistula (arrow) is displayed almost to full extent tracking through the lower half of the 
external anal sphincter. The internal opening of the fistula in the anal canal (arrowhead) is clearly demonstrated. 
E, external anal sphincter; I, internal anal sphincter; P, puborectalis muscle; L, levator ani muscle; endoanal coil (*).
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Figure5. High trans-sphincteric fistula with secondary extension. (A) Coronal T2-weighted fast spin-echo endoanal 
MR image ( TR/TE = 2443/100 ms) shows a high trans-sphincteric fistula (arrows) with the internal opening (arrow-
head) at the level of the junction of the puborectal muscle (P) and the levator plate (L). E, external anal sphincter; 
endoanal coil (*). (B) On the next coronal slice one can see an extension of fistula (arrow) within the left sided 
levator ani muscle causing local thickening (compare with the right sided levator ani muscle). Endoanal coil (*).
Figure 6. Intersphincteric abscess. (A) Axial T2-weighted fast spin echo (FSE) endoanal MR image ( TR/TE = 
2500/100 ms). Circumferential spread of fistula to the left (long arrow) predominantly within the intersphincteric 
space; also small extension of fistula is seen within the puborectalis muscle (arrowhead). In the midline posteriorly, 
local widening of the fistula (arrows) can be seen in the intersphincteric space, indicative of an abscess. I, internal 
anal sphincter; P, puborectalis muscle. (B) On the mid-sagittal T2-weighted FSE 
( TR/TE = 2454/100 ms) image the abscess can clearly be demonstrated (arrowheads). Note that part of the fistula 
(arrow) with an internal opening in the anal canal (small arrow) can also be seen on this slice. E, external anal 
sphincter; endoanal coil (*).
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Figure 7. Horseshoe-type fistula with fluid collection. (A) Axial T2-weighted fast spin-echo (FSE) endoanal image ( 
TR/TE = 2500/100 ms). Multiple circumferential spread of fistula tracks within the sphincter complex (arrowheads) 
with a fluid collection in the ischioanal space posteriorly (arrows). Please note the multiloculated aspect of the fluid 
collection with slightly different signal intensity within, suggestive of a chronic abscess. Endoanal coil (*). (B) On the 
coronal T2-weighted FSE image ( TR/TE = 2443/100 ms) fistula extensions are also seen cranially within the external 
sphincter and puborectalis muscles (small arrows) and in the levator ani muscle (L) on the right (thick arrow). On 
the left cranial extension of a fistula track is seen into the rectal wall (arrowheads). R, rectum; endoanal coil (*).
Figure 8. Concurrent perianal and anovaginal fistula. (A) Axial T2-weighted fast spin-echo (FSE) endoanal MR im-
age ( TR/TE = 2454/100 ms) with a perianal fistula (arrow) anteriorly extending from the anal canal to the lower part 
of the vagina. Local widening of the fistula tract (arrowheads) at the level of the rectovaginal septum can be seen, 
indicative of a small abscess. V, vagina; endoanal coil (*). (B) On the mid sagittal T2-weighted FSE image 
( TR/TE = 2443/100 ms), the anovaginal fistula track is demonstrated with the internal opening in the anal canal 
(arrowhead) and the internal opening in the vagina (thick arrow). The perianal fistula track (small arrows) is also 
demonstrated on this slice. V, vagina; endoanal coil (*).
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components may cause problems during surgery and are more likely to recur (2,4,6). Cryp-
toglandular fistulas are often relatively small and are located close to the anal sphincter 
complex (4,6). MR imaging with an endoanal surface coil provides high resolution images of 
the anal sphincter complex and is also accurate in the depiction and classification of crypto-
glandular fistulous disease (4). If one considers the anatomic knowledge obtained by using 
the endoanal coil, MR imaging with a phased array coil may also be sufficient for classifica-
tion of cryptoglandular fistulas (23,24). Localization of the internal opening with respect 
to the anal verge and anal sphincter complex is the first and most important step for the 
classification of the cryptoglandular fistulas (6). After identification of the primary tract, the 
distinction between an intersphincteric (Fig 3) and a trans-sphincteric (Figs 4 and 5) tract 
Figure 9. Crohn’s disease; phased-array coil versus 
endoanal coil. (A) Axial 
T2-weighted fast spin-echo (FSE) phased- array MR 
image ( TR/TE = 3000/128 ms) shows extensive scar-
ring with a large fistula in the  ischiorectal space 
posteriorly (arrowheads). Pr, prostate gland; C, os 
coccygeus; O, obturatorius internus muscles; G, glu-
teus maximus muscles. (B) Axial T2-weighted FSE 
endoanal image ( TR/TE = 2000/150 ms). The same 
level as (A) imaged with the endoanal coil. Structures 
within the near field of the coil (I, internal sphincter; 
P, puborectal muscle; Pr, prostate gland) are displayed 
with greater detail compared with (A). In A, a larger 
overview of the anatomic region is demonstrated 
due to the larger field of view of the phased-array coil 
compared with the endoanal coil (*). (C) Axial 
fat saturated T1-weighted gradient echo phased-
array image ( TR/TE = 375/3.2 ms),  obtained after in-
travenous administration of gadolinium-DTPA. Same 
level as A with intense enhancement of the inflamed 
region (arrows), as well as the walls of the fistula track 
(arrowheads). Extensive disease can favor the use of surface coils to obtain as much information as possible with 
the larger field of view compared to the endoluminal coils. Also the use of intravenous gadolinium in combination 
with fat suppression techniques may increase the conspicuity of the lesions, allowing the diagnosis to be made 
with confidence.
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is often a challenge. Typically, an intersphincteric tract runs in a straight or a spiral path be-
tween the internal and the external anal sphincters within the intersphincteric space (Fig 3). 
A typical trans-sphincteric tract runs through the external anal sphincter into the ischioanal 
space (Fig 4 and 5). The distance between a trans-sphincteric tract and the external anal 
sphincter may differ; some tracts run directly outside the external anal sphincter, whereas 
others are located a few centimeters from it. Secondary tracts are the side branches of a 
primary tract (Figs 5 and 6). In 5% to 15% of patients with cryptoglandular fistula disease, 
secondary extensions outside the anal sphincter are present (2,25). If present, secondary 
tracts are relatively small, and abscesses may or may not be present (Figs 6 and 7). 
Any widening of the primary or the secondary tract is considered a fistulous abscess (1). 
MR imaging enables direct multiplanar visualization of the anatomic structures and spaces, 
which facilitates the detection and localization of secondary tracts and abscesses. The pres-
ence, size, and exact location of a secondary tract and abscess should be described. Cryp-
toglandular horseshoe shaped fistulas (Fig 7) can accurately be assessed with MR imag-
ing (4,5,26). Any type of fistula may show a circumferential spread, but a typical horseshoe 
shaped fistula has two fistula tracks within the ischioanal space and one internal opening, 
often in the midline posteriorly at the level of the inferior border of the puborectalis muscle. 
Horseshoe shaped fistulas should be distinguished especially from trans-sphincteric fistulas. 
Sometimes one leg of a horseshoe shaped fistula may be shorter than the other, with only 
one external opening. Such a fistula could be misclassified as a simple trans-sphincteric fis-
tula during surgical assessment (4). Anovaginal fistulas with typical symptoms of recurrent 
vaginal infections with vaginal flatus and vaginal defecation can clearly be depicted with 
MR imaging using an endoanal coil (27) (Fig 8).
Figure 10. Subsphincteric fistula. Small fistula track is seen on the right (arrows). (A) Axial 
T2-weighted fast spin- echo (FSE) endoanal MR image ( TR/TE = 2500/100 ms). (B) Coronal T2-weighted FSE image 
( TR/TE = 2443/100 ms). (B) Thin fibrous strand (arrowheads) is seen extending from the fistula to the sphincter 
muscles. Endoanal coil (*).
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Crohn’s Fistulas
Typical Crohn’s fistulas consist of multiple tracks and abscesses. 
A well-defined primary fistula track is often not recognizable (6). The tracks tend to be 
relatively large, often with circumferential or horseshoe shaped spread and intramuscular 
spread (Fig 9). In addition to the anal canal, the tracts may involve the rectum, sigmoid co-
lon, small bowel loops, and other pelvic organs such as bladder and vagina (6). The fistulas 
and abscesses can be located below, within, or above the level of the levator ani muscle. 
There may not be an internal opening at the level of the anal canal. An external opening in 
the perineum may be absent, or there may be several external openings. The use of an intra-
luminal coil can be avoided in favor of phased array multicoils to obtain as much informa-
tion as possible with the larger field of view compared to endoanal coil (3,6). Also the use of 
gadolinium in combination with fat suppression techniques may increase the conspicuity 
of the lesions, allowing the diagnosis to be made with confidence (3,6) (Fig 9).
Figure 11. Pitfalls: fat mimicking fistula. (A) Sagittal 
T2-weighted fast spin echo (FSE) endoanal MR image 
( TR/TE= 2454/100 ms) shows a high signal intensity 
structure (arrows) anteriorly (compare with Fig 4B). 
(B) Axial T2- weighted FSE image ( TR/TE = 2500/100 
ms). The same structure (arrows) in the axial plane. E, 
external sphincter muscle. (C) Axial T2-weighted im-
age obtained with fat saturation ( TR/TE = 5086/100 
ms) of the same level as B demonstrates loss of signal 
intensity of the structure, which is consistent with 
fatty tissue. Please note marked thinning of the ex-
ternal sphincter muscle in B, in this case of atrophy. 
Endoanal coil (*).
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Pitfalls
Medical history, clinical examination, and findings from other investigations may help to 
avoid pitfalls during MR imaging of pelvic fistulas. Small fistulas confined to the subcutane-
ous fatty tissue (sub-sphincteric) (Fig 10) may fall outside the imaging field. Confirmation 
that the region of interest is within the field of view is essential. Fatty tissue may show a 
configuration that mimic a fistula track (Fig 11). This is often seen in cases of atrophy of the 
sphincter muscles where muscle fibers are replaced by fatty tissue. In these cases a fistula 
track can be excluded with confidence on the fat saturated images. Vascular structures can 
sometimes be prominent in the ischioanal fossa (Fig 12). The typical tubular configuration, 
which is continuous with the normal vascular channels (e.g., venous plexus from vagina or 
prostate), helps to make the differentiation from fistulas. Hemorrhoids can resemble small 
submucosal fluid collections on MR images. Fistulas located at the anterior aspect of the 
anorectum may simulate rectovaginal, recto-urethral, or rectovesical fistulas (27).
Figure 12. Pitfalls: vascular structure mimicking 
fistula. (A) Axial T2-weighted fast spin-echo (FSE) 
endoanal MR image ( TR/TE = 2500/100 ms). In the 
ischioanal fossa posteriorly tubular structures (ar-
rows) are seen with low and intermediate signal 
intensity (S.I.). (B) Axial T2-weighted image with fat 
saturation ( TR/TE = 5086/100 ms). With fat saturation 
these structures (arrows) demonstrate intense high 
S.I. and are continuous with the prominent venous 
plexus (arrowheads) around the vagina; findings that 
are  confirmative for vascular structures. Please note 
the typical serpiginous configuration and lack of sur-
rounding scar tissue, which suggests its vascular ori-
gin. V, vagina; U, urethra. (C) On a slice cranial to B, the 
prominent venous plexus (arrows) around the vagina 
is clearly demonstrated. V, vagina; 
Bl, bladder. Endoanal coil (*).
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Clinical correlation is essential. At MR imaging, old inactive fibrotic tissue in the perianal 
region, which sometimes produces perianal pain and simulates a recurrent fistula, may 
be difficult to distinguish from a recurrent or a longstanding active fistula. Imaging dur-
ing a period with clinically evident symptoms, preferably with perianal inflammation and 
fluid discharge, may be helpful. Pelvic abscesses with perianal fistulous tracts may occur in 
Crohn’s disease, AIDS, tuberculous or ulcerative colitis, or amoebiasis or may occur second-
ary to trauma, irradiation, and previous pelvic surgery (4,6). Perianal fistulous tracts with 
fluid collection in the ischioanal fossa may be due to malignant disease, for example, rectal 
mucinous adenocarcinoma (Fig 13). Medical history, symptomatology, and clinical exami-
nation, as well as contrast-enhanced MR imaging are essential to make the differentiation 
from benign fluid collections.
Figure 13. Pitfalls: tumor fistula. (A)AxialT2-weight-
ed fast spin-echo phased array MR image ( TR/TE = 
3583/120ms). Rectal carcinoma with obvious wall 
thickening (arrows) of the lower rectum is demon-
strated. Parts of the thickened wall shows high signal 
intensity (arrowhead) suggestive of mucinous com-
ponent of the tumor. Pr, prostate gland. (B) On a low-
er slice extensive fistulization (arrows) is seen from 
the tumor into the ischiorectal fossa. P, puborectalis 
muscle. (C) Three fistula tracks (arrows) are demon-
strated in the perianal region. An external opening is 
seen posteriorly (arrowhead). A, anal canal.
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concLusIon
The present review illustrates that imaging in the preoperative workup of perianal fistula 
disease is essential. Studies have shown that preoperative MR imaging revealed important 
additional information compared with surgery alone and better predicts clinical outcome 
of patients with fistula-in-ano than initial surgical exploration. With the emergence of novel 
surgical treatments like MRI guided surgery, laser, and adhesive treatments, MR imaging is 
a mainstay for pre-procedural and intraoperative evaluation to ensure the adequacy of the 
procedure. MRI can thus prevent an incomplete procedure and the potential requirement 
for a second operation. In addition, it can also be used as a tool to follow up disease activity.
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3.2
abstRact 
Purpose To evaluate endoanal magnetic resonance (MR) imaging in the assessment of ano-
vaginal fistulas and associated findings.
Material and methods In a retrospective descriptive study, two radiologists systematically 
reviewed MR findings in 20 patients with a clinically proved anovaginal fistula and looked 
for the main fistula tract, the internal opening in the anal canal and/or vagina, secondary 
fistula tracts, abscesses within the rectovaginal septum, and sphincter damage. Interob-
server variability was calculated, and clinical records were searched for possible underlying 
causes that could explain the complexity of anovaginal fistulas. The к value was calculated. 
Patients with or without a complex anovaginal fistula were compared in regard to the pres-
ence of any underlying disease or condition. Statistical significance was calculated with the 
Fisher exact test.
Results In all 20 patients, anovaginal fistulas were identified on T2-weighted MR images as 
predominantly high signal intensity linear abnormalities extending between the anal canal 
and the vagina. In all patients, the fistulas were typically located in the sagittal plane, and 
the mean distance from the anal verge to the fistula was 25.0 mm (range, 13–32 mm). The 
internal opening in the anal canal was detected in all patients. The internal opening in the 
vagina was detected in 19 (95%) patients. In seven (35%) patients, an anovaginal fistula with 
an additional abnormality was found and included an abscess within the rectovaginal 
septum (n= 1), a perianal fistula (n= 3), and a perianal fistula in combination with an abscess 
(n= 3). Defects of the external anal sphincter were present in three (15%) patients. There was 
complete agreement between observers for all items on endoanal MR images, except for 
the presence of secondary fistula extensions (agreement, 90%; к, 0.74). History of obstetric 
trauma, pelvic floor surgery, or Crohn disease was present in 10 (50%) patients. Of these 
patients, six (60%) had a complex anovaginal fistula and four (40%) had a simple anovagi-
nal fistula. In the remaining 10 patients without relevant medical history, one (10%) had a 
complex anovaginal fistula. This difference tended toward statistical significance (P= .057).
Conclusions Endoanal MR imaging allows evaluation of anovaginal fistulas and additional 
abnormalities, such as abscesses within the rectovaginal septum, secondary perianal fistula 
tracts, and sphincter damage.
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IntRoDuctIon
Anovaginal fistula is a socially disabling disease, in which patients pass gas and feces 
through the vagina and experience recurrent vaginal infections. In 5%–15% of patients with 
perianal fistula disease, secondary extensions outside the anal sphincter are present (1,2). 
Previous studies have shown anal sphincter defects to be an associated finding in patients 
with anovaginal or rectovaginal fistulas (3,4). To our knowledge, however, a comprehensive 
evaluation of anovaginal fistulas and a number of associated abnormalities suchc as edema 
and abscesses within the rectovaginal septum, additional fistula extensions, perianal fistu-
las, and concomitant sphincter damage with magnetic resonance (MR) imaging or another 
imaging modality has not been described. Accurate and comprehensive preoperative as-
sessment with imaging of the course of the primary anovaginal fistula and possible second-
ary extensions or abscesses may improve surgical treatment of these fistulas. 
Currently, an anovaginal fistula is diagnosed on the basis of typical clinical symptoms, such 
as recurrent vaginal infection with vaginal flatus and vaginal defecation, and a gynecologic 
or surgical examination performed with general anesthesia. In many institutions, the clinical 
diagnosis or suspicion of an anovaginal fistula is confirmed with imaging studies (5). These 
studies may include conventional fistulography and anal endosonography (6,7). Conven-
tional fistulography may not be possible in many patients because the internal openings of 
the fistulas may not be visible at physical examination. Mainly because of this problem, 
fistulographic findings are reported to be correct in only 16% of patients with anal fistulas 
(6). Endoanal ultrasonography (US) is often inaccurate in the depiction of anovaginal fistulas, 
mainly because endoanal US has inherent low soft tissue contrast (7,8). 
At our institution, endoanal MR imaging is routinely performed in the assessment of peri-
anal fistulas. The role of endoanal MR imaging in the detection and classification of perianal 
fistulas is well established (7). Endoanal MR imaging has proved to be an excellent imaging 
modality in the assessment of anal sphincter anatomy, anal sphincter damage, and perianal 
fistulas (7,9). This modality provides multiplanar images with high inherent contrast reso-
lution and high spatial contrast resolution of the anal canal, rectum, rectovaginal septum, 
and vagina (5,9). In particular, T2- weighted MR imaging sequences can depict lesions, such 
as fistulas and fluid collections, with high signal intensity (10). For surgical planning, the 
exact location of the main fistula and possible secondary extensions or abscesses must be 
established, and sphincter damage must be assessed. Thus, the purpose of this study was 
to evaluate endoanal MR imaging in the assessment of anovaginal fistulas and associated 
findings.
MateRIaLs anD MethoDs
Patients
We retrospectively reviewed all reports of endoanal MR imaging examinations of female 
patients that were performed between January 1997 and June 2000. During this period, 
443 female patients were referred to the MR imaging section at our institution for work up 
of suspected anorectal abnormalities. The MR imaging reports were cross-referenced with 
the clinical records and follow-up data. Our Medical Ethics Committee did not require its ap-
proval or patient informed consent for this study. 
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We found 36 consecutive patients who were referred because of suspected or proved ano-
vaginal fistula. Patients were included in this study if they had either (a) evidence of ano-
vaginal fistula at exploratory surgery or at examination by the surgeon or gynecologist with 
anorectoscopy and/or colposcopy or (b) persistent clinical symptoms of recurrent vaginal 
infections combined with the passage of gas, feces, or both through the vagina. Symptoms 
were present for more than 3 months.
Sixteen patients were excluded from the study because (a) no information was available 
concerning any of the inclusion criteria because patients were referred from other institu-
tions (n = 9), (b) MR imaging revealed a perianal fistula instead of an anovaginal fistula 
that was subsequently confirmed at surgery (n = 5), or (c) anovaginal fistulas could not be 
confirmed with a gynecologic examination and anosigmoidoscopy (n = 1) or with a barium 
enema examination and general anesthesia (n = 1). Thus, the remaining 20 patients formed 
the study group.
In all 407 patients with endoanal MR imaging reports that were negative for anovaginal 
fistula, a careful search of clinical findings was performed by two authors (S.D., S.M.H.). The 
follow-up period was 2–5 years. In this survey, we were unable to detect any instances of 
anovaginal fistulas that were not mentioned initially on the MR imaging report but were 
subsequently mentioned in the clinical records or proved to exist, either with endoscopic 
or gynecologic examinations or at surgery or follow-up MR imaging. 
The mean age of patients in the study group (n = 20) was 36 years (range, 20–55 years). All 
patients had anovaginal fistulas that were proved with exploratory surgery (n = 12), persis-
tent clinical symptoms of the passage of gas and feces through the vagina with recurrent 
vaginal infections (n= 5), or surgery and/or gynecologic consultation and examination 
(n= 3). Two authors (S.D., S.M.H.) compared MR findings with the detailed descriptions of 
surgical findings in patient records, and patient follow-up status was assessed with clinical 
records and follow-up data available in the hospital information system. 
MR Imaging
All MR imaging examinations were performed by using an endoanal coil with a 1.5-T MR 
imager (Gyroscan NT Intera 1.5; Philips Medical Systems, Best, the Netherlands). The endo-
anal coil is commercially available (Philips Medical Systems) and consisted of a fixed, rect-
angular, 60-mm long rigid receiver coil with a width of 16 mm. The coil is contained within 
an 80-mm long cylindrical coil holder with a diameter of 19 mm. Before the introduction 
of the coil into the anal canal, a condom was placed over the coil and US gel was used as 
a lubricant. The coil was introduced while the patient was lying in the left lateral position. 
After the coil was introduced, each patient carefully turned onto her back, and the position 
of the coil was rechecked. 
In each patient, the following three sequences were used. Transverse T2-weighted con-
trast-enhanced fast field echo imaging was performed (repetition time msec/echo time 
msec, 23/14; acquisition time, 5 minutes 39 seconds; matrix, 205 x 256; flip angle, 60°; field 
of view, 140 mm; section thickness, 2 mm with no gaps; and two signals acquired). Contrast- 
enhanced fast field echo is a term used by Philips Medical Systems and does not indicate 
contrast material administration. Transverse T2-weighted fast spin echo [SE] MR imaging 
was performed with and without fat saturation (5,086/100; acquisition time, 2 minutes 23 
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seconds; matrix, 186 x 256; flip angle, 90°; field of view, 120 mm; section thickness, 4 mm 
with a 0.4-mm gap; and three signals acquired). Coronal and sagittal T2-weighted SE MR 
imaging was performed without fat saturation (2,454/ 100; acquisition time, 2 minutes 34 
seconds; matrix, 186 x 256; flip angle, 90°; field of view, 120 mm; section thickness, 4 mm 
with a 0.4-mm gap; and four signals acquired).
Image Review
All MR images were transported from local digital media to a viewing station and were 
systematically and independently reviewed by two radiologists. Interobserver variability was 
calculated on the basis of the к statistics. After calculating the к value, images with disagree-
ment were reevaluated with both observers working together, and consensus was reached. 
One radiologist (S.D.) had 1 year of experience in abdominal imaging, which included MR 
imaging of the pelvic floor, and the other (S.M.H.) had practiced abdominal imaging for 6 
years, with scientific interest in MR imaging of abdominal and anorectal diseases. All MR 
images were assessed for the following items: (a) the presence of ano- vaginal fistulas, (b) 
the localization of anovaginal fistulas, (c) the distance of anovaginal fistulas from the anal 
verge in the sagittal plane, (d) the internal opening of anovaginal fistulas in the anal canal, 
(e) the internal opening of anovaginal fistulas in the vagina, (f ) the presence of edema or 
abscesses in the rectovaginal septum, (g) the presence of secondary perianal or other 
extensions, and (h) internal and external anal sphincter damage. An abscess within the 
rectovaginal septum was defined as a localized and well circumscribed dilatation of the 
main fistula or secondary extension with high signal intensity on the T2-weighted images, 
while edema was indicated by an ill-defined area of intermediate to high signal intensity 
around the area of the anovaginal fistula. Sphincter damage was identified as a local area 
of low signal intensity on the  T2-weighted images, which indicated scarring or discontinu-
ity of the internal or external anal sphincters. In addition, clinical records were searched by 
two authors (S.D., S.M.H.) for possible underlying conditions or diseases, such as obstetric 
trauma, pelvic floor surgery, or Crohn disease, that could explain the presence of simple 
or complex anovaginal fistulas. According to the literature (5), anovaginal fistulas were 
considered to be simple if only one fistulous tract was depicted that extended between the 
anal canal and the vagina. Anovaginal fistulas associated with any additional fistulous tracts 
or abscesses were considered to be complex (11,12).
Statistical analysis
All MR images were systematically and independently reviewed by two radiologists (S.D., 
S.M.H.). Interobserver variability was calculated on the basis of the к statistics. After cal-
culating the к value, the same two observers reevaluated the images with disagreement 
together, and consensus was reached. The number of patients with a complex anovaginal 
fistula and the number of patients without were compared with regard to the presence 
of any underlying disease or condition, and the significance was evaluated by using the 
Fisher exact test. A P- value less than or equal to .05 was considered to indicate a statistically 
significant difference.
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ResuLts 
There was complete agreement between the observers for all items on the evaluated MR 
images, except for the presence of secondary perianal fistulas or other extensions (agree-
ment, 90%; к, 0.74). 
The main anovaginal fistulas could be identified in all patients on T2-weighted images as 
predominantly high signal intensity linear abnormalities extending between the anal canal 
and the vagina. The fistulas were typically located in the mid- or parasagittal plane, just 
superior to the external anal sphincter (Fig 1). The mean distance from the anal verge to the 
fistula was 25.0 mm (range, 13–32 mm). In all 20 patients (100%), the internal opening of 
the main fistula tract in the anal canal was clearly identified. In 19 patients (95%), the internal 
opening in the posterior wall of the vagina could be seen. One patient had extensive edema 
within the rectovaginal septum, which caused difficulties in the identification of the internal 
opening in the vagina. 
In seven patients (35%), the main anovaginal fistula was associated with one or more addi-
tional perianal abnormalities. In six of these seven patients, the anovaginal fistulas had an 
additional extension with a separate external opening located at the level of the perineum 
(Fig 2). Among these six patients, one had a perianal intersphincteric fistula (Fig 3). Four of 
these seven patients also had one or more small abscesses located close to the main ano-
vaginal fistulas within the rectovaginal septum (Fig 4). Patients without any abscesses in the 
rectovaginal septum showed edema of the septum. In three patients (15%), the external 
anal sphincter had defects (Fig 5). Clinical data indicated that among our patients, 10 
(50%) had underlying Crohn disease, a history of obstetric trauma, or pelvic floor surgery. 
Figure 1. Simple anovaginal fistula. (a) Transverse T2-weighted fast Spin Echo (SE) MR image (2,500/100) shows an 
anovaginal fistula (straight arrow) as a high signal intensity linear abnormality, with direct depiction of the internal 
openings with the anal canal containing the endoanal coil () and the vagina containing some air (upper arrow). 
(b) Sagittal T2-weighted fast SE MR image (2,443/100) confirms the findings of transverse MR imaging and shows 
the relationship of the anovaginal fistula (thin straight arrow) to the lower edge of the anal sphincter complex 
(thick straight arrows) that clinically indicates the position of the anal verge. The vagina ( left arrow), puborectal 
muscle (arrowhead), and endoanal coil () are also shown.
a b
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The remaining 10 patients had no particular disease or condition that could explain the 
presence of anovaginal fistulas. In the 10 patients with an underlying cause, four (40%) had 
a simple anovaginal fistula and six (60%) had a complex anovaginal fistula. All six patients 
with a complex anovaginal fistula had a second perianal fistula, and three of these had an 
additional abscess in the rectovaginal septum. Of the 10 patients without any underlying 
disease or condition, only one (10%) had a complex anovaginal fistula with an abscess in 
the rectovaginal septum. The remaining nine patients (90%) had simple anovaginal fistulas 
( Table). Compared with the simple fistulas, the complex anovaginal fistulas tended to be 
associated with an underlying disease or condition, although the difference was not signifi-
cant (P = .057).
Figure 2. Anovaginal fistula with an additional extension between the anus and the vagina. (a) Transverse T2-
weighted fast SE image (2,500/100) shows a high-signal-intensity anovaginal fistula (thin straight arrow) contain-
ing low-signal-intensity air bubbles (arrowhead). The vagina (upper arrow), external anal sphincter (thick straight 
arrow), and endoanal coil () are also seen. (b) Midsagittal T2-weighted fast SE image (2,443/100) shows the ano-
vaginal fistula (thin straight arrow) and a part of an additional caudal extension (arrowhead). The vagina (upper 
arrow), external anal sphincter (thick straight arrow), and endoanal coil () are also shown.
Underlying Disease or Condition* Anovaginal Fistula 
Simple Complex Total
Present 4 6† 10
Absent 9 1† 10
Total 13 7 20
Note.—Data are numbers of patients.
* Crohn disease, previous obstetric trauma, or pelvic floor surgery.
† Comparison performed with the Fisher exact test. P = .057.
table 1. anovaginal Fistulas in Relation to the underlying Disease or condition
a b
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DIscussIon 
Our results indicate that endoanal MR imaging is suitable for use in the diagnostic work up of 
anovaginal fistulas. In this study, endoanal MR imaging was able to demonstrate the location 
and course of the main anovaginal fistulas in all patients. In addition, endoanal MR imaging 
showed a number of associated abnormalities, such as secondary fistula extensions, perianal 
fistulas, concomitant anal sphincter damage, and edema and abscesses within the rectovagi-
nal septum. To our knowledge and with the exception of anal sphincter damage, such associ-
ated abnormalities have not been depicted with MR imaging or other imaging modalities in 
patients with anovaginal fistulas. It is important to establish the exact location and course of 
the main fistulas and the presence of additional findings for proper surgical management (13).
Figure 3. Anovaginal fistula with an additional peri-
anal intersphincteric fistula. (a) Sagittal T2-weighted
fast SE MR image (2,454/100) shows a high signal in-
tensity anovaginal fistula (thin straight arrow) with a
large internal opening in the anal canal (arrowhead). 
Note edema of the posterior vaginal wall (upper ar-
row). The external anal sphincter (thick straight arrow) 
and endoanal coil () are also shown. (b) Transverse 
T2-weighted fast SE MR image (2,500/100) obtained at 
the level of the puborectal muscle shows a perianal 
intersphincteric fistula (thin straight arrow) between 
the internal anal sphincter (arrowhead) and the pu-
borectal muscle (thick straight arrow). The vagina 
(upper arrow) and endoanal coil () are also seen. (c) 
Coronal T2-weighted MR image (2,443/100) shows the 
intersphincteric fistula with full longitudinal extension 
(thin straight arrows). Note the healthy external anal 
sphincter (thin arrow), the puborectal muscle (thick 
arrow), and the internal anal sphincter (arrowhead) 
on the right side of the anal canal. Also, note that the 
internal sphincter on the left side of the anal canal is 
barely visible, which is mainly due to thinning. The endoanal coil () is also shown.
a b
c
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Anovaginal fistulas have a relatively thin low signal intensity fibrous wall, with a small 
amount of fluid or air present in the tract (7,14). At MR imaging, anovaginal fistulas appear 
as areas of high signal intensity on the T2-weighted images and often contain low signal 
intensity bubbles of air (5,7,14,15). A thin rim of low signal intensity surrounding the fistula 
tract illustrates the fibrous wall (7,14,15). Relatively less active tracts that contain less fluid 
and more scar tissue may appear as linear abnormalities with predominantly low signal in-
tensity (7,14,15). Previously, a number of other imaging modalities, including fistulography 
and transrectal and endoanal US, have been used in the work up of patients with anovagi-
nal fistula (10). In our experience, fistulography is often an inadequate procedure, because 
the internal opening of the fistulas in the anal canal and vagina are not always visible at 
physical examination (6). This makes cannulation for fistulography impossible. Also, this 
Figure 4. Anovaginal fistula with multiple small ab-
scesses in the rectovaginal septum. (a) Sagittal T2-
weighted fast SE MR image (2,454/100) shows a high 
signal intensity anovaginal fistula (thin straight arrow) 
with small abscesses within the rectovaginal septum 
(arrowhead). The endoanal coil () is also shown. (b) 
Transverse T2-weighted MR image obtained with-
out fat saturation (2,500/100) shows the anovaginal 
fistula (thin straight arrow) with multiple abscesses 
(arrowheads) within the rectovaginal septum. The 
vagina (curved arrow), puborectal muscle (thick 
straight arrow), and endoanal coil () are also shown. 
(c) Transverse T2-weighted MR image obtained with 
fat saturation (5,086/100) facilitates improved delin-
eation of the anovaginal fistula (thin straight arrow) 
and multiple abscesses (arrowheads) as high signal 
intensity structures due to the suppressed signal of 
fatty tissue. The puborectal muscle (thick straight ar-
row) is not well delineated due to fat suppression. 
The vagina (upper arrow) and endoanal coil () are 
also shown.
a b
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technique does not allow depiction of the anal sphincter, so the fistula cannot be imaged 
in relation to the anal sphincter complex. It is reported that a correct diagnosis is made with 
fistulography in only 16% of patients with anal fistulas (6). Almost 20 years ago, transrectal 
and endoanal US were introduced and resulted in improved imaging and classification of 
anal fistulous disease (10,13). Yee et al (3) described a retrospective review of records of 
25 female patients who underwent endoanal US before rectovaginal fistula repair. They 
concluded that transrectal US is not useful for imaging rectovaginal fistulas and cannot be 
recommended as a diagnostic or screening tool in the identification of rectovaginal fistulas. 
They did, however, recommend that transrectal US be performed before surgery in all pa-
tients with a known rectovaginal fistula to help identify and map occult sphincter defects 
(3). A comparative study of endoluminal US and endoluminal MR imaging in 28 patients 
revealed that classification is better with endoluminal MR imaging (7). Currently, MR imag-
ing has become a promising modality for imaging of the complex anatomy of the pelvic 
floor and related structures. MR imaging has an excellent soft tissue contrast resolution and 
multiplanar imaging capability, without the need for ionizing radiation (9,10). In our experi-
ence, however, the limited spatial resolution of the body coil and other external surface 
coils prevents identification of small fistula tracts and their relation to the normal anatomic 
structures (10,14). Developments in coil technology have resulted in phased array coils, 
which provide higher signal to noise ratios and can be used to improve the spatial resolu-
tion (16). Blomqvist et al (17) demonstrated that use of an endorectal coil results in a more 
detailed depiction of the rectal wall than does use of phased array coils. Endoluminal MR 
imaging further improves the signal to noise ratio in combination with relatively smaller 
fields of view (9). This provides exquisite images of the rectum, anal canal, rectovaginal sep-
tum, and vagina, with much higher spatial resolution compared with the external surface 
coils (5,7). 
Figure 5. Anovaginal fistula with sphincter damage. (a) Sagittal T2-weighted fast SE MR image (2,443/100) shows 
high signal intensity anovaginal fistula (thin straight arrow) between the anal canal and the posterior wall of the 
vagina (curved arrow). The endoanal coil () is also shown. (b) Coronal T2-weighted fast SE MR image (2,443/100) 
shows thickening and scarring of the external anal sphincter (thick straight arrow) on the left side. The internal 
sphincter shows thinning on the left side (thin straight arrow), whereas the sphincter remains healthy on the right 
side (arrowhead). The puborectal muscle (curved arrow) and endoanal coil () are also shown.
a b
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The role of endoanal MR imaging in the detection and classification of perianal fistulas 
has been reported previously (7). Our results show that endoanal MR imaging can depict 
anovaginal fistulas, as well as a number of associated abnormalities that are important for 
surgical management. The disadvantages of endoanal MR imaging include mild discomfort 
at introduction of the coil and a limited field of view due to signal drop off at some dis-
tance from the coil (9). In our study, however, the field of view limitations did not pose any 
problems. In all patients, the anovaginal fistulas were depicted to their full extent. Larger 
complex fistulas may extend outside the sensitive region of the endoanal coil. In these pa-
tients, additional sequences can be performed with body or phased array coils for complete 
depiction of the fistulas. 
Recently, the value of phased array coil MR imaging in the identification and classification 
of anal fistula disease has been reported (16). The use of phased array coils is advantageous 
because there is no need to introduce the coil into the anal canal or the rectum, whereas 
the larger field of view can provide images of the entire lower pelvic region. In our opinion, 
MR imaging with a phased array coil may identify most of the larger fistula tracts. The depic-
tion of smaller primary and secondary tracts and anatomy may be problematic with phased 
array coils. Endoanal MR imaging proved to be superior to endoanal US and MR imaging 
with body coils in the detection and classification of anal fistula disease (7). 
In our experience, T2-weighted MR imaging sequences are sufficient for depiction of fistulas 
and the surrounding anatomy. At our institution, we do not routinely use contrast mate-
rial with MR imaging in the evaluation of patients with fistula disease, as doing so would 
lengthen the examination time and increase the cost. Our results indicate that complex 
anovaginal fistulas are more often seen in patients with a known underlying disease or 
condition, namely, Crohn disease, previous obstetric trauma, or pelvic floor surgery, which 
could explain the presence of the fistulas. This difference is not statistically significant, how-
ever, and is probably due to the small sample size. 
Previously, Senatore (18) stated that obstetric injury is the most common cause of anovagi-
nal fistula. Hull and Fazio (11) found that 48 (55%) of all patients who underwent surgery for 
anovaginal fistula had Crohn disease. Both can be considered important causes of complex 
anal fistula disease. The results of our study indicate that it is important to comprehen-
sively evaluate patients before surgery. Complete mapping of the fistula with extensions, 
abscesses, and sphincter damage is important in the preoperative work up of the patient 
and may improve treatment (15,20). Scholefield et al. found that preoperative MR imaging 
was of little use in the surgical treatment of perianal fistulas (19). Beets-Tan et al. however, 
found that the largest additional value of preoperative MR imaging with the phased ar-
ray coil was obtained in patients with complex fistulas associated with Crohn disease and 
recurrent perianal fistula (20). Lunniss et al. suggested that MR imaging could depict more 
extensions than surgical exploration (15). 
Preoperative evaluation can help reduce the risk of procedure dependent complications. 
This could eventually lead to a reduction in the recurrence of fistulas and the occurrence 
of postoperative fecal incontinence. In our preliminary review, we also found five patients 
who were referred for MR imaging in whom an anovaginal fistula was suspected. In these 
patients, MR imaging showed a perianal fistula instead of an anovaginal fistula, a finding 
that was subsequently confirmed at surgery. It is likely that the additional information ob-
tained with MR imaging will improve the surgical results in patients with complex fistulas, 
although this can be reliably 
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established only with a prospective randomized trial of patients who undergo surgery after 
undergoing preoperative MR imaging and those who undergo surgery without undergo-
ing preoperative MR imaging (20). 
Limitations of our study are its retrospective design, the small number of patients, and the 
lack of a single uniform standard of reference. The observers may have known some of the 
findings at MR imaging; however, this could not be avoided due to the retrospective nature 
of our study. We believe the standard of reference should be exploratory surgery, because 
this is the only clinical technique that may be used to determine the internal structure of 
the fistula. Not all patients in our study group underwent surgery within the review period. 
Despite these limitations, we believe our results indicate that endoanal MR imaging has suf-
ficient value in the evaluation of primary anovaginal fistulas and additional abnormalities.
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Background Transanal advancement flap repair for the treatment of high transsphincteric 
fistulas fails in 1 of every 3 patients. Until now no definite risk factors for failure have been 
identified. The question is whether the more complex fistulas, such as those with horseshoe 
extensions and associated abscesses, have a less favorable outcome.
Objective Aim of the present study was to indentify whether more complex fistulas have a 
less favorable outcome.
Material and methods This study is a retrospective case series. Between 1995 and 2007 a 
series of 162 patients underwent endoanal MR imaging before transanal advancement flap 
repair. Two investigators, without prior knowledge of the surgical findings, reviewed all MR 
images.
Results Lateral fistulas were identified in 5 patients. Because of the small number, these pa-
tients were excluded from further analysis. Posterior fistulas were identified in 119 patients 
(76%). These fistulas had 3 types of extensions: a direct course (36%), a classic horseshoe 
extension (23%), or an intersphincteric horseshoe extension (41%). The corresponding heal-
ing rates were 37%, 81%, and 73%. Anterior fistulas were observed in 23% of the patients. 
These fistulas had 2 types of extensions: a direct course (61%) or a classic horseshoe exten-
sion (39%). The corresponding healing rates were 60% and 52%. The healing rate of fistulas 
with a direct course was significantly lower than the healing rate of fistulas with a classic 
or intersphincteric horseshoe extension. Associated abscesses were found in 47% of the 
posterior fistulas and 5% of the anterior fistulas. Once adequately drained, these abscesses 
did not affect the outcome of transanal advancement flap repair.
Conclusion The complexity of high transsphincteric fistulas does not affect the outcome of 
transanal advancement flap repair.
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IntRoDuctIon
Transanal advancement flap repair has been advocated as the treatment of choice for trans-
sphincteric fistulas passing through the upper and middle third of the external anal sphinc-
ter. This procedure enables healing of the fistula in 2 of every 3 patients without consequent 
sphincter damage. Several authors have tried to identify factors affecting the outcome of 
transanal advancement flap repair (1-4). However, until now, no definite predictive factors 
for failure have been identified. The question is whether the complexity of high transsphinc-
teric fistulas affects the outcome of transanal advancement flap repair. Most of these fistulas 
have their internal opening at the posterior or anterior midline. From this point they can 
extend in different ways. Some fistulas have a direct course from the internal to the ex-
ternal opening, whereas others extend in a more complex horseshoe manner. Associated 
abscesses are not an uncommon finding in patients with a high transsphincteric fistula. It 
is not known whether high transsphincteric fistulas with an associated abscess and those 
with a more complex course have a lower tendency to heal.
The classic way in which horseshoe fistulas develop has been described in detail and mainly 
involves the horseshoe extension of posterior fistulas (5-10). When such a fistula penetrates 
the external anal sphincter it enters the deep postanal space, which is bounded by the leva-
tor ani muscle, the anococcygeal ligament, the coccyx, and the anal canal. This anatomical 
space communicates on both sides with the ischioanal spaces. The easiest way to extend 
from the deep postanal space is to either one or both of these ischioanal spaces, thereby 
forming a classic horseshoe extension. However, it has been reported that the circumferen-
tial spread may also occur in the intersphincteric plane, forming an intersphincteric horse-
shoe extension (11). In 1900 Goodsall described in which way a fistula is most likely to 
traverse, based on the location of the external opening. His observations have been almost 
universally accepted and are commonly known as Goodsall’s rule. According to Goodsall’s 
rule, the majority of posterior fistulas should form a horseshoe extension, but anterior fis-
tulas should have a direct course (12). The aim of the present study was to determine the 
exact prevalence of horseshoe extensions in posterior and anterior high transsphincteric 
fistulas with the use of endoanal MR imaging. The present study was also conducted to 
answer the question of whether the more complex fistulas, such as those with horseshoe 
extensions and associated abscesses, have a less favorable outcome. The primary aim of the 
study was to assess whether the complexity of the fistula influences healing. A secondary 
aim was to determine the exact prevalence of horseshoe extensions in posterior and ante-
rior high transsphincteric fistulas with the use of endoanal MR imaging.
MateRIaLs anD MethoDs
Between June 1995 and December 2007 a consecutive series of 178 patients with a crypto-
glandular, transsphincteric fistula, passing through the upper or middle third of the external 
anal sphincter, underwent transanal advancement flap repair. In 162 of these patients MR 
imaging was performed before this procedure. Patients in whom no MR imaging was per-
formed were excluded. Median age at time of repair was 47 (range, 21–73) years. Healing of 
the fistula was defined as complete wound healing and closure of all external openings in 
combination with the absence of symptoms. Follow-up was at least 12 months. 
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Exclusion criteria
Patients with a rectovaginal fistula or a fistula caused by Crohn’s disease were excluded from 
the present series.
MR Imaging
Before transanal advancement flap repair was performed all patients underwent endoanal 
MR imaging. All MR imaging examinations were performed with the use of an endoanal coil 
with a 1.5-T MR imager (Gyroscan NT Intera 1.5; Philips Medical Systems, Best, the Nether-
lands). The endoanal coil (Philips Medical Systems) consisted of a fixed, rectangular, 60-mm-
long rigid receiver coil with a width of 16 mm. The coil is contained within an 80-mm- long 
cylindrical coil holder with a diameter of 19 mm. Before the introduction of the coil into the 
anal canal, a condom was placed over the coil and ultrasound gel was used as a lubricant. 
The coil was introduced while the patient was lying in the left lateral position. After the coil 
was introduced, patients were carefully turned onto their back, and the position of the coil 
was rechecked. 
In each patient, the following 3 sequences were used. Transverse T2-weighted contrast-
enhanced fast field-echo imaging was performed (repetition time/echo time, 23 ms/14 ms; 
acquisition time, 5 minutes 39 seconds; matrix, 205 x 256; flip angle, 60°; field of view, 140 
mm; section thickness, 2 mm with no gaps; and 2 signals acquired). Contrast-enhanced fast 
field-echo is a term used by Philips Medical Systems and does not indicate contrast material 
administration. Transverse T2-weighted fast spin-echo [SE] MR imaging was performed with 
and without fat saturation (5086/100; acquisition time, 2 minutes 23 seconds; matrix, 186 x 
256; flip angle, 90°; field of view, 120 mm; section thickness, 4 mm with a 0.4-mm gap; and 3 
signals acquired). Coronal and sagittal T2-weighted SE MR imaging was performed without 
fat saturation (2454/100; acquisition time, 2 minutes 34 seconds; matrix, 186 x 256; flip angle, 
90°; field of view, 120 mm; section thickness, 4 mm with a 0.4-mm gap; and 4 signals acquired).
Two investigators, without prior knowledge of the surgical findings, independently re-
viewed all MR images. Images with disagreement were reevaluated with both observers 
working together, and consensus was reached. 
 
Surgical technique
Patients underwent complete mechanical bowel preparation (polyethylene glycol: Klean-
prep Helsinn Birex Pharmaceuticals, Dublin, Ireland). After induction of general endotra-
cheal anesthesia, metronidazole (500 mg) together with cefuroxime (1500 mg) was admin-
istered intravenously. With the patient in a prone jackknife position, the external opening 
was enlarged and the fistulous tract was excised as far as possible. The internal opening of 
the fistula was exposed using a Lone Star retractor (Lone Star Retractor System, Lone Star 
Medical Products, Inc. Houston, TX). The cryptbearing tissue around the internal opening 
and the overlying anodermis were then excised. The fistulous tract was cored out of the 
sphincters. The defect in the internal anal sphincter was closed with absorbable sutures. 
A flap consisting of mucosa, submucosa, and some of the most superficial fibers of the 
internal anal sphincter, was raised from the level of the dentate line and mobilized over a 
distance of 4 to 6 cm proximally. The flap was advanced and sutured to the neodentate line 
with absorbable sutures. One surgeon performed all operations ( W.R.S.). 
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Drainage of associated abscesses
At the same time flap repair was performed, all associated abscesses, detected with MR 
imaging, were drained with a 4-winged malecot catheter. A separate elliptical incision was 
made to gain access to the abscess cavity. Through another small incision the drain was in-
serted, tunneled subcutaneously, and positioned into the abscess cavity. The abscess cavity 
was irrigated 6 times daily with saline for 10 days.
Postoperative care
All patients were immobilized for 5 days. All patients received a clear liquid diet for 5 days. 
During this time period metronidazole and cefuroxime were administered intravenously 3 
times daily.
ResuLts
Of the 162 patients who underwent endoanal MR imaging before the flap repair the internal 
opening of the fistula was located posterior in 119 patients, anterior in 38 patients, and at 
the lateral side of the anal canal in 5 patients. Because of the small number, patients with a 
lateral fistula were excluded from further analysis. Posterior fistulas were identified in 76% of 
the patients ( Table 1). In 36% of these patients endoanal MRI revealed a direct course of the 
fistula, running from the internal to the external opening in the dorsal quadrant. Associated 
abscesses were found in 51% of these patients. The healing rate among patients with this 
fistula type was 37%. A classic horseshoe extension was found in 23% of the patients with 
a posterior fistula. In these patients, the fistula passed through the external anal sphincter 
in the posterior midline, extending from that point in a horseshoe manner to either one or 
both sides (Fig. 1). In 33% of these patients an associated abscess was detected. The healing 
rate was 81%. In 41% of the patients, the posterior fistula extended circumferentially in the 
Figure 1. MRimagesofclassichorseshoefistula.1=fistula;2= internal anal sphincter; 3 = external anal sphincter.
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intersphincteric plane, passing through the external anal sphincter at either one or both 
lateral sides (Fig. 2). This fistula type was associated with an abscess in 47% of the cases. 
The healing rate was 73%. The healing rate of posterior fistulas with a direct course was sig-
nificantly lower than the healing rate of fistulas with a classic or intersphincteric horseshoe 
extension (P = .001). Regarding the healing rate, no significant difference was observed 
between patients with a classic and those with an intersphincteric horseshoe extension. 
Anterior fistulas were identified in 23% of the patients ( Table 2). Endoanal MRI revealed 2 
types of anterior fistulas. The first type includes the fistulas with a direct course between 
the internal opening and the external opening in the anterior quadrant. This fistula type 
was found in 23 (61%) of the patients with an internal opening at the anterior midline. The 
healing rate in these patients was 52%. In only one (4%) of these patients was an associated 
abscess detected. The second type was characterized by a classic horseshoe extension, ob-
served in 15 (39%) of the patients. The healing rate among these patients was 60%. These 
fistulas were associated with an abscess in 6% of the cases. Anterior fistulas showed no 
intersphincteric extensions. The healing rate of anterior fistulas did not significantly differ 
from the healing rate of posterior fistulas. 
table 1. healing rates and prevalence of associated abscesses in high transsphincteric posterior fistulas
Internal opening Fistula type n (%)
Associated 
abscesses n (%)
Healing rate  
n (%)
Posterior (76%) Classic horseshoe 27 (23) 9 (33) 22 (81)
Intersphincteric 
horseshoe
49 (41) 23 (47) 36 (73)
Direct course 43 (36) 22 (51) 16 (37)
Total 119 (100) 56 (47) 74 (62)
Figure 2. MRimagesofintersphincterichorseshoefistula.1= fistula; 2 = internal anal sphincter; 3 = external anal 
sphincter.
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table 2. healing rates and prevalence of associated abscesses in high transsphincteric anterior fistulas
Internal opening Fistula type n (%)
Associated 
abscesses n (%)
Healing rate  
n (%)
Anterior (23%) Classic horseshoe 15 (39) 1 (7) 9 (60)
Direct course 23 (61) 1 (4) 12 (52)
Total 38 (100) 2 (5) 21 (55)
Endoanal MR imaging revealed associated abscesses in 47% of the patients with a posterior 
fistula and in 5% of the patients with an anterior fistula. These abscesses were classified as 
intersphincteric (18%), infralevator (13%), intralevator (51%), supralevator (11%), and trans-
levator (7%) 
(Fig. 3). Intersphincteric abscesses are located in the plane between the internal and ex-
ternal anal sphincter. Infralevator abscesses are located below the levator muscle and are 
commonly known as deep postanal space abscesses. Intralevator abscesses are located in 
the levator muscle itself. Abscesses above the pelvic floor are referred to as supralevator ab-
scesses. Some abscesses are located below the levator muscle and from there on penetrate 
the pelvic floor to extend above the levator muscle. These hourglass-shaped abscesses are 
referred to as translevator abscesses. 
Figure 3. MRimagesofabscesses.A,Intersphinctericabscess.B,Supralevatorabscess.C,Infralevatorabscess.D,Intralev
atorabscess.E, Translevator abscess. 1 = abscess; 2 = internal anal sphincter; 3 = external anal sphincter; 4 = levator 
muscle; 5 = fistulous tract.
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Associated abscesses were significantly more often present in posterior fistulas than in an-
terior fistulas. Posterior fistulas with a direct course were significantly less often associated 
with an abscess than fistulas with either a classic or intersphincteric horseshoe extension. 
In a comparison of patients with and without an associated abscess, the healing rate was 
found to be 57% and 62%. This difference did not reach statistical significance. All abscesses 
were drained as previously described. Once adequately drained, abscesses did not affect 
the outcome of transanal advancement flap repair. 
DIscussIon
Perianal fistulas passing through the upper or middle third of the external anal sphincter 
present a challenge to many surgeons. Transanal  advancement flap repair provides a useful 
tool in the treatment of these fistulas. It enables the healing of the fistula without damage 
of the external sphincter and consequent fecal incontinence. Initially, the reported healing 
rates varied between 84 and 100% (13-16). However, during the past decade it has become 
clear that transanal advancement flap repair fails in 1 of 3 patients (1-14,18). The majority 
of high transsphincteric fistulas, examined in the present study, had their internal opening 
at the posterior midline. These posterior fistulas showed 3 different ways of extension: a di-
rect course, a classic horseshoe extension, and, the most common one, an intersphincteric 
horseshoe extension. Anterior fistulas extended in 2 different ways: a direct course and a 
classic horseshoe course. The healing rate of fistulas with a direct course was significantly 
lower than the healing rate of fistulas with a classic or intersphincteric horseshoe extension. 
Associated abscesses were found in 47% of the posterior fistulas and in 5% of the anterior 
fistulas. Once adequately drained, these abscesses did not affect the outcome of transanal 
advancement flap repair. Concordance between surgical findings and MR images was very 
high. However, the surgeon was aware of the MR images, so an objective correlation be-
tween MRI and surgical findings cannot be given based on these data. The most striking 
finding of the present study is the poor outcome after flap repair in patients with a high 
transsphincteric fistula, traversing the external anal sphincter in a direct course to the ex-
ternal opening. This finding is difficult to explain and has not been described before. In our 
opinion it might be possible that both anterior and posterior fistulas with a direct course 
represent a more aggressive form of perianal fistulous disease. 
Another finding of the present study is the high prevalence of associated abscesses, espe-
cially in high transsphincteric fistulas with their internal opening at the posterior midline. 
Most of these abscesses could not be detected by physical examination. Although some of 
these abscesses presented a rather complex and bizarre course above the pelvic floor, they 
all could be detected and drained because of preoperative MR imaging. 
Endoanal MR imaging provides a useful tool for the visualization of these abscesses, en-
abling adequate drainage. The abscess cavity was deroofed, drained, and irrigated for 10 
days with a malecot catheter. This might explain why these abscesses in themselves had no 
detrimental effect on the outcome. Because the present study was not aimed at compar-
ing flap repair with and without drainage of associated abscesses, it is not known what the 
outcome would have been had these abscesses been overlooked and not drained. In most 
studies, no distinction is made between classic and intersphincteric horseshoe extensions. 
Furthermore, the exact prevalence of these extensions is not known. MR imaging with an 
endoanal coil, used in the present study, has revealed that horseshoe extensions of posteri-
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or fistulas most frequently occur in the intersphincteric plane. This finding has not been de-
scribed before. Distinction between the 2 different types of horseshoe extensions is difficult 
without preoperative MR imaging. During flap repair, the fistulous tract is excised as far as 
possible, from the external opening to the exterior of the external anal sphincter. In a fistula 
with a classic horseshoe extension, a large part of the fistulous tract can be excised without 
damaging the external anal sphincter. While treating fistulas with an intersphincteric horse-
shoe extension one should be aware that the fistulous tract penetrates the external anal 
sphincter closer to the external opening. In this instance, only a limited part of the fistulous 
tract can be removed. Based on these considerations, it seems likely that preoperative im-
aging decreases the risk of sphincter damage in patients with horseshoe extensions. High 
transsphincteric fistulas with horseshoe extensions and associated abscesses are consid-
ered as complex fistulas (17). The present study shows that the complexity of these fistulas 
does not affect the healing rate of transanal advancement flap repair. In contrast to our ex-
pectations, the more simple fistulas with a direct course had a worse outcome. This finding 
is hard to explain. One of our hypotheses regarding this unexpected finding might be the 
possibility that the course of the fistula depends on the severity of the fistulous disease. The 
more fulminant the fistulous disease, the more straightforward the fistula might traverse 
the anal sphincter muscles, resulting in a direct course to the external anal 
opening. Whether a fistula develops after incision and drainage of a perianal abscess might 
also depend on the severity of the fistulous disease. Further research is warranted to inves-
tigate this possibility. Another reason for this finding might be the fact that more complex 
fistulas are referred earlier to our hospital. We are a tertiary referral center and a substantial 
number of our patients are referred from other hospitals. It is possible that the direct fis-
tulas represent a group of persistent fistulas that are only referred when prior surgery has 
failed. Because we did not have complete data of prior treatment elsewhere, we did not 
analyze this possibility. For several years, it has been our policy to offer patients a repeat 
flap repair if the first attempt has failed. In all patients who underwent a second procedure, 
complete healing of the flap was observed, with the exception of the site of the original in-
ternal opening (18). This remarkable clinical finding suggests that the persistence of fistulas 
might be caused by ongoing disease within the remaining fistulous tract. Further research 
is warranted regarding this possibility to control this ongoing disease, thereby increasing 
the healing rate.
concLusIon
The complexity of high transsphincteric fistulas characterized by horseshoe extensions and 
associated abscesses does not affect the outcome of transanal advancement flap repair. 
Horseshoe extensions occur in 2 of every 3 patients with a posterior fistula. Extension in 
the intersphincteric plane is the most frequent one. In patients with an anterior fistula, only 
classic extensions are observed. Fistulas with a horseshoe extension have a significantly bet-
ter outcome than the more simple fistulas with a direct course.
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abstRact
Objective. The purpose of this study was to assess the diagnostic value of anorectal MRI in 
the care of patients with chronic anal and perianal pain but without findings of abnormali-
ties in the clinical workup.
Materials and Methods. Patients referred from a tertiary department of colorectal surgery to 
the MRI unit with clinically occult chronic anal and perianal pain were included. MRI of the 
anorectum was performed with an endoanal or pelvic phased array coil. The images from 
all examinations were read by two radiologists. MRI findings were correlated with clinical 
follow-up data.
Results. The study group (103 patients) was stratified into patients with no history of ano-
rectal disease (n = 60) and those who had a history of surgery for anorectal disease (n = 
43). MRI findings suggested the final diagnoses in 40 patients (39%). These diagnoses were 
28 cases of suppurative lesions (27%), 11 cases of painful scarring of the anus (11%), and 
one case of metastasis to the sacrum (1%). Suppurative lesions were surgically proved with 
marked relief of pain after surgery. In the other patients the final diagnoses were 37 cases 
of levator ani syndrome (36%) and 26 cases of unspecified functional anorectal pain (25%). 
No MRI abnormalities were found in 33 of the patients with levator ani syndrome and 26 
of the patients with unspecified anorectal pain. The two readers had very good agreement 
(κ= 0.92). The patients with a history of anorectal disease had significantly more MRI find-
ings of abnormalities (60%) than did patients without a history of anorectal disease (23%). 
The positive predictive value of MRI was 91%, and the negative predictive value was 100%.
Conclusion. In 39% of patients, MRI showed abnormalities that were clinically confirmed 
as the final diagnosis. Surgical treatment will especially benefit patients with suppurative 
lesions, resulting in relief of pain.
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IntRoDuctIon 
Chronic anal and perianal pain is a common problem in gastroenterologic practice (1,2). 
It is defined as recurrent or persistent pain in the anal canal, usually deep and severe, that 
lasts more than 3 months and has variable radiation (2). Chronic anal and perianal pain is 
thought to be present as a major symptom in as many as 6% of U.S. residents (1). Patients 
generally present with a combination of symptoms that can include pain, soiling, loss of 
blood or pus from the anus, fecal incontinence, and a palpable mass in and around the 
anus. The combination of  symptoms suggests the presence of disease, and a clinical exami-
nation is performed to assess local anal abnormalities, including complicated hemorrhoids, 
hypertrophied anal papillae, anal fissure, and perianal suppurative conditions. 
When the only presentation is pain in the anal region and no local abnormality is found 
at initial clinical evaluation, the clinician is faced with a challenge. It has been speculated 
that patients without a clinically confirmed physical explanation for the pain may have an 
underlying functional disorder or that chronic anal and perianal pain may result from a 
psychologic overlay (3-5). The aim of further investigations, including imaging, must be to 
identify causes of pain not initially detected at clinical examination (6). The purpose of this 
study was to evaluate the diagnostic role of anorectal MRI in the care of these patients.
MateRIaLs anD MethoDs
This study was performed without financial support, and the authors had exclusive control 
of the data and information presented.
Patient selection, clinical workup, and reference standard
Institutional review board approval was obtained for this retrospective study, and the re-
quirement for informed consent was waived. The records of all patients referred to the MRI 
unit from a tertiary department of colorectal surgery between January 1999 and 
December 2007 were reviewed with regard to symptoms and indication for MRI. The cases 
were selected from databases in the departments of radiology and surgery, and a patient 
was included in the study population when chronic anal and perianal pain was the only 
symptom. In cases in which the patient had been previously treated for anorectal disease, a 
disease-free period of at least 1 year was required for inclusion.  
The clinical workup included evaluation and registration of symptoms in the patient re-
cord, anal inspection, and digital rectal examination by an experienced colorectal surgeon 
(the principal investigator). The findings at this initial workup guided a clinical decision to 
proceed with either proctoscopy or examination under general anesthesia performed by 
the principal investigator. All patients underwent a complete clinical work-up, including 
proctoscopy (n = 29) and examination under general anesthesia (n = 103), with no physical 
cause detected before admittance to the MRI unit (Fig. 1). After MRI, all patients underwent 
clinical reevaluation within 3 months. This sequence of patient evaluation and use of MRI is 
standard practice at our institution. 
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Two investigators not involved in image interpretation reviewed the medical records to as-
sess the final clinical diagnosis, treatment method, and follow-up information on the symp-
toms. The reference standard was surgical confirmation of MRI findings, histologic proof of 
disease, or clinical assessment of MRI findings, including follow-up data.
Functional gastrointestinal disorders were classified according to the Rome III Diagnostic 
Criteria for Functional Gastrointestinal Disorders (7-9), which include levator ani syndrome 
and unspecified functional anorectal pain. Levator ani syndrome is characterized by symp-
tom criteria for chronic proctalgia and tenderness during posterior traction on the puborec-
talis and levator ani muscles during digital rectal examination. The diagnosis of unspecified 
functional anorectal pain is based on symptom criteria for chronic proctalgia but without 
tenderness during posterior traction on the puborectalis and levator ani muscles (10,11). 
The follow-up period for the study group ranged from 4 months to 7 years after MRI (me-
dian, 18 months; mean, 23 months).
From January 1998 through December 2007, 2016 
patients referred from DCS to the MRI department
Eligible patients (n = 158)
Included patients (n = 103)
Clinical workup, including proctoscopy (n = 29) and 
EUA (n = 103) with no physical cause for CAP identified
Excluded patients (n = 55)
•	 MRI	 referral	 information	 includes	 CAP	 in	 clinical	 records;	 also	
soiling, fecal incontinence, or bloody stool (n = 39)
•	 No	data	available	on	proctoscopy	and	EUA	(n	=	14)
•	 No	data	available	on	final	diagnosis	after	MRI	(n	=	2)
No history of anorectal disease (n = 60)
Previous surgery for anorectal disease (n = 43)
Fig. 1. Flow diagram summarizes patient sampling. DCS = department of colorectal surgery, CAP = chronic anal 
and perianal pain, EUA = examination under general anesthesia.
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MRI
All examinations were performed with a 1.5- T MR imager (Gyroscan NT Intera 1.5, Philips 
Healthcare). In 96 cases a rigid endoluminal coil) was inserted into the anal canal. This coil 
is commercially available and consists of a fixed, rectangular, 60-mm-long rigid receiver coil 
with a width of 16 mm. The coil is contained in an 80-mm-long cylindric coil holder with 
a diameter of 19 mm. Before introduction of the coil into the anal canal, a condom was 
placed over the coil, and ultrasound gel was used as a lubricant. Two patients refused use 
of the endoluminal coil, and five found it too painful. In these cases imaging was performed 
with a phased array coil. The phased array coil is a commercially available four-channel coil 
placed around the pelvis. A standardized imaging protocol of the anus and lower rectum 
was performed with T2-weighted fast spin-echo sequences in the axial, sagittal, and coronal 
planes. The protocol included axial T2-weighted images with fat saturation obtained with 
the endoluminal or phased array coil. Additional imaging of the entire pelvic region in the 
axial and sagittal planes was followed by imaging with a phased array or body coil. 
The parameters for imaging with the endoluminal coil were as follows: TR/TE, 5086/100; 
FOV, 120 mm; section thickness, 2 mm; gap, 0.2 mm; number of signals acquired, 3; matrix, 
186 × 256; flip angle, 90°. The parameters for acquisition with the phased-array coil were as 
follows: 
TR/ TE, 2500/70; FOV, 180 mm; section thickness, 3 mm; gap, 0.3 mm; number of signals 
acquired, 3; matrix, 512 × 256; flip angle, 60°. The parameters for acquisition with the body 
coil were as follows: TR/TE, 5075/100; FOV, 250 mm; section thickness, 5 mm; gap, 0.5 mm; 
number of signals acquired, 2; matrix, 512 × 256.
Image analysis
MRI examinations of patients in the study group were uploaded to a PACS viewing station 
from digital storage facilities and evaluated by a radiologist with 8 years of experience in 
pelvic imaging (second reader). This reader was blinded to the original radiologic report 
and final diagnosis. The second reader recorded the following MRI findings: normal findings; 
fistulas, including abscesses; abscesses; scarring of anal sphincter muscles; suspicion of ma-
lignancy; and other abnormalities. The original readings with prospective image interpreta-
tion and reporting were performed by three radiologists with varying levels of experience 
in MRI of the pelvis (2, 2.5, and 5 years). Agreement between the second reading and the 
original radiologic report was assessed for type of lesion, location of lesion, and final diag-
nosis. If the two readings did not indicate the same type and location of lesion, the case was 
classified as disagreement. If the final diagnosis differed between readings, the case also 
was classified as disagreement.
Fistulas have a typical appearance on T2- weighted MR images: a central track of high sig-
nal intensity surrounded by a wall of relatively low signal intensity (12). This appearance 
presumably illustrates the true lumen with granulation tissue surrounded by an outer sec-
tion comprising fibrotic tissue. Any obvious widening of the fistula track is considered a 
fistulous abscess (13,14). Usually an internal opening of the lesion in the anorectal lumen 
is present, but this may not be evident on images (15). The second reader located fistulas 
and abscesses according to the Parks classification (16), which includes lesion site (anterior 
or posterior), apparent internal opening, and local thinning of the internal sphincter at the 
site where the lesion is closest to the anorectal lumen. Scarring was defined as a region of 
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fibrosis of low or intermediate signal intensity on T2-weighted images and adhesion to the 
muscular structure of the anal sphincters.
Statistical analysis
The study group was stratified into patients without a history of anorectal disease and pa-
tients who had undergone surgery for anorectal disease. We calculated 95% CIs for posi-
tive predictive value and negative predictive value. Comparisons of percentages between 
groups were made with chisquare tests. Agreement between readers was assessed for type 
of lesion, location of lesion, and final diagnosis. Kappa statistics were used to quantify the 
degrees of agreement between two readers. Analysis was performed with SPSS software 
(version 11, SPSS). A kappa value of 0.2 or less was generally interpreted as poor agreement; 
0.21– 0.40, fair agreement; 0.41–0.60, moderate agreement; 0.61–0.80, substantial agree-
ment; and 0.81 or greater, almost perfect agreement. The limit of significance was set at p 
= 0.05 (two-sided).
ResuLts
The study group consisted of 103 patients (54 men, 49 women; mean age, 48.3 years; range, 
23–85 years). Figure 1 shows details of patient inclusion and stratification of the study popu-
lation into the two groups. MRI findings suggested the final diagnoses in 40 patients (39%). 
Forty-three patients had undergone surgery for anorectal disease. The procedures included 
sphincterotomy for anal fissure (n = 15), surgery for perianal (n = 8) or anovaginal (n = 1) 
fistulas, incision and drainage of a perianal abscess (n = 6), anterior anal repair (n = 5), rec-
tocele repair (n = 3), hemorrhoidectomy (n = 2), and proctocolectomy, including ileo-anal 
anastomosis for ulcerative colitis (n = 2), and low anterior resection with colorectal anasto-
mosis for T2N0 rectal carcinoma (n = 1).
Patients without a history of anorectal disease
Table 1 shows the results for the 60 patients without a history of anorectal disease. Forty-
six of these patients (77%) were found to have either levator ani syndrome or unspecified 
Final Clinical Diagnosis MRI Findings
Diagnosis No. % Finding No.
Levator ani syndrome 25 42 No abnormality 24
Scarring of rectovaginal septum 1
Unspecified functional anorectal pain 21 35 No abnormality 21
Perianal suppurative lesions
Fistula 9 15 Visualized with MRI 9
Fistula with abscess 5 8 Visualized with MRI 5
table 1: Results for Patients without a history of anorectal Disease (n = 60)
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functional anorectal pain. The other 14 patients (23%) had perianal fistula disease. Scarring 
of the rectovaginal septum was visualized on MR images of one patient (2%), but clinical 
assessment revealed that levator ani syndrome was the actual cause of pain. Patients with 
suppurative lesions (n = 14, 23%) underwent surgery.
Patients with a history of surgery for anorectal disease
The results for the 43 patients with a history of surgery for anorectal disease are shown in Ta-
ble 2. A morphologic cause of chronic anal and perianal pain was found in 26 of the patients 
in this group (60%), 14 of whom (54%) had suppurative lesions. Eleven of the 26 patients 
(42%) had potentially painful scarring of the anus. One patient (2%) had a clinically occult 
metastasis to the sacrum from an unknown primary tumor. Seventeen patients (40%) un-
derwent surgery, including all 14 patients with suppurative lesions (33%) and three patients 
(7%) with potentially painful scarring of the sphincter muscles. MRI showed a statistically 
Fig. 2. 52-year-old man with chronic anal pain and no 
abnormalities at proctoscopy or examination under 
general anesthesia. Asterisk indicates endoluminal coil 
in anal canal. A and B, Axial T2-weighted MR images 
show clinically occult intersphincteric fistulas (short ar-
rows), including abscess (long arrow, A) and multiple 
fistula tracks (short arrow, B) C, Almost 2 years after 
surgery patient has recurrent chronic anal and perianal 
pain, but no abnormalities were found at repeat exami-
nation under general anesthesia. MR image shows re-
sidual fistula (short arrow) and remains of abscess (long 
arrow).
a b
c
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significant higher number of abnormalities (26/43, 60%) in the patients with a history of 
surgery for anorectal disease than in patients without a history of anorectal disease (14/60, 
23%) (p = 0.001, chi-square test).
Levator ani syndrome and unspecified functional anorectal pain
In the entire study population of 103 patients, levator ani syndrome and unspecified func-
tional anorectal pain were the most frequently established final diagnoses and were found 
in 63 patients (61%).
Final Clinical Diagnosis MRI Findings
Diagnosis No. % Finding No.
Levator ani syndrome 12 28 No abnormality 9
Scarring of anal sphincter muscles 3
Unspecified functional anorectal pain 5 12 No abnormality 5
Potential painful scarring anal sphincter muscles 11 26 Scarring anal sphincter muscles 11
Perianal suppurative lesions
Fistula with abscesses 6 14 Visualized with MRI 6
Recurrent fistulas with abscesses 3 7 Visualized with MRI 3
Recurrent fistulas 2 5 Visualized with MRI 2
Fistulas 1 2 Visualized with MRI 1
Abscess 1 2 Visualized with MRI 1
Recurrent presacral abscess 1 2 Visualized with MRI 1
Sacral metastasis of unknown primary tumor 1 2 Visualized with MRI 1
table 2: Results for Patients with a history of surgery for anorectal
table 3: Locations of anorectal Fistulas and abscesses in 28 Patients
Anatomic Location
Predominant Location of Lesion Site in 
Relation to Anorectum
Ventral Dorsal
Intersphincteric 1 14
Transsphincteric 1 5
Perineum and anovaginal septum 3 0
Below the level of sphincter muscles (subsphincteric) 0 3
Presacral 0 1
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Anorectal suppurative lesions
In the study population of 103 patients, most abnormalities seen at MRI were fistulas and 
abscesses in 28 patients (27%). Surgery was performed within 4 months (median, 42 days; 
mean, 44.9 days) after MRI. MR images served as a roadmap to guide the surgical procedure, 
and confirmation of fistulas and abscesses was documented in the surgical reports. Patient 
follow-up data indicated substantial relief of symptoms after surgery.
Significantly more abscesses were seen in the group of patients with a history of surgery for 
anorectal disease (11/43, 26%) than in the patients without a history of anorectal disease 
Fig. 3. 37-year-old man with chronic anal and perianal 
pain and no abnormalities found at proctoscopy or ex-
amination under general anesthesia.
A and B, Coronal T2-weighted MR images show full ex-
tent of right posterior transsphincteric fistula (arrows) 
with no clear external or internal ostia.
C, Axial T2-weighted MR image with local thinning of 
internal anal sphincter (arrowheads) at site of contact 
with proximal end of fistula (arrow). Asterisk indicates 
endoluminal coil in anal canal. Blind ending distal part 
of fistula track in the ischio-anal fossa (A) with proximal 
transsphincteric run through the puborectal muscle 
(B).
a b
c
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(5/60, 8%) (p = 0.035, chi-square test). Most fis-
tulas, including abscesses, were located in the 
intersphincteric space (n = 15) (Fig. 2). Other 
locations were transsphincteric (Fig. 3), sub-
sphincteric (Fig. 4), anterior perineal with ano-
vaginal septum (Fig. 5), and presacral (Fig. 6). 
Table 3 summarizes the abscess locations. In 
relation to the anorectum, most suppurative lesions (23/28 [82%]; 95% CI, 63– 94%) had a 
predominantly dorsal, or posterior, location (Figs. 2, 3, and 6) as opposed to a ventral, or an-
terior, location (Figs. 5 and 7). In the group of patients without a history of anorectal disease, 
9 of 14 patients (64%) had fistulas in contact with the internal anal sphincter (IAS), including 
local thinning of the IAS at the site of contact, but without obvious communication with 
the anal lumen (Fig. 3). The other five patients had no contact between a fistula and the IAS. 
In group of patients with a history of surgery for anorectal disease, 2 of 14 patients (14%) 
had close contact between a lesion and the IAS (Fig. 5), a significantly lower frequency (p< 
0.05) than in patients without a history of anorectal disease.
Two patients with intersphincteric fistulas and an abscess were included in both groups. One 
patient had clear improvement of the abscess with residual fistulas (Fig. 2). The other had 
clearance of the initial abscess with a new intersphincteric abscess and persistent fistulas.
Fig. 4. 43-year-old man with chronic anal and perianal 
pain radiating anteriorly and in left perianal area 2 years 
after lateral sphincterotomy for anal fissure.
At examination under general anesthesia no obvious ab-
normalities were found. Coronal T2-weighted MR image 
shows small abscess (arrows) in skin below level of anal 
muscular sphincters (subsphincteric). Asterisk indicates 
endoluminal coil in anal canal.
Fig. 5. 29-year-old woman with anterior anal and perianal 
pain 2.5 years after surgery for rectovaginal fistula. No 
abnormalities were found at examination under general 
anesthesia. Axial T2-weighted MR image with fat satura-
tion shows linear structure of high signal intensity (arrow), 
which suggests presence of active fistula. Lesion extends 
from anus to perineum. No extension of fistula to vagina 
(V) is evident; finding was confirmed at surgery. Fistula is 
in contact with internal anal sphincter, and local thinning 
of internal anal sphincter at site of contact is evident. As-
terisk indicates endoluminal coil in anal canal.
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Scarring and pain
Scarring of the anus was assessed as a potential cause of pain in 11 (11%) patients. Surgical 
exploration (two patients) and resection (one patient) of scar tissue were performed with 
partial relief of symptoms. In the other eight cases, clinical examination revealed local stiff-
ness with obvious exacerbation of pain when the site of scarring as visualized on MR im-
ages was provoked by digital rectal examination. In another four patients (4%), MRI showed 
scarring of the anus, but clinical examination revealed levator ani syndrome as the actual 
cause of pain (Fig. 8). 
Malignancy
One patient (1%) was found to have a clinically occult malignant tumor of the sacrum, 
which was biopsy proven to be adenocarcinoma with an unknown primary lesion (Fig. 9).
Final Clinical Diagnosis Women Men
No. Mean Age (y) No. Mean Age (y)
Levator ani syndrome 23 48.5 14 53
Unspecified functional anorectal pain 14 53.2 12 52
Anorectal sepsis 6 47.6 22 47.3
Scarring 6 49.6 5 45.4
Malignancy of sacrum 0  1 40
Total 49 54
table 4: Final clinical Diagnoses by sex and age
Fig. 6. 55-year-old woman 6 years after radiotherapy and 
total mesorectal excision for T2N0 rectal carcinoma with 
colorectal anastomosis and 2 years after surgical drain-
age of abscess in presacral space with persistent anal and 
perianal pain after relative pain-free interval. Examination 
under general anesthesia revealed no obvious abnor-
malities of perianal region that could explain pain. Sag-
ittal T2-weighted MR image shows complex fluid pocket 
(arrowheads) with air bubble (arrow) in presacral space in 
contact with colorectal anastomotic area. Surgical extirpa-
tion of rectal remnant, clearing out of fluid pocket, and 
establishment of permanent ileostomy were performed. 
Pathologic analysis of resection specimen revealed chron-
ic abscess with fibrotic and inflammatory changes and no 
malignancy. A = anus, R = rectal remnant, U = uterus.
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Diagnosis and Sex
There was a significant difference between men and women regarding anorectal suppura-
tive lesions, which had a male preponderance (overall p = 0.009, chi-square test; men, 41%; 
women, 12%; p = 0.002), and levator ani syndrome, which had a female preponderance 
(women, 47%; men, 26%; p = 0.044) ( Table 4). 
Positive and negative predictive values and interobserver agreement 
Morphologic alteration was visualized with MRI in 40 of 103 patients (39%). The positive 
predictive value of MRI was 91% (40/44; 95% CI, 78–95%). The negative predictive value 
was 100% (59/59; 95% CI, 94–100%). The first and second readers had excellent agreement 
in the evaluation of MRI examinations, agreeing in 96% of cases (99/103) (κ = 0.92). One 
abscess, associated with an intersphincteric fistula, was described in the original radiologic 
report and confirmed at surgery but was not recorded by the second reader. Three cases 
were originally reported as having a suggestion of small intersphincteric fistulas; none of 
these lesions was recorded by the second reader or confirmed at clinical follow-up. All cases 
of scarring and malignancy were reported by both readers.
Fig. 7. 35-year-old woman with persistent anal and perianal pain after episiotomy and surgery for perianal fistula 
at another hospital 6 years earlier. Examination under general anesthesia revealed no obvious history of anorectal 
disease had significantabnormalities that could explain pain. A and B, Axial T2-weighted images through lower 
external anal sphincter (A) and at more proximal level (B) show extensive scarring (arrowheads) of anterior aspect 
of external anal sphincter and perineum and active small fistula (arrows) in scar tissue. Surgery revealed trans-
sphincteric fistula. Asterisk indicates endoluminal coil in anal canal.
a b
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DIscussIon
Although chronic anal and perianal pain is a relatively common problem in the general 
population (1), few studies have focused on this problem. To our knowledge, the current 
study is the first use of MRI in a cohort of patients with chronic anal and perianal pain. 
The efficacy of this imaging modality in the evaluation of chronic anal and perianal pain is 
shown in the identification of suppurative lesions in 27% of all patients. This is an important 
finding, and these patients will benefit from surgery.
Results of few imaging studies in which the patient cohort had chronic anal and perianal pain 
have been published (3, 17–19). These ultrasound-based studies showed a common weak-
ness in that a clear clinical reference standard for the reported ultrasound findings was lack-
ing. In addition, the nature of ultrasound as an operator-dependent imaging modality leads 
to limitations in the reproducibility of findings. On the other hand, the results of these studies 
indicated that patients with clinically occult chronic anal and perianal pain need further imag-
ing studies before the diagnosis of a functional gastrointestinal disorder can be made. 
Although we found lesions in other locations, most suppurative lesions were located dor-
sally in the intersphincteric space, which may reflect the higher anatomic prevalence of 
posterior location of anal glands (20). Among 28 patients with suppurative lesions, no ob-
Fig. 8. Examples of cases in which MRI findings suggested scarring of the anus. Asterisk indicates endoluminal 
coil in anal canal. A, 62-year-old woman 5 years after anterior anal repair for persistent anal and perianal pain that 
had lasted 1.5 years. Axial T2-weighted MR image shows scarring (long arrow) of anterior aspect of external anal 
sphincter (arrowhead) and perineum but clinical examination revealed levator ani syndrome as cause of pain. 
Short arrow indicates internal anal sphincter. V = vagina. B, 59-year-old man 7 years after surgery for perianal 
fistula disease. Chronic anal and perianal pain had lasted for 2 years with no abnormalities found at proctoscopy 
or examination under general anesthesia. MR image shows part of intact muscular structure of external anal 
sphincter (arrowhead) on left side. On right, external anal sphincter is replaced by hypointense linear structure 
(long arrow) suggestive of fibrotic strand with anterior adjacent area of intermediate signal intensity (short arrow). 
These abnormalities were interpreted as scarring at MRI, and obvious painful local stiffness was found at clinical 
evaluation. Final diagnosis was potentially painful scarring.
a b
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vious internal opening of the lesion in the lumen of the anorectum was seen. Previous 
investigators (14, 21) have described accurate visualization of the internal opening of peri-
anal fistulas with an endoluminal coil similar to that used in this study. In 11 cases in our 
study close contact was found between the lesion and local thinning of the IAS. It can be 
assumed that the internal opening of fistulas and abscesses was obstructed, probably by 
granulation tissue. This may have prohibited drainage of these lesions in the anal lumen, 
explaining their clinically occult status with pain as the only presentation. Compared with 
the group of patients who had a history of surgery for anorectal disease, patients without 
a history of anorectal disease had significantly more suppurative lesions in close contact 
with the IAS. This finding suggests a different mechanism of infection: patients without a 
history of anorectal disease had a predominantly cryptoglandular type of fistula disease as 
opposed to the secondary iatrogenic infections in the group of patients with a history of 
surgery for anorectal disease (15). In addition, significantly more abscesses were found in 
the patients with a history of surgery for anorectal disease, which may be explained by the 
more severe iatrogenic infectious mechanism. 
Spatial resolution on MR images can be improved by use of a receiver endoluminal coil in 
the anal canal itself; however, care should be taken to perform additional imaging of more 
distant structures with the phased-array or body coil. Focusing on the immediate perianal 
region in imaging of patients with chronic anal and perianal pain is insufficient, as illustrated 
by the detection of one case of malignancy of the sacrococcygeal spine in this study (Fig. 9). 
Fig. 9. 40-year-old man 17 years after surgical drainage of perianal abscess with persistent and increasing anal and 
perianal pain for almost 1 year with no abnormalities at proctoscopy or examination under general anesthesia.
A, Endoanal MR image shows thickened anococcygeus ligament (arrowhead). Asterisk indicates endoluminal coil 
in anal canal.
B, Whole-pelvis image acquired with body coil shows tumor at sacrococcygeus joint (arrow), which was adeno-
carcinoma with unknown primary lesion. Patient also had retroperitoneal lymph node and other bone metastasis 
(not shown).
a b
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The second most common abnormality encountered at MRI was scarring of anal sphincter 
muscles. Only 3 of 11 patients with scarring as a potential cause of chronic anal and peri-
anal pain had undergone surgery for scar tissue, and they had partial relief of symptoms. In 
another four patients, clinical assessment revealed levator ani syndrome as the final diag-
nosis and no perianal scarring, as was found with MRI. This result emphasizes the point that 
functional gastrointestinal disorders can coexist with morphologic abnormalities and be 
mainly responsible for pain. In cases of perianal scarring, a thorough physical examination 
by an experienced gastrointestinal clinician is recommended. Future studies are needed to 
clarify the role of scarring in the pain experience of patients. In addition, the diagnosis of 
unspecified functional anorectal pain can be made with considerable certainty when no 
abnormalities can be established with either clinical workup or MRI. This conclusion was 
reflected by the finding that no patient with a final diagnosis of levator ani syndrome or un-
specified functional anorectal pain was readmitted to the department of colorectal surgery 
with a change in symptoms that would suggest an occult morphologic cause. Anorectal 
suppurative lesions were found with significantly higher frequency in men than in women 
in our study. In contrast, levator ani syndrome was found more often in women, an associa-
tion that has not been previously reported, to our knowledge. 
Our study had limitations, one of which was the retrospective design, which may be prone 
to selection bias. However, given our strict inclusion criteria and the fact that at our insti-
tution performing MRI is standard practice in the care of patients with chronic anal and 
perianal pain, we believe the study population representative for the aims of this study in 
a tertiary clinical setting. Another limitation may be the inclusion of patients who had un-
dergone surgery for anorectal disease. Their pain may have been related to their previous 
disease or treatment. We classified these patients in a separate subgroup and compared 
their current status with previous findings. Therefore, we believe that the results can be ap-
plied to this patient population. Chronic anal and perianal pain due to scarring of the anal 
sphincter muscles lacks a solid reference standard. In addition, in using MRI to guide the fi-
nal diagnosis of potentially painful scarring in these patients, we may have overemphasized 
the roles of both MRI and scar tissue in these patients. We believe this drawback can be 
alleviated by thorough clinical workups by an experienced colorectal surgeon before and 
after MRI. The exclusion of other physical and functional disorders makes the current clas-
sification acceptable. It might also be helpful to extend clinical follow- up and collect more 
recent updates on the conditions of patients included in our study, especially those with 
levator ani syndrome or unspecified functional anorectal pain. This task was beyond the 
scope of our institutional approval. Because existing follow-up data showed no evidence 
for a need to reconsider established final diagnoses, we do not consider this a serious weak-
ness of the study.
concLusIon
Anorectal MRI is an effective imaging modality for visualization and exclusion of morpho-
logic abnormalities, especially perianal suppurative lesions and scarring. Using MRI, we were 
able to identify lesions in 39% of patients with chronic anal and perianal pain, for whom a 
standard clinical workup had failed to reveal abnormalities. MRI is therefore a recommend-
ed constituent of the workup of these patients before their symptoms are considered part 
of a functional gastrointestinal disorder.
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4.1
abstRact
Objective Chronic lower urinary tract symptoms are common in women. We present a clas-
sification of abnormalities that can be considered in the differential diagnosis for lower 
urinary tract symptoms and can show the value of dedicated state-of-the art MRI in the 
workup of patients. 
Conclusion Dedicated MRI tailored to patient symptoms and clinical findings has the po-
tential to map out morphologic causes and categorize dysfunctional conditions from those 
that are truly non-morphologic.
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IntRoDuctIon 
Lower urinary tract symptoms are a group of symptoms with abnormalities that may be 
categorized into seven groups: storage problems, voiding problems, postmicturition symp-
toms, symptoms associated with sexual intercourse or pelvic organ prolapse, lower urinary 
tract pain, and lower urinary tract dysfunction syndrome [1]. New insights suggest that low-
er urinary tract symptoms are a non-organ-specific group of symptoms, which are some-
times age related and progressive, affecting up to 26% of women 40 years old and older [2, 
3]. The presentation of symptoms can be diverse and the differential diagnoses extensive. It 
is of importance to differentiate morphologic abnormalities from dysfunctional conditions 
that are responsible for a patient’s complaints. Dedicated MRI and urodynamic studies are 
important tools in this respect [4]. This article presents a classification of morphologic or 
functional abnormalities that can be considered in the differential diagnoses of women 
with chronic lower urinary tract symptoms. This classification is based on common and less-
common causes for lower urinary tract symptoms according to the literature and our expe-
rience at a tertiary referral center for female genitourinary symptoms and dedicated MRI of 
the pelvis and pelvic floor. On the basis of this classification, morphologic abnormalities will 
be described and illustrated on MRI. Important information for clinical management and 
key features on MRI will be elucidated. 
MRI
With its excellent soft-tissue contrast and multiplanar acquisition, MRI has become the 
imaging modality of choice for diagnosis and preoperative evaluation in female patients 
with urethral and periurethral disease. Previously, pelvic phased-array coils were applied 
for female pelvic imaging, including imaging of the urethra and periurethral region. Sub-
sequently, intracavitary MRI coil design (for endovaginal and endorectal placement) made 
imaging with increased spatial resolution and high signal-to-noise ratio of this anatomic 
region possible [4–6]. Until 2009, our institute performed pelvic imaging on a 1.5-T MR sys-
tem (Gyroscan NT Intera 1.5, Philips Healthcare) using a 4-channel pelvic phased-array coil 
placed around the pelvis or a rigid endoluminal coil placed in the vagina. The endoluminal 
coil was commercially available and consisted of a fixed rectangular 60-mm-long rigid re-
ceiver coil with a width of 16 mm. The coil was contained within an 80-mm-long cylindric 
coil holder with a diameter of 19 mm. Since 2009, both a 1.5-T system (Discovery MR450, 
GE Healthcare) and a 3-T system (Discovery MR750, GE Healthcare) have been used. For 
female pelvic imaging, an 18-channel phased-array multicoil is placed around the pelvis; 
in addition, an endoluminal coil placed in the vagina is applied for dedicated urethral and 
periurethral imaging. Both the endoluminal coil for 1.5- T imaging and for 3-T imaging are 
custom built and consist of a dual coil arrangement orthogonally positioned, with a total 
length of 195 mm (active region, 90 mm) and a diameter of 20 mm. Before the introduc-
tion of the coil into the vagina by the patient herself, a condom is placed over the coil and 
ultrasound gel is used as a lubricant. It should be noted that this rigid endoluminal coil is 
not the same as the inflatable rectal coil but is of smaller diameter and is designed to be 
placed in the anus or vagina.
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MRI Protocol
A concise imaging protocol of T2-weighted turbo spin-echo (TSE) sequences with high-
resolution slices in three planes (axial, coronal, and sagittal) through the urethra and peri-
urethral region is performed including axial T2-weighted TSE with fat saturation and T1-
weighted gradient-echo sequences (Tables 1 and 2). The FOV includes the bladder base 
and perianal region. With the phased-array multicoils, the FOV can be adjusted to the entire 
pelvic region. On endoluminal MRI, image volume encompasses the entire sensitive re-
gion of the coil. With this concise protocol, scanning times may be limited to an average 
of 20 minutes per patient. If malignancy is suspected or has to be excluded, a dynamic 
contrast-enhanced series may be considered. Lesion detection and characterization may 
be enhanced with diffusion-weighted imaging and apparent diffusion coefficient mapping 
[7]. To evaluate for prolapse, a dynamic true fast imaging with steady-state free precession 
(true FISP) or HASTE sequence in the midsagittal plane may be performed [8]. The true FISP 
sequence is performed as a continuous acquisition with the patient alternating every 5 
seconds between rest and maximal strain. The dynamic HASTE sequence is performed with 
multiple acquisitions per slice alternating between rest and maximal strain. Especially for 
ectopic ureter, MR urography has proven to be a sensitive diagnostic tool [9]. 
Intravaginal Coil 
Placement 
TR/TE 
(ms) 
FOV 
(mm) 
Matrix Slice Thickness/
Gap (mm)
MRI system 1.5 T 3 T 1.5 T 3 T 1.5 T 3 T 1.5 T 3 T
Axial T2-weighted TSE 3581/119 5321/116 120 120 384 × 256 256 × 256 2.5/0.3 2/0.2
Axial T2-weighted TSE 
with fat saturation 
5494/82 3366/120 120 120 256 × 224 224 × 224 2.5/0.3 2/0.2
Coronal T2-weighted TSE 3091/113 4182/102 140 120 320 × 224 224 × 224 2.5/0.3 2/0.2
Sagittal T2-weighted TSE 2601/94 4175/101 120 120 320 × 224 224 × 224 2.5/0.3 2/0.2
Note—TSE = turbo spin-echo.
Pelvic Phased-Array Coils TR/TE (ms) FOV (mm) Matrix Slice Thickness/
Gap (mm)
MRI System 1.5 T 3 T 1.5 T 3 T 1.5 T 3 T 1.5 T 3 T
Axial T2-weighted TSE 5860/121 6010/127 200 200 384 × 256 416 × 384 3.0/0.3 3.0/0.3
Axial T2-weighted TSE with fat 
saturation 
5060/80 5733/121 200 200 256 × 224 224 × 224 3.0/0.3 3.0/0.3
Coronal or sagittal T2-weighted 
TSE 
3360/111 3568/127 200 200 320 × 224 416 × 384 3.0/0.3 3.0/0.3
Note—TSE = turbo spin-echo.
table I: suggested MRI scan Parameters for high Resolution t2-weighted Imaging of the Female urethra 
and Periurethral region using an endoluminal coil
table 2: suggested MRI scan Parameters for Dedicated t2-weighted Imaging of the Female urethra and 
Periurethral region using an external Pelvic coil
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Urodynamic Studies
Urodynamic studies, or urodynamics, include cystometry, urinary flow and urethral pres-
sure studies, stress testing, video-urodynamic studies, and electrophysiological studies. The 
main indications for urodynamic studies are incontinence and associated voiding problems 
(lower urinary tract symptoms). In a study of 60 women with clinically evaluated chronic 
lower urinary tract symptoms, urodynamic studies showed the final diagnosis in 22% of 
patients, which included dysfunctional voiding (12%) and interstitial cystitis (10%) [4]. 
cLassIFIcatIon
A classification for lower urinary tract symptoms based on the causal substrate may be 
complicated. However, considering the more common causes for lower urinary tract symp-
toms, we believe that lower urinary tract symptoms can be subcategorized into morpho-
logic abnormalities of the bladder, urethra, and periurethral region or functional disorders 
of the lower urinary tract and pelvic floor. We propose the following subclassification, the 
categories of which will be more fully discussed.
Structural Abnormalities of the Lower Urinary Tract and Periurethral 
Region 
Lesions of the urethra
•		 Cystic	lesions:	urethra	diverticula,	non-communicating	submucosal	cyst
•		 Urethritis,	inflammatory	conditions,	and	fistulization
•		 Urethral	caruncle
•		 Neoplastic	 alterations	 and	malignancy:	benign	 tumors,	nephrogenic	 adenoma,	pseu-
doinflammatory tumor, urethral carcinoma, malignant melanoma
Lesions of the periurethral region
•		 Cystic	lesions:	vagina	wall	 inclusion	cyst,	cyst	of	urogenital	sinus	origin	(cyst	of	Skene,	
cyst of Bartholin), developmental cysts of paramesonephric duct (müllerian cyst) and 
mesonephric duct origin (Gartner cyst), others
•		 Benign	solid	lesions:	fibroma,	leiomyoma,	neurofibroma,	lipoma,	myoblastoma,	heman-
gioblastoma, others.
•		 Altered	structure	of	urethra	and	periurethral	region:	defects	of	the	urethral	supporting	
structures, periurethral fibrosis.
•		 Endometriosis
•		 Locally	advanced	carcinoma	with	urethral	involvement
Prolapse abnormalities of the lower urinary tract
•		 Hypermobility	of	the	urethra,	urethrocele,	cystocele
•		 Prolapse	of	the	urethra	
Miscellaneous
•		 Ectopic	ureter	
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Functional Abnormalities of the Lower Urinary Tract
•	Dysfunctional	voiding
•	Interstitial	cystitis	(painful	bladder	syndrome)
•	Others	
 
LesIons oF the uRethRa
Cystic Lesions
Urethral diverticula in women are generally thought to be acquired (Fig. 1), most often as a 
result of obstructed drainage of the periurethral glands, with subsequent cystic dilatation 
or abscess formation. Other causes are direct or indirect trauma to the urethra mainly from 
vaginal birth, urethral catheterization (Fig. 2), cystoscopy, urethral dilatation, or surgical pro-
Fig. 1. 37-year-old woman with dysuria and dyspareu-
nia. A, 1.5-T axial T2-weighted image with pelvic coil 
obtained in 2004 shows crescent-shaped urethral di-
verticulum (arrow) that was managed conservatively. 
Patient returned in 2011 with complaints of persistent 
and increasing symptoms. B, In repeat study performed 
in 2011, 3-T axial T2-weighted image with intravaginal 
coil (asterisk) shows increase in size of urethral diver-
ticulum (long arrow) with ventral extension, including 
diverticular neck and ostium (short arrow). C, Photomi-
crograph (H and E, ×200) shows histology slice through 
this urethral diverticulum (after surgical resection) with 
urothelium lining of lumen, including subepithelial in-
filtration of lymphocytes and plasma cells.
a b
c
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cedures of the urethra. Dedicated MRI will show the configuration of urethral diverticula, 
including visualization of the ostium in 84% of cases [4].
Urethritis, Inflammatory Conditions, and Fistulization
Inflammation of the urethra and periurethral glands can result from bacterial (common: 
gonorrhea and Chlamydia) infections and noninfectious causes, such as Reiter disease and 
Crohn disease. Radiation injury can be another cause (Fig. 3). Sometimes, inflammation may 
Fig. 2. 26-year-old woman with postmicturition dripping, dyspareunia, recurrent lower urinary tract infections, 
and inability for bladder catheter insertion. Symptoms originated after painful urethral catheterization at delivery 
8 months before imaging. A and B, Midline (A) and off-midline (B) 3-T sagittal T2-weighted images with intravagi-
nal coil (asterisk) show traumatic urethral diverticulum (long arrow). Short arrow indicated new urethral lumen, 
and arrowhead indicates original lumen.
Fig. 3. 82-year-old woman 3 years after low anterior 
resection for T3N0M0 rectal cancer and colostomy. 
Local recurrence (not shown) left pelvic side wall on 
follow-up MRI after neoadjuvant combined chemo-
radiotherapy. Patient complained of obstructive 
urinary symptoms and dysuria. Sagittal T2-weighted 
1.5-T image with pelvic coil shows thickened urethra 
(arrows) with preserved layered structure of wall 
consistent with radiation-induced inflammatory 
reaction. Star indicates centrally located thickened 
mucosal layer surrounded by thickened submucosal 
layer (arrowheads). A = anus, B = bladder. Compare 
with normal structure of urethra in Figure 6.
a b
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become extensive and may mimic malig-
nancy. Clinical history and evaluation are 
important for proper diagnosis. On MRI, 
urethritis can be seen as a fusiform thick-
ening of the urethra with retained layering 
structure of the urethral wall (Fig. 3).
Malignancy, however, usually shows a loss 
of the layered structure of the urethra wall. 
In equivocal cases, ultimately pathologic 
analysis may be needed. Fistulization from 
genital organs to the urethra or bladder 
may complicate inflammation or local sur-
gery (Fig. 4). 
Urethral Caruncle
Urethral caruncle is a common benign 
exophytic lesion of the urethral meatus 
usually encountered in postmenopausal 
women. Urethral caruncle most likely rep-
resents ectropion of the dorsal urethral 
mucosa secondary to postmenopausal 
regression of the vaginal mucosa. At his-
tologic examination, caruncles exhibit a hyperplastic squamous epithelium with underlying 
submucosal vascularity, fibrosis, and inflammation. Imaging of urethral caruncle is generally 
not necessary. 
Fig. 4. 34-year-old woman 10 months after cesarean 
delivery with recurrent lower urinary tract infections, 
involuntary loss of urine, and dyspareunia. Sagittal T2-
weighted 1.5-T image with pelvic coil shows vesicocer-
vical-vaginal fistula (arrow) as high-signalintensity lin-
ear structure connecting bladder lumen with cervical 
lumen.
Fig. 5. 43-year-old woman with obstructive urinary 
flow symptoms, including painful intralabial lump on 
physical examination. Sagittal T2-weighted 3-T image 
with intravaginal coil (asterisk) shows smoothbor-
dered tumor (arrow) with homogeneous high signal 
intensity (SI). Lesion was initially interpreted (clinically 
and on imaging) as fibroepithelial polyp because of 
polypoid appearance, which seems to be in continu-
ity with submucosal layer (arrowhead) of urethra and 
relative high SI on T2-weighted imaging. Complete 
surgical resection was performed with leiomyoma 
proven on pathology analysis. Urethral leiomyoma 
typically has low or intermediate SI on T2-weighted 
images (compare with Fig. 11) and paraurethral ori-
entation locating lesion in relation to outer muscle 
layers of urethral wall.
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Neoplastic Alterations and Malignancy
Benign tumors—Common benign urethral masses include condyloma, fibroepithelial pol-
yps, hemangioma, and leiomyoma. These may present as an intralabial mass with obstruc-
tive symptoms. Urethral involvement by condylomata is reported in 5–31% of patients 
with genital condylomata caused by human papilloma virus and in 50% of patients with 
a condyloma at the urethral meatus [10, 11]. Fibroepithelial polyps are rare intraurethral 
lesions in young women. Urethral hemangiomas are exceedingly rare. They appear as an 
erythematous inflamed mass surrounding the urethral meatus [12]. Urethral leiomyoma 
(Fig. 5) usually arises from the circular smooth layer of the urethra. MRI may show the site 
of origin and extension of the lesion, which may be beneficial for surgery. Imaging features 
suggestive of benignity are well-defined borders and homogeneous signal intensity (SI) of 
the lesion (Fig. 5).
Nephrogenic Adenoma
Diverticula are characteristically lined by urothelium (Fig. 1), but squamous and glandular 
metaplasia commonly occur in response to chronic  inflammation [13]. Nephrogenic ad-
enoma is a benign epithelial tumor localized at the level of the urothelium and caused by 
metaplasia. The lesion may present as thick irregular septa (Fig. 6A) or a mass lesion within a 
urethral diverticulum on MRI and may be interpreted as carcinoma within the diverticulum. 
Distinguishing nephrogenic metaplasia (Fig. 6B) from adenocarcinoma on histology can be 
challenging [13].
Fig. 6. 45-year-old woman with dysuria, dyspareunia, and postmicturition dripping. A, Axial T2-weighted 1.5-T 
image with pelvic coil shows multilocular multiseptated cystic lesion (arrow) surrounding midurethra. Surgical 
resection revealed complicated urethral diverticulum with thickened wall, internal septa, debris, and small calculi. 
A = anus, V = vagina. B, Photomicrograph (H and E, ×200) at histology analysis shows nephrogenic adenoma 
composed of small tubules and microcysts embedded in edematous stroma with chronic inflammation within 
urethral diverticulum. Tubules and microcysts are covered by flat and cubical epithelium and locally hobnail cells 
encircled by prominent eosinophilic basal membrane (arrows).
a b
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Pseudoinflammatory Tumor of the Urethra
Clinically and radiologically, inflammatory pseudotumors resemble malignant tumors with 
extension into adjacent structures and organs, including heterogeneous SI and contrast 
enhancement on MRI (Fig. 7). Histopathology examination reveals the presence of spindle 
cells, myofibroblasts, plasma cells, lymphocytes, and histiocytes.
a b
Fig. 7. 73-year-old woman with dysuria, nocturia, 
and obstructive urinary flow. Axial T2-weighted 
1.5-T image with pelvic coil shows tumor of urethra 
(long arrow) with expansion into vaginal wall (short 
arrows). Biopsy of lesion revealed inflammatory 
pseudotumor with extensive inflammation consist-
ing of lymphocytes, plasma cells, histiocytes, and 
eosinophilic and neutrophilic granulocytes within 
subepithelial connective tissue, together with ne-
crosis. Additional histochemical staining (periodic 
acid and Ziehl-Neelsen) did not reveal fungi or my-
cobacteria. After treatment with corticosteroids, tu-
mor reduced significantly in size.
Fig. 8. 56-year-old woman with initial symptoms of painful and obstructive urinary flow. Imaging took place 
almost 6 weeks after surgical intervention in another hospital because of urethral stenosis with proven squamous 
cell carcinoma, probably arising within urethral diverticulum. Symptoms at time of imaging were fast-growing 
extremely painful mass at urethral meatus and vaginal wall. A and B, Axial T2-weighted 1.5-T image with pelvic 
coil (A) and axial T1-weighted image with fat saturation after IV administration of gadolinium chelate (B) show 
locally advanced tumor of distal urethra extending to os pubis on right (arrow). Gadolinium-enhanced image (B) 
reveals invasion of right pubic bone (arrowhead), finding that is not clear on A.
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Urethral Carcinoma
Approximately 10% of surgically resected 
diverticula show atypical glandular find-
ings, including invasive adenocarcinoma 
[14]. Adenocarcinoma accounts for up to 
70% of carcinomas arising in urethral di-
verticula. Squamous cell carcinoma usually affects the distal urethra (Fig. 8); adenocarcino-
ma and transitional cell carcinoma occur in the proximal urethra. Pelvic examination (under 
anesthesia) combined with cystourethroscopy and biopsy of the lesion is required. MRI can 
be used for proper local staging (Fig. 8). 
Malignant Melanoma
Malignant melanoma may rarely include 
the urethra as either a primary (Fig. 9) or 
a metastatic site. Initially, the lesion may 
present as a well-defined polypoid mass 
lesion with homogeneous SI (Fig. 9) and 
may resemble a benign lesion on MRI. Final 
diagnosis is usually assessed by pathology.
LesIons oF the 
PeRIuRethRaL RegIon
Periurethral masses may be cystic or solid. 
The clinical presentation correlates with 
the position of the mass in relation to the 
urethra. Centrally located masses may 
lead to dysuria, frequency, dyspareunia, 
hematuria,
and obstructive symptoms. Imaging may 
be considered to confirm the cystic or 
solid nature and to assess the depth and 
extent of the lesion before surgery.
Fig. 9. 79-year-old woman with painful mass at 
urethral meatus, dysuria, and obstructive urinary 
symptoms. Sagittal T2-weighted 1.5-T imagewith 
pelvic coil shows pathology-proven primary mela-
noma (arrow) located in dorsal urethral meatus with 
extension in perineum and involvement of ventral 
vaginal wall. Note cystocele of dorsal bladder wall 
(arrowhead) with position below pubococcygeal 
line (dashed line).
Fig. 10. 32-year-old woman with increasingly painful 
lump behind urethral orifice with obstructed urinary 
flow and dyspareunia. Sagittal T2-weighted 1.5-T image 
with intravaginal coil (asterisk) shows surgically con-
firmed infected cyst of Skene (arrow). Lesion has typical 
location in floor of distal urethra (left-sided) with low-
signal-intensity content, which is suggestive of infected 
cyst of Skene.
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Cystic Lesions
Benign vaginal and periurethral cystic le-
sions are frequently encountered in gy-
necologic and female urologic practices. 
These may be congenital or acquired. Pre-
existent asymptomatic cystic lesions may 
become symptomatic after intralesional 
hemorrhage or infection. Symptomatic le-
sions will therefore often display atypical SI 
characteristics of the content of the lesion. 
Hemorrhagic cysts may show low SI on 
T2-weighted and high SI on T1-weighted 
imaging. Infected cysts may show debris 
(sedimentation layer) within the cyst and 
a thick enhancing border. Vaginal wall in-
clusion cysts are small, often asymptom-
atic, and more common in the anterior wall 
[15]. Surgical treatment in which a vaginal 
mucosa island is buried leads to a risk of 
epithelial inclusion cyst formation. The cyst 
of Skene is thought to result from inflam-
mation of the glands and ducts of Skene 
with subsequent obstruction at its urethral 
connection (Fig. 10). Complete surgical 
excision is effective [16–18]. The cyst of 
Bartholin is typically located in the lateral 
introitus medial to the labia minora. Pain 
may herald infection of the cyst and may require surgical attention. Clinically, the distinction 
between müllerian cysts and Gartner duct cysts is of little importance. Müllerian cysts rep-
resent vaginal cysts of paramesonephric duct origin that are lined with stratified squamous 
epithelium and originate anywhere in the proximal four fifths of the vagina. Gartner cysts are 
lined with cuboid or low columnar epithelium and are located on the anterolateral aspects 
of the vagina. Gartner duct cysts can also be associated with abnormalities of the metaneph-
ric urinary system (ectopic ureter, unilateral 
renal agenesis, and renal hypoplasia) [19]. 
Benign Solid Lesions
Primary lesions are usually evident on 
physical examination and include fibroma, 
leiomyoma, neurofibroma, lipoma, myo-
Fig. 11. 36-year-old woman with pollakisuria, urge-
complaints with no incontinence, dysuria at end mic-
turition, and dyspareunia. Unclear mass lesion was seen 
at bladder base on clinical examination with endovagi-
nal ultrasound. Sagittal T2-weighted 1.5-T image with 
pelvic coil shows rounded tumor (T) with low signal 
intensity below bladder base that cannot be clearly dis-
criminated from bladder wall. Complete laparoscopic 
resection of lesion was performed and proved to be 
hyalinized leiomyoma of Retzius space.
Fig. 12. 59-year-old woman with stress-urinary in-
continence and dysuria. Axial T2-weighted 3-T MR 
image with endoluminal coil (asterisk) in anus shows 
disruption of periurethral ligament (arrow) and loss 
of vaginolevator attachment (arrowhead) on right 
with dorsal displacement of vagina (V).
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blastoma, and hemangioblastoma. Once 
biopsy establishes the diagnosis, surgical 
resection is performed for symptomatic 
relief. Periurethral leiomyoma (Fig. 11) commonly arises from the anterior vaginal smooth 
muscle or vesicovaginal septum. These are rare benign tumors representing about 4% of 
periurethral masses in women between 30 and 50 years old [20]. 
Altered Structure of Urethra and Periurethral Region; Defects of the 
Urethral Supporting Structures, Periurethral Fibrosis
Although the periurethral ligaments may not be clearly shown on MRI  without an endo-
vaginal coil, wherever possible the symmetry and integrity of the periurethral ligaments 
should be analyzed, especially in women with symptoms of urinary incontinence [21]. 
Fig. 13. 69-year-old woman with clinical occult pain 
in vagina and retropubic region and dysuria (pain-
ful and obstructive micturition). Axial T2-weighted 
1.5-T image with pelvic coil shows fibrous strands 
(arrowhead) with adhesions of urethra, vagina, and 
puborectal muscle (P) on left. Patient was treated 
conservatively with repeated local infiltration of an-
esthetic on left side of urethra and vagina, with sig-
nificant relief of symptoms. Patient refused surgery. 
In this case, MRI served as road map to guide local 
therapy.
Fig. 14. 40-year-old woman with medical history of pelvic surgery for endometriosis with intractable pain in 
pelvic region and dyspareunia, including painful lump in vaginal wall. A and B, Axial 3-T images with pelvic coil 
show endometrioma (surgically and histologically confirmed) in vaginal wall (arrows). Note low signal intensity 
(SI) on T2-weighted image (A) and high SI on T1-weighted image (B), suggestive of bloody content of lesion. Local 
symptoms improved significantly after surgical clearance of lesion.
a b
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Stress urinary incontinence may be as-
sociated with defects of the urethral sup-
porting structures [22] (Fig. 12).
Periurethral fibrosis is not rare in women 
with lower urinary tract symptoms and 
urodynamic evidence of obstruction [4, 6]. 
Periurethral fibrosis may be treated surgically with transvaginal ureterolysis [6]. Periurethral 
fibrosis may be recognized on MRI as a non-mass-forming lesion with strands of low SI ad-
hesive to adjacent structures (Fig. 13). 
Endometriosis
Primary occurrence of endometriosis in the periurethral region is rare and usually repre-
sents a secondary manifestation of pelvic disease. Endometriosis should be considered in 
patients with a history of pelvic pain who present with lower urinary tract symptoms and 
a periurethral lesion [23]. Typically, the lesion will display high SI on T1-weighted imaging, 
which is indicative of the hemorrhagic content (Fig. 14). 
Fig. 15. 56-year-old woman with newly diagnosed 
vaginal carcinoma (cT4aN0M0). Symptoms include 
vaginal blood spotting with dyspareunia and dys-
uria. Axial T2-weighted 1.5-T image with pelvic coil 
shows vaginal carcinoma on left with extension to 
puborectal muscle (arrow) and tumor invasion of 
urethra (arrowhead).
Fig. 16. 74-year-old woman with obstructive micturition and dysuria.
A and B, Midline sagittal HASTE 1.5-T images with body coil obtained at rest (A) and maximal strain (B) reveal ure-
thral hypermobility. Note horizontal translation (B) of urethra away from normal vertical oriented axis (A) during 
strain, which is consistent with hypermobility of urethra (arrowhead).
a b
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Locally Advanced Carcinoma With Urethral Involvement
Locally advanced carcinoma with urethral involvement may include stage IV bladder, va-
gina, vulva, cervix, and anorectal carcinoma. Tumor extension to the urethra with loss of the 
normal layered structure of the urethra may be discerned (Fig. 15). 
Prolapse Abnormalities of the Lower Urinary Tract
Pelvic organ prolapse results when the support mechanisms to individual organs are dis-
rupted. Symptoms may range from mild vaginal pressure to urinary incontinence or reten-
tion. Urodynamics and anorectal manometry are useful in localizing the problems to the 
anterior (bladder and urethra), middle (vagina, cervix, uterus, and adnexa), and posterior 
(anus and rectum) compartments [24].
Hypermobility of the Urethra, 
Urethrocele, Cystocele
Cystocele or urethrocele forms when the 
bladder base or urethra descends below 
the pubococcygeal line (extends from the 
most inferior portion of the symphysis pu-
bis to the last coccygeal joint and defines 
the level of the pelvic floor) (Fig. 9). This 
results from a loss of the normal fascial 
supports [25].
Hypermobility of the urethra is defined 
as a horizontal translation of the urethra 
away from the normal vertically oriented 
axis, with strain at an angle greater than 
30° [8] (Fig. 16).
Prolapse of the Urethra
Urethral prolapse presents as a circular 
mucosal eversion of the distal urethra 
from the external meatus (in contrast to 
a caruncula, which usually presents with 
a partial eversion of the dorsal urethra). 
Diagnosis is usually certain on physical 
examination and no imaging is necessary.
Ectopic Ureter
An ectopic ureter (Fig. 17) may present 
as incontinence in an older girl or young 
woman in combination with recurrent uri-
Fig. 17. 13-year-old girl with recurrent intractable drop 
incontinence (day and night), including recurrent lower 
urinary tract infection. Clinical evaluation, including 
urethrocystoscopy showed no abnormalities. Repeated 
ultrasound examinations revealed no abnormalities. 
MR urography at 1.5 T with body coil (coronal 3D, thick 
slab, heavily T2-weighted fast spin-echo with fat satu-
ration) shows duplicature of collecting system of right 
kidney with dysplastic upper pole, including dilated 
ureter with ectopic termination in upper vagina on 
right. Surgical resection was performed of upper pole, 
including associated ureter, with histology-confirmed 
segmental tubulointerstitial nephritis and atrophy. 
Clearance of symptoms was observed after surgery. 
Note medial position of dilated right-sided upper pole 
ureter (arrow) compared with normal lateral position of 
lower pole ureter and left ureter (arrowheads). Normal 
termination of these at ureteral meatus was confirmed 
at cystoscopy.
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nary tract infections. MR urography (Fig. 17) has proven to be a sensitive tool for diagnosis 
[9].
concLusIon
We have presented a subclassification of morphologic abnormalities based on anatomic 
region that can be considered in the differential diagnoses for chronic lower urinary tract 
symptoms in women. In addition, we have shown the power of dedicated state-of-the-art 
MRI for diagnosis. Dedicated MRI tailored to patient symptoms and clinical findings has the 
potential to map morphologic causes and facilitate appropriate treatment.
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abstRact
Objective The purpose of this study was to evaluate the role of MRI in the diagnosis and dif-
ferential diagnosis of urethral diverticula in symptomatic women.
Materials and methods Women referred for MRI at a single institution because of suspicion 
of urethral diverticula were included. All MRI examinations were independently evaluated 
by two radiologists and compared with patients’ follow-up data. Sensitivity and specificity 
of MRI for urethral diverticula were calculated using surgery and clinical confirmation as the 
reference standards. Image quality of the urethra and periurethral region performed with 
the endoluminal coil was compared with the pelvic phased-array coil.
Results From a study group of 60 patients (mean age, 44 years), 20 patients (33%) had ure-
thral diverticula and 28 (47%) had an alternative diagnosis, of which 13 (46%) were visual-
ized with MRI. In the remaining 12 patients (20%) no abnormalities were found. For urethral 
diverticula, MRI had both sensitivity and specificity of 100%. Twenty patients had a total of 
27 diverticula; these were mostly locally round (n = 12) with sharp margins (n = 25) and high 
(n = 19)  homogeneous (n = 16) signal intensity on T2- weighted sequences. The ostium of 
urethral diverticula was identified in 23 diverticula (85%) by both readers. Agreement was 
93% with κ = 0.72. Endoluminal coil placement in the vagina showed the best image quality 
of the urethra and periurethral region.
Conclusion Dedicated MRI is an excellent imaging modality for urethral diverticula; further-
more, MRI will show the alternative diagnosis in almost one half of the remaining patients. 
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IntRoDuctIon
Female urethral diverticulum is often overlooked and frequently misdiagnosed because 
of unawareness of the condition. Urethral diverticula are estimated to occur in 1–6% of 
women. Although usually diagnosed between the third and fifth decade of life, it can affect 
all age groups [1–3]. Usually, an array of nonspecific genitourinary symptoms predominate. 
The most frequent symptoms described are frequency and urgency (40–100%), dysuria 
(30–70%), recurrent urinary tract infection (30–50%), postmicturition dribble (10–30%), dys-
pareunia (10–25%), and hematuria (10–25%) [4, 5]. It may also present with a tender mass 
(35%), urinary incontinence (32%), stones (1–10%), discharge of pus from the urethra (12%), 
and retention (4%) [6]. This condition should always be considered in women with unex-
plained lower urinary tract ymptoms. In addition to interstitial cystitis, urethral syndrome, 
and urgency-frequency syndrome, the clinician should include urethral diverticula in the 
differential diagnosis [7]. Appropriate investigations play an important role in the diagnosis 
of urethral diverticula and ideally should provide the surgeon with information regarding 
location, number, size, configuration, and communication of the urethral diverticula [8]. MRI 
has now become the imaging study of choice [8]. The purpose of this study was to evalu-
ate the role of MRI in the diagnosis of urethral diverticula and differential diagnosis for this 
condition in symptomatic women. 
MateRIaLs anD MethoDs
This study was performed without financial support, and the authors had exclusive control 
of the data and information presented in this article. 
Patient Population
Institutional review board approval was obtained for this retrospective study, and informed 
consent was waived. Women referred for MRI at a single institution because of clinical sus-
picion of urethral diverticula were included in the study. Patients were electronically identi-
fied using a department database. All patients had two or more lower urinary tract symp-
toms, including pain, urinary incontinence, dyspareunia, and frequency or urgency. Patients 
were excluded when no convincing information for suspicion of urethral diverticula was 
presented. From hospital- and department-based digital information systems, a search was 
performed to assess the specific diagnosis for the complaints for which the patient was 
referred to the MRI unit. The reference standard was surgery or, in case no surgery was 
performed, confirmation of MRI findings with a second imaging modality, including video 
urodynamic studies and voiding cystourethrography and clinical examination. 
MRI Technique
All examinations were performed using a 1.5-T MR imager (Gyroscan NT Intera 1.5, Philips 
Healthcare) with application of a rigid endoluminal coil placed in the vagina (n = 17) or 
in the anus (n = 2) or with a pelvic phased-array coil (n = 6). The endoluminal coil is com-
mercially available and consists of a fixed, rectangular, 60-mm-long rigid receiver coil with 
a width of 16 mm. The coil is contained within an 80-mm-long cylindric coil holder with a 
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diameter of 19 mm. Before the introduction of the coil into the vagina or anus, a condom 
was placed over the coil and ultrasound gel was used as a lubricant. It should be noted 
that this rigid endoluminal coil is not the same as the inflatable rectal coil but is of smaller 
diameter and is designed to be placed in the vagina or anus. The phased-array coil is a 
commercially available four-channel coil (Synergy, Philips Healthcare) placed around the 
pelvis. A standardized imaging protocol of T2-weighted turbo spin-echo and gradient-echo 
sequences with and without fat saturation was performed in all cases, with high-resolution 
slices in three planes (axial, coronal, and sagittal) through the urethra and periurethral re-
gion. The FOV included the bladder base and perianal region. At endoluminal MRI, image 
volume encompassed the entire sensitive region of coil. For the endoluminal coil, param-
eters were transverse T2-weighted fast-field echo imaging (TR/TE, 23/14; matrix, 205 × 256; 
flip angle, 60°; FOV, 140 mm; thickness, 2 mm with no gaps; and two signals acquired). 
Transverse T2-weighted fast spin-echo MRI was performed with and without fat saturation 
(TR/TE, 5086/100; matrix, 186 × 256; flip angle, 90°; FOV, 120 mm; section thickness, 4 mm 
with a 0.4-mm gap; and three signals acquired). Coronal and sagittal T2-weighted fast spin-
echo MRI was performed without fat saturation (TR/ TE, 2454/100; matrix, 186 × 256; flip 
angle, 90°; FOV, 120 mm; section thickness, 4 mm with a 0.4-mm gap; and four signals ac-
quired). For the pelvic phased-array coils, parameters were transverse, coronal, and sagittal 
T2-weighted fast spin-echo sequences without fat suppression (TR/TE, 2500/70; matrix, 512 
× 256; flip angle, 60°; FOV, 300 mm; section thickness and gap, 3 mm and 0.3 mm, respec-
tively; and two signals acquired) and transverse T2-weighted fast spin-echo with fat sup-
pression (TR/TE, 4000/85; matrix, 512 × 256; flip angle, 60°; FOV, 300 mm; section thickness 
and gap, 3 mm and 0.3 mm, respectively; and two signals acquired). Transverse fat-saturat-
ed T1-weighted fast spin-echo imaging after IV gadolinium chelate administration (0.2 mL/
kg of 0.5 mmol/mL of gadopentetate dimeglumine [Magnevist, Schering]) was performed 
in few (n = 6) cases (TR/TE, 3.61/1.4; matrix, 512 × 256; flip angle, 15°; FOV, 300 mm; section 
thickness and gap, 4 mm and 0.4 mm, respectively; and one signal acquired). 
Image Analysis
All MRI examinations were loaded in a PACS viewing station from digital storage facilities 
and were examined by two observers with experience in reading approximately 2500 and 
500 pelvic MR examinations, respectively. The observers were blinded to the patient history, 
findings in the clinical workup, or other imaging studies and to each other’s results. The 
following items were evaluated separately by both observers: MRI examination technique 
using the pelvic phased-array or endoluminal coil placed in the vagina or in the anal canal; 
number of urethral diverticula; size of urethral diverticula on three axes: anteroposterior, 
transverse, and craniocaudal measured in mm; shape of urethral diverticula (locally round, 
oval shaped, circumferential, or elongated); identification of the ostium of urethral divertic-
ula in the urethra; localization of the ostium with “uncertain” added as a separate category; 
distance of the ostium to the bladder neck measured in mm; signal intensity of urethral 
diverticula on T2-weighted images; borders of urethral diverticula (well-defined or ill-de-
fined); important remarks, such as stones or suggestion of other solid components within 
urethral diverticula; added value of T1-weighted sequences with IV gadolinium chelate ad-
ministration; and alternative diagnoses. The ostium of urethral diverticula was defined as 
a beaklike linear extension of the diverticular neck through the muscular and submucosal 
layers of the urethra with high signal intensity on T2-weighted images. Image quality of the 
urethra and periurethral region with the pelvic phased-array or endoluminal coil was evalu-
ated by both observers. Every examination was scored independently by both observers 
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using a 3-point scale (fair, satisfactory, and excellent), indicating the best detailed anatomy 
of the urethra and periurethral region in the perception of the observer. 
Statistical Analysis 
Ninety-five percent confidence intervals were calculated for sensitivity and specificity. Com-
parisons of percentages between groups were performed using Fisher’s exact test. The limit 
of significance was set at p = 0.05 (two-sided). Kappa statistics were used to quantify de-
grees of agreement between readers for identifying the ostium of the diverticulum in the 
urethra. The classification “uncertain” was included in the latter calculation as a separate 
category. A kappa value ≤ 0.20 was interpreted as slight agreement; 0.21–0.40, fair agree-
ment; 0.41–0.60, moderate agreement; 0.61–0.80, substantial agreement; and ≥ 0.81, almost 
perfect agreement. 
ResuLts
Between January 1995 and December 2006, 1541 women underwent MRI of the pelvis 
and pelvic floor for a variety of reasons. We identified 60 patients (all women; mean age, 44 
years; age range, 18–80 years) who fulfilled the criteria for inclusion in the study population. 
In total, 20 patients had 27 urethral diverticula on 25 different MRI examinations. This in-
cluded three patients with follow-up MRI examinations after surgery because of persistent 
complaints and proved residual or recurrent urethral diverticula. Two patients underwent 
control MRI before surgery because of a long delay of 19 and 26 months, respectively, be-
tween the first MRI examination and surgery. Two patients had two separate urethral diver-
ticula with separate outlines and diverticular necks on a single MRI examination (Fig. 1). In 
16 patients, urethral diverticula were surgically proven. Surgery was performed between 2 
and 10 weeks after MRI. These patients had a total of 19 surgical procedures for urethral di-
verticula, including three patients with recurrent or residual urethral diverticula. In 17 cases, 
urethrocystoscopy was performed as a preoperative tool, with visualization of the ostium of 
urethral diverticula in eight cases. The lo-
cation of the ostium described in the sur-
gical report was in agreement with MRI. In 
the remaining nine surgical cases, identifi-
Fig. 1. 43-year-old-woman with multiple urethral 
diverticula. Axial T2-weighted image with fat satura-
tion performed with pelvic phased-array coil shows 
urethral diverticulum in 9-o’clock position (short ar-
row), including diverticular neck (curved arrow). Os-
tium (not shown) was located in midline anteriorly 
(12-o’clock position). Separate urethral diverticulum 
is seen posteriorly (long arrow) with ostium in mid-
line posteriorly (6-o’clock position). Both urethral 
diverticula, including diverticular neck and ostia, 
were confirmed surgically. U = urethra, V = vagina, 
A = anus.
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Fig. 2. 42-year-old-woman with elongated urethral 
diverticulum. A, Axial T2-weighted image shows 
subtle linear structure (arrow) with high signal inten-
sity within submucosal layer of urethra posteriorly, 
indicating location of ostium of urethral diverticu-
lum. Asterisk indicates endoluminal coil, A = anus.
B and C, Axial T2-weighted images show track of this elongated urethral diverticulum (arrow). Arrowhead in C 
indicates debris in apex of urethral diverticulum. Asterisk indicates endoluminal coil, R = rectum.
D, Voiding cystoureterogram shows same urethral diverticulum (arrows) with good correlation with MRI appear-
ance. To our knowledge, this type of urethral diverticula with its elongated nature has not been described before. 
Patient had no additional abnormalities of kidneys, ureters, and lower urinary tract.
a b
c
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cation and excision of urethral diverticula, including the diverticular neck, was documented. 
In these cases, MRI had good correlation concerning the orientation of urethral diverticula, 
including the diverticular neck, as was described in the surgical report. Four patients either 
refused surgery or preferred expectant management for urethral diverticula. In the patients 
with no surgery (n = 4), MRI findings of urethral diverticula were confirmed with follow-
up video urodynamics within 3 months after MRI (n= 4), including visualization of urethral 
diverticula on an initial voiding cystourethrography (n = 2), which was performed 4 and 5 
months before MRI (Fig. 2). In the clinical workup, which included palpation and massage 
of the urethra through the vagina, the diagnosis of urethral diverticula was considered con-
firmed and proved by the urologist as was documented in patients’ records. We searched for 
the clinically confirmed final diagnoses in the rest of the study group (Fig. 3). Twenty-eight 
of 60 patients (47%) had an alternative diagnosis. Thirteen (46%) were correctly diagnosed 
with MRI. Periurethral scarring, urethrovaginal fistula, infected cyst of Skene, cystocele, and 
endometriosis of the vaginal vault were confirmed by surgery. Periurethritis and inflam-
matory pseudotumor of the urethra were proved by biopsy. Dysfunctional voiding and in-
terstitial cystitis were confirmed by clinical evaluation, including video urodynamics, with 
no abnormalities found on MRI. Urethritis and vaginitis by Candida species was proved by 
specific laboratory findings and response to specific therapy, with no abnormalities found 
on MRI. In the remaining 12 patients (20%), no abnormalities were found on MRI and in 
the clinical follow-up. The follow-up period was at least 18 months and ranged from 1.5 
to 8 years (mean, 5 years). MRI showed the final diagnosis (urethral diverticula or alterna-
tive diagnosis) in 33 of 60 patients (55%). On the basis of MRI; clinical evaluation, including 
video urodynamics; and clinical data, 80% of patients were diagnosed with an abnormality 
that was responsible for their complaints. For the diagnosis of urethral diverticula, MRI had 
sensitivity of 100% (20 of 20 patients; 95% CI, 83–100%) and specificity of 100% (40 of 40 
patients; 95% CI, 91–100%). Of 25 MRI examinations with findings of urethral diverticula, 19 
were performed with the endoluminal coil placed in the vagina (n = 17) or anal canal (n = 
2), and 6 examinations were performed with the pelvic phased-array coil (Table 1). Imaging 
Quality Rigid Endoluminal  
Coil in Vagina
Phased-Array Coil Rigid Endoluminal  
Coil in Anus
Fair 0 0 2
Satisfactory 0 6 0
Excellent 17 0 0
table 1: Quality of Images of the urethra and Periurethral Region using Different MRI coils
table 2: shape of 27 urethral Diverticula on 25 MRI examinations in 20 women
Shape No. of Diverticula Largest Axis Range (mm)
Circumferential (100%) 4
26–33
Circumferential (50–99%) 8
Locally round or oval shaped 12 4–22
Locally crescent shaped 2 7–21
Truncated or fistulalike 1 25
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1541 female patients with MRI pelvis and pelvic floor
60 female patients with suspicion of urethra diverticula
Excluded 1481 patients
28 patients with alternative diagnosis (all diag-
noses considered proved by clinical follow-up 
data)
 
MRI proved 
7 dysfunctional voiding  –
6 interstitial cystitis  –
6 periurethral scarring  +
2 urethrovaginal fistula  +
1 urethritis by Candida species  –
1 vaginitis by Candida species  –
1 periurethritis not otherwise specified  + 
1 cystocele  +
1 urethral pseudoinflammatory tumor  + 
1 infected cyst of Skene  + 
1 endometriosis of vaginal vault  +
12 patients with no abnor-
malities found on MRI and 
clinical follow-up
20 patients with MRI di-
agnosis of urethral diver-
ticulum:
•		 16	proved	by	surgery
•		 4	 considered	 proved	
by clinical workup, 
including confirma-
tion of MRI findings 
by video urodynamics 
and voiding cystoure-
thrography
Fig. 3. Flow diagram summarizes patient sampling.
Fig. 4. 39-year-old-woman with urethral diverticulum imaged with pelvic phased-array coil. A, Axial T2-weighted 
image shows circumferential urethral diverticulum (short arrows) with internal inhomogeneity as a result of de-
bris, septa, and stone (long arrow).
B, Axial T2-weighted image shows unsharp margins of diverticulum, best seen on left (arrowheads), which is 
caused by perilesional inflammation (pathology proven). Ostium of this complicated urethral diverticulum was 
considered by two observers as “not identified” and “uncertain,” respectively.
a b
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with the endoluminal coil placed in the vagina had 17 of 17 graded excellent versus 0 of 6 
with phased-array imaging (p < 0.001, Fisher’s exact test). Too few patients (n = 2) were im-
aged with the endoluminal coil placed in the anus to evaluate the results statistically. Both 
observers fully agreed in each of the gradings displayed in Table 1 that visualization of the 
best image quality of the urethra and periurethral region occurred with the endoluminal 
coil placed in the vagina. Urethral diverticula had different shapes (Table 2). The most fre-
quent shape was locally round or oval. When considering the borders of the urethral diver-
ticula, most cases showed well-defined margins (n = 25). Two urethral diverticula showed 
partly sharp and partly ill-defined margins. This was caused by perilesional inflammation, 
which was proved by histology (Fig. 4). The ostia of urethral diverticula could be identi-
fied in 23 of 27 cases (85%) by both observers. Observer 2 could not identify the ostium in 
two diverticula and, in another two diverticula, considered this to be uncertain. Observer 
1 scored the same four diverticula as uncertain. The agreement was 93% (25/27) with κ = 
0.72. Twenty-three identified ostia of urethral diverticula by both observers were located in 
the midline anterior (12-o’clock position) (n = 1); left lower quadrant (between 3-o’clock and 
6-o’clock positions) (n = 11); midline posterior (6-o’clock position) (n = 4); and right lower 
Fig. 5. 35-year-old-woman with urethral diverticu-
lum. A, Axial T2-weighted image shows endoluminal 
coil (asterisk) placed in vagina. Arrow indicates locally 
rounded urethral diverticulum on left, A indicates 
anus. B, On next lower slice image, ostium of urethral 
diverticulum can be seen posteriorly as linear exten-
sion of diverticular neck through layered structure of 
urethra in midline (arrow). Arrowheads show puborec-
tal muscles with thinning and fibrosis of left compared 
with normal muscle thickness on right side. Asterisk 
indicates endoluminal coil, A indicates anus. C, Sagit-
tal T2-weighted image shows diverticulum consisting 
of two parts (straight arrows) and facilitates precise 
measurement of distance of diverticular neck (curved 
arrow) to bladder base. Asterisk indicates endoluminal 
coil placed in vagina, B = bladder, S = pubic symphysis, 
A = anus.
a b
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quadrant (between 6-o’clock and 9-o’clock positions) (n = 7) with the patient in the supine 
position. The mean distance of the ostia to the bladder neck was 12 mm (range, 7–36 mm) 
(Fig. 5). Twenty-three identified ostia of urethral diverticula by both observers were imaged 
with the endoluminal coil placed in the vagina (17 of 18 diverticula), or anal canal (2 of 2 
diverticula), or with the pelvic phased-array coil (4 of 7 diverticula). These findings tended 
toward significance regarding the identification of the ostium of urethral diverticula with 
the endoluminal coil placed in the vagina compared with the phased-array coil (p = 0.053, 
Fig. 7. 47-year-old-woman with circumferential urethra diverticulum. A, Axial T2-weighted image shows endolu-
minal coil (asterisk) placement in vagina results in better image quality of urethra and periurethral region com-
pared with Figure 2. Urethral diverticulum with sharp borders, homogeneous hyperintense signal intensity, and 
identification of ostium in right lower quadrant (arrow) are visualized. A indicates anus. B, Contrast-enhanced axial 
T1-weighted turbo spinecho image with fat saturation after IV gadolinium chelate administration image obtained 
at same level as A shows no enhancing components within urethral diverticula. Asterisk indicates endoluminal 
coil.
Fig. 6. 42-year-old-woman with circumferential urethral diverticulum. A, Axial T2-weighted image shows sharp 
borders (straight arrows) of urethral diverticulum with high inhomogeneous signal intensity containing debris 
on dependent side. Endoluminal coil (asterisk) is placed in anal canal. Curved arrow indicates urethra, and ar-
rowheads indicate puborectal muscles. B, Axial T2-weighted image acquired almost 1.5 years after surgery shows 
recurrent or residual urethral diverticulum (arrows). Image was acquired with four-channel phased-array pelvic 
coil. For optimal imaging results of urethral diverticula, smaller FOV is recommended (see also Figure 5).
a b
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Fisher’s exact test). On T2-weighted images, urethral diverticula had high signal intensity 
similar (n = 19) or slightly lower (n = 8) than the signal intensity of urine in the bladder. 
Signal intensity on T2-weighted sequences was homogeneous (n = 16) (Fig. 5) or inhomo-
geneous (n = 11) (Figs. 4 and 6A). Inhomogeneous signal intensity was found in diverticula 
containing debris (n = 9) (Fig. 6A) or debris, septa, and stone (n = 2) (Fig. 4). In six MRI ex-
aminations, gadolinium enhanced T1-weighted series were performed in addition to the 
T2-weighted sequences. Both observers were of opinion that contrast enhanced studies 
had no additional value for the diagnosis of urethral diverticula (Fig. 7). 
DIscussIon
In our study, urethral diverticula were diagnosed in 20 of 60 symptomatic women (33%) 
referred for MRI. Other studies reported urethral diverticula in 10% of patients examined 
with endorectal coil MRI or 74% of patients examined with a combination of transvaginal, 
transperineal, and urethral sonography (using a catheter-based transducer) [9, 10]. Previous 
MRI studies of symptomatic female urethral and periurethral diseases were based on the 
use of the pelvic phased array coil or the inflatable endoluminal coil placed in the vagina or 
in the rectum. To our knowledge, our study is the first with application of the rigid endolu-
minal coil in these patients. The rigid endoluminal coil can be inserted into the vagina by 
the patient herself, and there is no need for administration of glucagon or butylbromide to 
prevent rectal spasm, which could be the case when using the inflatable endoluminal coil 
[9]. Although a limited number of patients in our study was examined with the endoluminal 
coil placed in the anal canal or with the pelvic phased- array coil, a qualitative comparison 
suggests better image quality of the urethra and periurethral region with the endoluminal 
coil placed in the vagina (Table 1 and Figs. 4, 6A, and 7A). With intraanal placement of the 
endoluminal coil, the urethra falls slightly outside the sensitive region of the coil, whereas 
the perianal region is displayed in great detail (Fig. 6A). According to data in the literature 
and our experience, care should be taken to use the right scanning parameters. With the 
pelvic phased-array coil, a slice thickness of 3 mm and the use of axial T2-weighted turbo 
spin-echo sequences from the bladder base through the entire urethra has been recom-
mended [11] with no need for T1-weighted sequences or contrast-enhanced series for the 
diagnosis of urethral diverticula [8] (Fig. 7). With this dedicated imaging protocol, imaging 
times can be limited to an average of 15 minutes [8]. Contrast-enhanced studies, however, 
may improve visualization of granulation tissue or carcinoma within urethral diverticula and 
tumor spread to adjacent adipose tissue [12, 13]. Malignancy arising from a diverticulum 
can be visualized as enhancing soft tissue within the diverticulum [14]. Cancer within ure-
thral diverticula that is still small may be overlooked with torso phased-array MRI including 
gadolinium-enhanced sequences [15]. In our study, among 19 resected and pathology-
proven urethral diverticula, no carcinoma was found. Few studies have focused on the dif-
ferential diagnosis of patients with urethral diverticula. In the differential diagnosis, one 
should also consider other regional cystic lesions. Visualization of  communication between 
the lesion and the urethra confirms urethral diverticula [16]. The differentiation between a 
communicating or non-communicating cystic lesion with the urethra is important because 
the surgical approach for the two entities differs. Both lesions are resected; however, a di-
verticulum may require urethral reconstruction procedures [16–18]. To our knowledge, our 
study is the first to identify the ostium of urethral diverticula in the majority of cases (85%) 
on MRI with improved confidence using the rigid endoluminal coil rather than the pelvic 
phased-array coil. Kim et al. [19] could not identify the ostium of urethral diverticula on MRI 
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with application of the body or pelvic coil. Blander et al. [20] identified the diverticular neck 
(ostium) in 11 of 27 patients (41%) on MRI with the inflatable endoluminal coil. In our study, 
urethrocystoscopy showed the ostium of urethral diverticula in 47% of cases. Other studies 
have reported 52% accuracy of urethrocystoscopy in identifying the ostium of urethral di-
verticula [20]. This warrants accurate preoperative imaging to assess the precise location of 
urethral diverticula, including the diverticular neck and ostium with additional information 
regarding size, extent, content, and complexity of the lesion. This practice may shorten the 
duration and improve the outcome of the surgical procedure. The only study we found to 
clearly identify the ostium of urethral diverticula in the majority of cases used a combina-
tion of transvaginal, transperineal, and urethral sonography (using a catheter-based trans-
ducer) in 19 women with urethral symptoms [10]. The neck was precisely seen in 13 of 15 
diverticula on sonography, especially via the transurethral approach. The disadvantages of 
this modality are that most diverticular necks were identified using the transurethral ap-
proach, which is not as convenient for the patient and is not as readily available as trans-
vaginal and transperineal sonography [10]. Furthermore, transurethral sonography requires 
a dedicated intravascular sonographic unit as well as a catheter-based transducer [10]. In 
our study, MRI showed the final diagnosis (urethral diverticula or alternative diagnosis) in 33 
of 60 patients (55%). On the basis of MRI; clinical workup, including functional urodynamic 
studies; and clinical data, 80% of patients were diagnosed with an abnormality that was 
responsible for their complaints. According to these findings, in the diagnostic workup of 
women with suspicion of urethral diverticula, both MRI and urodynamic studies can be 
considered. After clinical evaluation, MRI can be considered to assess a physical cause. In 
addition, urodynamic studies may be used to evaluate associated urinary incontinence and 
for planning additional incontinence surgery to obtain the best postoperative results for 
urethral diverticula [8, 18, 21]. Bennett et al. [22] advocated that addition of a sagittal dy-
namic sequence to the MRI protocol will permit detection of pelvic organ prolapse that 
may not be evident on static at-rest images and that may also go undetected at physical 
examination. In 20% of our study group, no clear diagnosis could be established. No physi-
cal abnormalities were found on MRI and in the clinical follow-up. We believe that func-
tional aspects of the pelvic floor and supporting ligaments of the bladder base and urethra 
may be a cause for the complaints in these patients. Follow-up studies, including dynamic 
MRI and functional urodynamic studies, may be needed to evaluate these patients thor-
oughly. There were limitations to this study. First, our study was retrospective and included 
a relatively small number of urethral diverticula. Second, two control MRI examinations (be-
cause of a long delay of 19 and 26 months between the first MRI examination and surgery) 
were included for analysis of specific imaging features of urethral diverticula. This may have 
led to selection bias; however, we believe that the morphology of urethral diverticula may 
change in time depending on the state of filling and secondary inflammation. This may 
justify the inclusion of both examinations per patient. Third, we found that sensitivity and 
specificity of MRI for urethral diverticula were both 100%, using surgery and clinical confir-
mation as the reference standards. Not all 60 patients had the same additional evaluation 
for urethral diverticula, and thus the true sensitivity may not be 100%. Finally, there was no 
uniform reference standard. We consider surgery as the reference standard for urethral di-
verticula. Surgery was performed in the majority of patients (80%), with urethral diverticula 
proved. In the remaining patients, MRI findings of urethral diverticula were confirmed with 
a second imaging modality (video urodynamic studies and voiding cystourethrography) 
and considered proved by clinical examination and evaluation by the urologist. Further-
more, no reports were found in the hospital-based long-term follow-up data of these pa-
tients for whom the MRI findings of urethral diverticula were clinically in doubt. Neverthe-
less, we believe that adequate imaging and clinical follow-up information was available for 
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all patients, and therefore we consider our conclusions valid. In conclusion, there is an ex-
panding role for dedicated MRI in women with suspicion of urethral diverticula. MRI will 
show the diagnosis in more than one half of all patients. On the basis of MRI, functional 
urodynamic studies, and clinical evaluation, 80% of patients will be diagnosed with an ab-
normality that is responsible for their complaints. Additional studies should follow to clarify 
the reason for complaints in the remaining 20% of patients. 
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5.1
abstRact
Objective To assess the value of MRI for predicting surgical outcome of locally recurrent 
rectal cancer (LRRC). In addition, patterns for diagnosis of LRRC on MRI using T2- weighted 
sequences (T2W) and contrast enhanced series (CE MRI)  were evaluated. 
Methods Surgically resected LRRC with curative intent were included. MR image analysis, 
using T2W and CEMRI  of LRRC was done through visual interpretation by an experienced 
observer (reader 1) and compared with post processing image evaluation by an inexperi-
enced observer (reader 2). MRI findings of LRRC were correlated with surgery and histopa-
thology (PA) of the resected specimen.
Results A total of 51 lesions (47 patient) were included. Thirty (59%) tumors were radically 
resected (R0), 21 (41%) tumors were incompletely resected (R1). Lesions fixed to the pel-
vic side walls or presacral fascia (n=28) had 36% R0; non-fixed lesions (n=23) had 87% R0 
(p=0.001). Tumor measurements on CE MRI had better agreement with PA than T2W. Imag-
ing characteristics of LRRC on CE MRI include: arterial enhancement (100 %), persistent en-
hancement (100 %), dominant peripheral rim enhancement (59%), heterogeneous mosaic 
enhancement (21%).
Conclusions Tumor fixation to the pelvic side walls or presacral fascia yield incomplete re-
section margins in 64%, whereas non- fixed tumors were completely resected in 87%. CE 
MRI has typical imaging characteristics for LRRC and is more accurate for tumor assessment 
than T2W.
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IntRoDuctIon
Colorectal cancer  is a common malignancy and rectal cancer accounts for approximately 
one third of the colorectal malignancies [1]. Developments in the treatment of rectal can-
cer, such as neo-adjuvant (chemo) radiotherapy and total mesorectal excision, have signifi-
cantly reduced  local recurrence rate over the last decades. Currently, the local recurrence 
rate after rectal surgery amounts 5-10 % [2]. Locally recurrent rectal cancer (LRRC) often 
occurs within the first 2 years after treatment of the primary tumor and has often disabling 
and difficult to treat symptoms, such as severe pain, fistulating and bleeding tumors [3; 
4]. Radical surgical resection of the local recurrence offers the highest chance of  cure and 
leads to survival rates ranging between 14 % and 30 % [5; 6]. On the contrary, without surgi-
cal intervention LRRC is associated with a dismal 5-year survival rate of less than 4% (4). Early 
detection of LRRC may facilitate radical resection and thus achieve a better survival [6; 7].
Magnetic Resonance imaging (MRI)  is widely used for diagnosis and surgical planning of 
LRRC [8]. The diagnosis is challenging due to difficulty of differentiating actual recurrent dis-
ease from fibrosis and scarring [4; 7; 8]. This hinders the detection of local recurrences and 
also poses a problem in defining the exact tumor extent [8]. In addition to conventional MRI 
sequences (T1- and T2- weighted MRI),  contrast enhancement (CE MRI) has the potential 
to increase lesion visibility and conspicuity and thus may be of additional value in distin-
guishing malignant from non-malignant tissue. CE MRI effects are based on the principle 
of increased tumoral neovascularization with vascular permeability will display earlier and 
higher contrast enhancement than surrounding fibrosis or normal tissue [7; 9; 10]. 
The aim of this study was to evaluate the additional value of CE MRI, using image post 
processing tools and compare with visual image interpretation, for the assessment of LRRC. 
In addition, the value of MRI for predicting surgical outcome (radical or involved resection 
margins) was assessed.
MateRIaL anD MethoDs
Institutional approval was obtained for this retrospective analysis and informed consent 
was waived.
Patient selection 
From a prospectively collected database we selected all patients with histologically proven 
LRRCs who were treated by intentionally curative surgery between January 2003 and De-
cember 2012 in a tertiary referral center. All patients were discussed in a multidisciplinary 
tumor board which included a specialized surgeon, radiologist, oncologist and radiothera-
pist to determine the optimal treatment strategy. During this period all patients were staged 
by a standard MRI protocol, which included T1-, T2- weighted sequences and CE MRI series. 
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MR Imaging protocol  
MRI examinations were performed on a 1.5 T system (General Electric Medical systems, 
Milwaukee, USA) using a pelvic coil (8- or 16-channel phased array multicoil). A standard-
ized imaging protocol of rectum and anus was performed with T2-weighted (T2W) fast 
spin-echo (FSE) sequences in axial, sagittal, and coronal planes. The scan parameters were: 
TR/ TE, 4570 / 80-85; FOV, 24,0 cm; slice thickness, 3 mm; gap, 0.3 mm; matrix,  320x256; 
512-x 275; flip angle, 90°-150°; NSA, 2. In all patients, an additional axial T2W FSE sequence 
with fat saturation was performed (TR/TE, 5090/85). Transverse fat-saturated T1-weighted 
(T1W) gradient echo (GRE) imaging unenhanced and after intravenous gadolinium che-
late administration (bolus of 0.2 mL/kg of 0.5 mmol/mL of gadopentetate dimeglumine 
[Magnevist, Schering], power injected at a rate of 2 ml/s) followed by a 20- ml saline flush 
was performed. The scan parameters were: TR/TE, 3.61/1.4; matrix, 256 x 224; flip angle, 15°; 
FOV, 300 mm; section thickness and gap, 4 mm and 0.4 mm, respectively; and one signal 
acquired. After intravenous contrast administration 10 scans were acquired within a time 
frame of 200 seconds, starting with an early arterial phase 6 seconds after contrast infusion. 
Every scan was executed at regular time intervals of 20 seconds after the previous scan 
with data sets acquired during 8.0 seconds of breath hold at expiration. Five minutes after 
gadolinium administration, sagittal and coronal T1-weighted GRE images were obtained 
using identical imaging parameters to those used for the pre- contrast T1W sequences. No 
special rectal preparation and no spasmolytic medication was used. With this contrast series 
arterial, venous, parenchymal and late dominant phases were obtained. 
Image post- processing
MR images were exported in DICOM format from the picture archiving and communica-
tions system (PACS) to a viewing workstation (AW Server 2.0 from GE Healthcare, 2012). Fu-
sion images were produced as an overlay of axial T2W images and last CE MRI scan. The field 
of view and slice level of the CE MRI images were automatically attuned to exactly match 
the T2W MRI. The CE MRI images were converted to a red-to-yellow color scale and semi-
automatically adjusted to a blue-to-red color scale if an overexposed picture was gener-
ated (Fig. 1). Subtraction CE MRI (SCE MRI) images were digitally performed for the arterial-
dominant phase (first or second scan after intravenous contrast infusion) (Fig. 2) and the 
late phase (last scan of the CE MRI series) (Fig. 2,3). To perform time intensity curves (TICs), 
regions of interest (ROIs) were selected and manually encircled with a cursor on the display 
screen of the last scan. Several (3, 5, or 7) ROI samples of variable size (20 – 40 mm2) were 
drawn, depending on the tumor size. These ROIs were placed well within the confines of 
the tumor and distributed evenly within the tumor volume. The workstation generated TICs 
automatically after ROI placement (Fig. 3). The TIC per lesion was recorded. 
MRI Evaluation
All MRI examinations were available in a PACS viewing station and were evaluated visually 
by a radiologist with ten years of experience in pelvic MRI (reader 1). This reader used a 
standard form to register the following items: number and location of the recurrences. For 
tumor site a subdivision was made into lesions fixed to the pelvic side walls or presacral 
fascia (subgroup A) and lesions that were not fixed to the pelvic inner surroundings (sub-
group B). Tumor fixation was defined as firm contact of tumor, with no fat interface, to the 
pelvic inner surfaces. Furthermore, the tumor outline facing the pelvic inner surface had to 
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be fixed for a significant portion (visual estimate of at least a quarter of the tumor circumfer-
ence) to the pelvis. Additional items registered include: invasion of adjacent organs, pelvic 
floor, perineum; maximum tumor size measured on T2W and CE MRI separately and con-
trast enhancement characteristics: no enhancement; initial enhancement in arterial, venous 
or late dominant phase; persistent contrast pooling or wash-out; any obvious enhance-
ment pattern in the perception of the reader. Reader 2, a medical student in his master 
degree, with no experience in reading pelvic MRI, did a separate assessment using a post 
processing workstation. In the preparation stage, reader 2 was trained by reader 1 in MRI 
of pelvic anatomy, MRI sequences, including demonstration of recurrent rectal carcinoma. 
The required post-processing skills at a dedicated viewing workstation were trained by a 
member of our PACS maintenance team. The examinations were transferred to this worksta-
tion without reports and with no access to the digital hospital information system. Reader 2 
gave a confident level score to T2W, CE MRI and fusion images for detection and delineation 
of the lesion (1, not confident; 2, probably but not sure; 3, confident). Reader 2 measured 
the maximum tumor size on T2W, CE MRI and on fusion images using post processing tools. 
Additionally, Reader 2 acquired SCE MRI images and created TICs for all lesions. The addi-
tional images were uploaded in PACS. Based on this execution an interpretation was given 
to the following items per lesion: initial enhancement (arterial, venous, late phase), persis-
tent enhancement or wash out, most frequent TIC. A radiologist with 8 years of experience 
in abdominal and pelvic imaging and an experienced surgeon in surgical oncology, both 
not involved with image interpretation, did an assessment of local tumor staging based on 
the surgical reports and of tumor size based on reports from PA of the resected specimen. 
Reference standard 
MRI findings were correlated with surgical findings and histopathology analysis (PA) of the 
resected specimens. Surgical findings as documented in the surgical reports served as refer-
ence for tumor localization, fixation to the pelvic side walls or presacral fascia and invasion 
in adjacent organs, pelvic floor or perineum. PA reports of the resected specimens served 
as the reference for completeness of resection: R0 (resection margins are microscopically 
free of tumor) or R1 (tumor cells in resection margins) and for maximum tumor size of R0 
resected lesions. 
Statistical analysis 
Data analysis was done with SPSS software (IBM SPSS statistics 20 for windows, SPSS, Chi-
cago). Bland and Altman plots (11) were used to determine the limits of agreement for the 
measurements between two readers, performed on T2W and CE MRI. Bland and Altman 
plots were also used to assess agreement between  measurements on T2W and CE MRI of 
LRRC and histopathology analysis (11, 12). To determine actual tumor size, only R0 resected 
lesions were included for comparison between MRI and PA. Categorical variables were com-
pared using Chi-square test.  A 2-sided significance level of 0.05 was used.
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ResuLts 
Patient characteristics
During the study period, a total of 47 patients (32 men, 15 women, mean age 63 years, 
range 39-80 years) were eligible for analysis. One patient had tumors at two separate loca-
tions in the pelvis, three patients developed a re-recurrence and underwent re-resection. A 
total of 51 lesions and resected specimen were available for evaluation.
Time interval MRI, neo- adjuvant (chemo) radiotherapy and surgery
In 40 patients MRI was performed after completion of neo- adjuvant (chemo) radiotherapy 
within a mean time interval of 3 weeks (range 3-5 weeks) and prior to surgery (mean 6 
weeks, range 4-7 weeks). Six patients had MRI prior to neo- adjuvant therapy (mean 6 weeks, 
Figure 1. Recurrent rectal carcinoma in the perineum: Value of contrast enhanced MRI and fusion with T2- 
weighted images for tumor identification and delineation
68- years old man, 3.5 years after rectal resection for rectal cancer (T2N0M0; R0). Local recurrence within perineal 
scar tissue. Pre- operative MRI (after 30 Gy radiotherapy on pelvis): T2-weighted MR image (A) shows two masses 
in the perineum (arrows) within scar tissue. Both lesions appear to enhance after gadolinium administration on 
the CE MR image (B). The red-to-yellow color fusion image (C) displays an overexposed image that hinders an 
obvious conclusion, the blue-to-red color scaled fusion image (D) makes clear that the ventral lesion (dashed ar-
row) does not demonstrate intense enhancement, while the dorsally located lesion (arrow) demonstrates intense 
enhancement in a dominant rim pattern. Pathology analysis of  the ventral lesion demonstrated fibrotic tissue 
with no tumor cells, the dorsal lesion corresponded with active local tumor recurrent. The lesion was completely 
resected (R0).
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range 6-7 weeks) and prior to surgery (mean 15 weeks, range 13-15 weeks). One patient did 
not receive neo-adjuvant therapy with MRI performed 7 weeks prior to surgery. 
Tumor site and resection status 
There was agreement for tumor site, fixation to the pelvic side walls or presacral fascia, 
invasion of adjacent organs, pelvic floor or perineum as described by reader 1 and surgical 
findings for all lesions. Thirty lesions (59%) were radically resected (R0). In the remaining 
21 lesions (41%) no radical resection was achieved (R1). On MRI, 28 lesions (55%) demon-
strated attachment to the pelvic side walls (Fig. 2) or presacral fascia (Fig. 4) (subgroup A), 
the remaining 23 lesions (45 %) were not attached to the pelvic inner surroundings (Fig. 1, 3) 
(subgroup B).  Subgroup A resulted in 64 % R1  resections compared to 13 % R1 resections 
in subgroup B. (p = 0.001, table 1).
Tumor size measured by reader 1 and reader 2: all lesions 
Maximum tumor size by reader 1: median 25 mm (IQR 19 – 40) for T2W; median 28 mm (IQR 
20 - 40) for CE MRI. Corresponding measurements performed by reader 2 were: median 26 
mm (IQR 20 - 40) for T2W; median 28 mm (IQR 23 - 45) for CE MRI and median 27 mm (IQR 
21 - 41) for T2W/CE MRI fusion images. See figure 5, measurements performed on CE MRI 
table 1: association of Locally Recurrent Rectal cancer Fixed to the Pelvic side walls or Presacral Fascia 
and Resection status
Tumor Site R1 resection R0 resection Total 
n (%) n (%) (n) 
Fixed to the pelvic walls  
or presacral fascia
18 (64 %) 10 (36%) 28  
 Pelvic side walls (n = 16) 
 Presacral fascia (n = 12)
Not fixed to the pelvic side walls  
or presacral fascia
3 (13 %) 20 (87%) 23
 Anastomotic, genitourinary  
 organs (n = 15)
 Pelvic floor (n = 4)
 Perineum  (n = 4)
Total 21 30 51
 
Site is based on the predominant site of tumor tissue in case of extended lesions; (n), number of lesions
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images show smaller limits of agreement than measurements performed on T2W images, 
thus the degree of conformity is higher on measurements performed on CE MRI images. 
The subjective interpretation of reader 2 for tumor identification and delineation was: For 
T2W: not confident 55 %, probably 33% and confident 12 %. Using CE MRI, including fusion 
with T2W images, these figures were respectively 6 %, 18 % and 76 %.  
Figure 2. Recurrent rectal cancer located in the rectal wall with transmural tumor extension and fixed to the 
pelvic side wall 
43- years old woman, 3 years after low anterior resection for rectal cancer (T3N2M0; R0) with local recurrence in 
the rectal wall including mesorectum and fixation to the right dorsolateral pelvic wall. Pre- operative MRI after 50 
Gy radiotherapy on the pelvis. Axial T2-weighted MR images (A) shows the tumor (arrow) located within the rectal 
wall, adjacent mesorectum and fixed to the sacrospinous ligaments (arrowhead). Low anterior resection was per-
formed of the tumor, including rectum, dorsal vagina wall, cervix, uterus and right ovary, followed by ileostomy 
and reconstructive surgery with a colo-anal pouch. The lesion was incompletely resected (R1) at the pelvic side 
wall with 10 Gy intra-operative radiotherapy on the resected surface during operation. B) Adenocarcinoma was 
located in the surgical resection margin (H-E 100x, encircled area 200X). Characteristic peripheral enhancement 
pattern of the lesion is seen on the contrast enhanced subtraction images (SCE MRI; C, arterial dominant phase; 
D, late phase). On D a persistent enhancement (no wash-out) is demonstrated. Close contact is seen with the 
posterior vagina and cervix on T2W without evidence of invasion on DCES as was proven by histopathology. C, 
cervix; R, rectum.
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Tumor size determined by histopathology analysis (PA) and MRI: R0 
lesions 
Of R0 lesions (n=30), 27 lesions were documented with an accurate maximum size of vital 
tumor tissue on PA. Based on these 27 lesions, mean tumor size on PA was 20 mm (IQR 30-
17 = 13 mm). All lesions were evaluated on MRI after neo-adjuvant (chemo) radiotherapy. 
Figure 3. Local recurrent rectal cancer, located at the anastomotic level of the rectal wall with extension in the 
mesorectum, not fixed to the pelvic walls 
66- years old man, 5 years after low anterior resection for rectal cancer (pT3N1M0; R0). Pre- operative MRI, after 
45 Gy radiotherapy on the pelvis. Axial (a) T2W image demonstrates the tumor  (arrow) at the anastomotic level 
in the rectal wall with extension in the mesorectum and invasion of the right seminal vesicle (not shown). No 
fixation to the adjacent pelvic wall (arrowhead: peritoneal surface pelvic wall). The dynamic contrast- enhanced 
image (late dominant phase) with region of interest (red ring) and corresponding time intensity curve (TIC) dem-
onstrates arterial enhancement with no wash out (TIC, Type 3). Fusion image of DCE and T2W demonstrates a 
heterogenous mosaic enhancement pattern of the lesion. Total excenterative surgery was performed with clean 
resection margins (R0).  
Figure 4. Re-recurrent rectal carcinoma (mucinous type adenocarcinoma) fixed to the presacral fascia
42- years old man, with local re-recurrent rectal carcinoma, 2 years after resection of the first local recurrence 
(T3N0M0; R0). Previous total mesorectal extirpation and proctocolectomy with ileo-anal J-pouch. A) Pre- op-
erative MRI (after concomitant chemo- radiotherapy (Capacitabine, 50 Gy on pelvis) with active lesions (arrows) 
fixed to the presacral fascia (arrowhead). Note the high signal intensity content on T2W image which reflects the 
mucinous content of the tumor and makes it difficult to discern and discriminate from the pouch (P). On SCE MR 
images (late phase) typical rim- enhancement can be appreciated on consecutive slices (composite image of a 
more proximal  and distal level with corresponding T2W/CE MRI fusion image (C).  The lesions were incompletely 
resected (abdominal peritoneal resection of the pouch, R1, with 10 Gy intra- operative radiotherapy on the re-
sected presacral surface). 
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For reader 1, average tumor size on T2W, mean 20 mm (IQR 36-19 = 17 mm); CE MRI, mean 
24 mm (IQR 35-20 = 15 mm). For reader 2, mean tumor size on T2W, 22 mm (IQR 39-18 
= 21 mm); CE MRI, mean 25 mm (IQR 35-20 = 15 mm); T2W/CE MRI fusion, mean 23 mm 
(IQR 35-19 = 16 mm). Figure 6 shows Bland-Altman plots with difference between MRI and 
PA measurements plotted against PA (reference standard). The solid (base) lines represent 
agreement between PA and MRI with the dashed lines representing the upper and lower 95 
% limits of agreement. For reader 1, CE MRI shows better agreement with PA than T2W. For 
reader 2, best agreement with PA is found for T2W/CE MRI fusion. 
Contrast enhancement pattern
Reader 1 reported arterial visual contrast enhancement after gadolinium administration with 
no wash-out of all lesions (100 %) (Fig 3). This finding was confirmed by reader 2, using SCE 
MRI (Fig 2) images and TICs. The flow volume curves of lesions showed fast (steep angle) and 
persisting plateau contrast enhancement, without wash out (TIC, type 3) (Fig 3). Two main 
contrast enhancement patterns were distinguishable: dominant peripheral rim enhance-
ment (n=30, 59%) (Fig 1,2,4) or heterogeneous mosaic enhancement (n=11, 21%) (Fig. 3). In 
the remaining cases no clear enhancement pattern was observed (n=10, 20%). See table 2.
Figure 5. Agreement of vital tumor measurement by 2 readers for T2W (A) and CE MRI (B) on 51 lesions. Diff, dif-
ference.
table 2: characteristics of Locally Recurrent Rectal cancer on contrast enhanced MRI based on analysis 
of 51 tumors 
Characteristic feature n (%)
Arterial dominant enhancement 51 (100)
Contrast pooling; no wash- out 51 (100)
Dominant peripheral rim enhancement 30 (59)
Heterogeneous mosaic enhancement 11 (21 )
 
n, number of lesions.
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Figure 6. Agreement between histopathology (PA) 
assessment of vital tumor tissue in resected specimen 
and  MRI measurements. Measurements done by read-
er 1 on T2W (A), CE MRI (B) and reader 2 on T2W (C), CE 
MRI (D) and T2W/CE MRI fusion images (E) on 27 R0 le-
sions.	(•),	n=1;		(), n=2; (), n=3. Diff, difference
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DIscussIon 
The aim of this study was to assess the additional value of CE MRI for diagnosis and pre-oper-
ative assessment of LRRC. Furthermore, the value of MRI for predicting surgical outcome was 
evaluated. We found that compared with T2W, there is better agreement between both read-
ers of measurements performed on CE MRI images. In addition, CE is more accurate than T2W 
in measuring the size of vital tumor tissue in R0 resected lesions. We found a combination 
of contrast enhancement characteristics (Table 2). It should be noted that  immature fibrosis 
and inflammation may demonstrate high signal intensity on T2W, and may demonstrate con-
trast enhancement [11]. However, the CE MRI enhancement characteristics found in this our 
study may be supportive to diagnose LRRC and differentiate from fibrosis (Fig 1). Messiou et 
al. described that rectal tumor recurrences may exhibit rim enhancement patterns on CE MRI 
[4]. To our knowledge, our study is the first to assess a combination of typical CE MRI char-
acteristics, including dominant peripheral rim- or heterogeneous mosaic enhancement pat-
tern, in a cohort of patients. Diffusion weighted MR imaging (DWI) may increase confidence 
for the detection of LRRC [12; 13]. However, the application of DWI to the abdomen and 
pelvis has proved to be challenging due to artifacts which may cause image distortion [14]. 
Furthermore, adding DWI to T2 weighted MRI, does not significantly improve performance of 
MRI for diagnosis, but will increase specificity and interobserver agreement [15]. CE MRI not 
only increases confidence in detection, but is more accurate than T2W to assess vital tumor 
dimensions, and thus seems especially valuable for pre-operative assessment and surgical 
planning. Another potential for CE MRI in the management of LRRC is monitoring of local im-
age guided therapies like radio frequency ablation. In our experience CE MRI is less effected 
by post procedural effects than T2W and DWI to confidently demonstrate local residual or re-
current disease. Future studies are needed to present evidence for this. Our results show that 
tumor fixation to the pelvic side walls or presacral fascia is of importance to predict surgical 
outcome, with an incomplete resection margin in the majority of cases (64%), in contrary to 
non-fixed lesions (13%). A clinical study by Moore et al. [16] reported that pelvic recurrences 
of rectal and colon cancer in the  axial and anterior locations, are more likely to be completely 
resectable than those involving the pelvic sidewall. To our knowledge, our study is the first 
MRI based study for LRRC that endorses these clinical results. In our center intra-operative ra-
diotherapy will be applied on the resected surface in case of tumor fixation to the pelvic side 
walls or presacral fascia [17; 18]. Although our study explored especially morphologic criteria 
of  LRRC using CE MRI, a recent study suggests that quantitative DCE-MRI measures of flow 
and permeability into and out of the tumor mass may be used to predict resection status, 
chance of re- recurrence and survival [19]. Our study has some limitations. First, because of 
the retrospective design. Furthermore, the reading of MRI examinations of the study popu-
lation was done by one radiologist and the post processing evaluation by a master degree 
medical student. In the contemplations of our study design we focused on the additional 
value of CE MRI and invited a non- radiologist as the second reader for post processing image 
evaluation. The post processing could therefore be performed without being influenced by 
the own frame of reference based on experience with T2W and CE MRI reading. We believe 
that the second reader had a decisive role in our study design by objectifying patterns of 
enhancement using post- processing tools. Another point of consideration is that our study 
design was not based on direct comparison between LRRC and surrounding fibrosis. This 
was technically not feasible because the surgical resection specimen was aimed at the LRRC 
and some, but not all, of the surrounding fibrosis. Thus, the only acceptable reference was 
maximum tumor size in R0 resected lesions and not the amount of fibrosis. Another point 
to stress is that our study population is a retrospective analysis in a cohort of patients with 
a well- known final diagnosis. It is not sure what the additional value of CE MRI is in patients 
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with follow up MRI for screening or clinical suspicion of LRRC. Lambregt et al. [15] found that 
T2W MRI, on its own, has a high accuracy for the diagnosis of local recurrent rectal cancer 
in 42 patients with clinical suspicion of LRRC. Based on our results in table 2, CE MRI has the 
potential to confidently diagnose LRRC in a screening population. The results of our study are 
promising and warrant further study in a prospective fashion to confirm this.
In conclusion, our study has demonstrated that CE MRI is a valuable supplement in the 
MRI protocol for diagnosis and pre-operative evaluation of LRRC. LRRC has typical CE MRI 
findings of arterial and persistent enhancement (100%), dominant peripheral rim- or het-
erogeneous mosaic enhancement pattern (80%), and is more consistent for assessment of 
vital tumor dimensions than T2W. For surgical outcome, tumor fixation to pelvic side walls 
or presacral fascia will result in incomplete resection margins in 64% of cases, whereas non-
fixed tumors will be completely resected in 87%. 
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5.2
abstRact 
Purpose To assess the a priori chance that primary cystic lesions of the retrorectal space 
(RCL) are malignant and investigate MRI characteristics which indicate malignancy.
Materials and Methods Patients referred to a center for colorectal surgery were recruited 
from 2000-2014.
Lesions were proven by clinical assessment and histopathology. MRI was performed on 1.5 
T with examinations evaluated by two radiologists. Interobserver agreement was assessed 
(Cohen's Kappa) and differences between malignant and benign lesions calculated (Fisher's 
exact test).
Results Twenty eight patients (22 female, 6 male, 18-70 years) with 31 lesions were included.
Lesions were subdivided into: tailgut cyst (n=16, 52 %), epidermoid and dermoid cyst (n=6, 
19%), colorectal (n=4, 13%), teratoma (n=3, 10%), neurogenic (n=2, 6%). Five patients (18%) 
had malignancy. Colorectal lesions had the highest percentage of malignancy (3/4, 75%). 
Solid tissue component was found in all 5 (100 %) malignant lesions, and 2 (8%) of be-
nign lesions, both teratoma's (p < 0.05). For unilocularity, multilocularity, debris, septa and 
wall thickening, differences were not significant. Interobserver agreement was excellent 
(kappa = 1) for all characteristics except debris (kappa = 0.795).
Conclusion Eighteen percent of patients with RCL display malignancy, with MRI findings of 
solid tissue component indicative of a malignant lesion.
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IntRoDuctIon 
The retrorectal space, also known as the presacral space, is a space bounded anteriorly 
by the posterior wall of the rectum, posteriorly by the sacrum and coccyx, superiorly by 
the peritoneal reflection, and inferiorly by the pelvic floor muscles. Laterally, the space is 
bounded by the iliac vessels and ureters. This space contains remnants derived from em-
bryonic neuro-ectoderm, notochord, and hindgut, and hence may result in a wide variety 
of congenital lesions herein (1-4). Malignancy is more common in the pediatric population, 
and solid lesions are more likely to be malignant than are cystic lesions (5). Retrorectal cystic 
lesions (RCL) in adults are rare with little literature available and an unknown prevalence. 
Often the basic clinical problem is whether a RCL should be considered a malignant lesion. 
The purpose of this study was to assess the a priori chance that RCL are malignant and 
identify MR imaging characteristics which indicate malignancy. 
MateRIaLs anD MethoDs
Institutional ethical committee approved this retrospective study and informed consent 
was waved.
Patient selection and inclusion criteria 
Patients were referred to a tertiary center for colorectal surgery between January 2000 and 
October 2014 and were recruited from prospective collected databases from the depart-
ments of surgery and radiology. Criteria for inclusion were: minimum patient age 18 years; 
lesion found at first referral consultation at our center with no surgery of the pelvis and pel-
vic floor for at least 3 years prior to referral; histology proven lesion; MRI performed within 
3 months of histology; at initial prospective evaluation lesion characterization was “cystic” 
clinically and on MRI. 
MRI and MR Imaging protocol
MRI was performed in all patients on 1.5 T (General Electric Medical systems, Milwaukee, 
USA) using a 8 or 16- channel phased array multicoil. In all cases T2- weighted (T2W) fast 
spin-echo (FSE) images were acquired in axial, sagittal, and coronal planes through the en-
tire pelvis and pelvic floor: TR/TE, 4570/80-85; FOV, 24.0 cm; slice thickness, 3 mm; gap, 0.3 
mm; matrix, 320x256; 512x275; flip angle, 90°-150°; NSA, 2. Axial T2W FSE with fat saturation: 
TR/TE, 5090/85. Axial T1W gradient echo (GRE) imaging with and without fat saturation: 
TR/TE, 3.61-7.0 /1.4-3.0; matrix, 256 x 224; flip angle, 15°; FOV, 300 mm; slice thickness and 
gap, 4 mm and 0.4 mm; NSA, 1. Contrast enhanced series were available in all but one case. 
Axial T1W GRE fat saturated imaging unenhanced and after intravenous gadolinium chelate 
administration (bolus of 0.2 mL/kg of 0.5 mmol/ml of gadopentetate dimeglumine [Magn-
evist, Schering].
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MRI reading  
 MRI examinations were evaluated by a radiologist with 10 years of experience in MRI of the 
pelvis and pelvic floor (reader 1). Second reader was a  radiologist with one year of profes-
sional experience (reader 2). All examinations were evaluated separately by both readers 
who were blinded to the final diagnosis. A standard form was used to record: number of 
lesions; lesion composition (solid, cystic, mixed); lesion size  (largest axis in 3 planes (mm)); 
configuration (lobulated or smooth); unilocular or multilocular; containing septa; measure-
ment of thickest septa (mm); debris; solid tissue component; site according to the level 
of the sacral vertebral body (SL) and coccygeal level (CL) in sagittal plane; attached to the 
presacral fascia; confinement within the mesorectal compartment; infralevatoir extension; 
epicenter: (median or paramedian orientation in the axial plane); erosion or destruction 
of the sacrococcygeal spine, signal intensity (SI) on T1W and T2W MRI; additional remarks. 
Cases were discussed between both readers, in case of disagreement and consensus was 
reached. Histopathology assessment, clinical management and follow-up information were 
obtained from patients’ records in the digital hospital information system.
Definitions
See figure 1 below for an illustration of the definitions.  
 
Reference standard
All lesions were pathology proven. This assessment was done after surgical resection (n=24) 
or thick needle biopsies of the lesion (n= 3). One case of Curanino syndrome was assessed 
by typical MRI findings and clinical confirmation of an alteration of the HLXB9- gene at 
patient’ genomic analysis. Lesion characteristics on MRI were matched with reports from 
surgery and histopathology. 
Statistical analysis
Interobserver agreement for both readers was assessed by calculating Cohen’s Kappa value 
for each lesion characteristic separately. Significance of differences between malignant and 
benign lesions was calculated with a 95% confidence level, using a two-sided Fisher’s exact 
test. All calculations were performed with SPSS Statistics, version 21.
a  b  c  D
Figure 1. Illustration of septa (A), debris (B), solid components (C), wall thickening (D)
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ResuLts 
A total of 28 patients were included. See figure 2 for patients sampling and table 1 for  char-
acteristics of the study population, including final diagnoses.
Twenty eight patients (22 female, 6 male, 18-70 years) with 31 lesions were included.
Lesions were subdivided into: tailgut cyst (n=16, 52 %), epidermoid and dermoid cyst (n=6, 
19%), colorectal origin (n=4, 13%), teratoma (n=3, 10%), neurogenic (n=2, 6%). Tailgut cysts 
(TGC) were the most prevalent lesion, consisting of 13/28 (46 %) patients or 16/31(52%) 
lesions. On patient level, 5 of 28 patients had malignancy (18%); on lesion level 5 out of 31 
were malignant (16%). The subgroup of lesions from colorectal origin had the highest per-
centage of malignancy (3 of 4, 75%). Age of patients with malignancy ranged from 18 to 59 
years, median 50 years, with 2 patients younger or equal to 40 years. Solid tissue component 
was found in all 5 (100 %) malignant lesions, whereas 2 (8%) benign lesions demonstrated 
solid components. This is a significant finding (p < 0.05), with a difference of 92.3% (95% CI 
= [82.1% – 102.6%]). 
Diagnosis Patients Lesions
(n) F M Age (years)
m, mean; r, range
(n)
Tailgut cyst 13 11 2 m 60, r 40-70 16
Epidermoid cyst 5 4 1 m 47, r 28-56 5
Recurrent mature dermoid cyst with carcinoid 1 1 0 18 1
Mature cystic teratoma 2 1 1 20, 34 2
Recurrent mature cystic teratoma with abscess 1 1 0 44 1
Rectal duplication cyst 1 0 1 34 1
Rectal duplication cyst with mucinous adenocarcinoma 1 1 0 57 1
Mucinous adenocarcinoma of rectum primary 1 0 1 59 1
Subperitoneal pelvic mucinous adenocarcinoma
from colorectal origin
1 1 0 50 1
Anterior sacral meningomyelocoele
(Curanino Syndrome)
1 1 0 22 1
Differentiating neuroblastoma 1 1 0 40 1
table 1. Included patients with diagnosis, patient characteristics and number of lesions 
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For unilocularity, multilocularity, debris, septa and wall thickening, differences were not sig-
nificant between malignant and benign lesions. Interobserver agreement between both 
readers was perfect (kappa = 1) for all items except debris. In two lesions reader 2 interpret-
ed initially debris and reader 1 heterogeneous signal intensity (SI). After consensus reading 
this finding was assessed as inhomogeneous SI. For debris, kappa = 0.795, which is consid-
ered substantial agreement. The different subgroups of lesions will be more fully discussed.
Tailgut cysts
Primary lesions in 11 patients  (total of 13 lesions) and recurrent lesions in 2 patients (total 
of 3 lesions). Recurrent lesions at 6 and 32 years post- surgery respectively. 
In 8 (62 %) patients lesions were incidentally detected on previous imaging (Fig 3A). Five 
patients (38 %) were symptomatic, including two patients with non- specific pelvic pain, 
two patients with obstructed defecation (Fig 3 B) and one patient who presented with 
chronic perianal fistulas and pararectal abscesses. This patient had undergone 3 surgical 
procedures for fistula disease with 10 repeat MRI, including T1W and T2W sequences (no 
contrast administration). Fifteen (94 %) lesions were attached to the presacral fascia with a 
midline (n=8) or paramedian (n=7) orientation, including 14 lesions above the pelvic floor 
(supralevatoir) and one lesion above and below the pelvic floor (supra- and infralevatoir) 
Eligible patients, n= 39
Excluded patients, n= 11
No histopathology available (n=5):                                                                                                       
       Presacral multilocular cystic lesion (n= 2);    
       Clinical presacral abscess, surgical treatment with no histopathology (n= 3)
No cystic, but predominantly solid with cystic components (n=4): 
       Chordoma (n= 2)   
       Necrotic pleiomorphic sarcoma of the rectum (n=1) 
       Recurrent presacral schwannoma with meningomyelocele (n=1)
No primary lesions of the retrorectal space, but diffuse pelvic cystic lesions 
with expansion to the presacral space (n=2):  
       Cystic mesothelioma (n=1)  
       Papillary cystadenocarcinoma of the prostate (n=1)
Included patients, n= 28
Figure 2. Flow diagram summarizes patient sampling
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(Fig 3 C). One patient had 2 recurrent lesions, including one lesion in the left ischiorectal 
fossa (Fig 3D). Lesion location with respect to  the sacrococcygeal spine: first sacral vertebral 
body (SL 1) – coccygeal level (CL) (n=1), SL 1 - SL 4 (n=1), SL 4 – SL 5 (n=5), SL 4 - CL (n=5), 
CL (n=3), left ischiorectal fossa (n=1). 
a b
c D
Figure 3.  A) 44-year-old man with multilocular tailgut cyst (TGC) at the coccygeal level. Note different shades 
of high signal intensity within the lesion. Thickened peritoneal reflection from the rectum (upper arrowhead) 
indicates the upper border of the retrorectal space (RRS), with the levator ani muscle (lower arrowhead) at the 
level of the lower border of the RRS. The lesion was an incidental finding on previous imaging. B) 64-year-old man 
with a recurrent unilocular TGC, 10 years after incomplete resection. Note homogeneous high signal intensity 
and thin wall of the lesion. The lesion was symptomatic with obstructed defecation through compression on the 
rectum. C) 52-year-old woman with a large TGC at first presentation, hourglass appearance, located partly above 
and partly below the pelvic floor. Arrowhead indicates the level of the pelvic floor. Patient had a painfull perianal 
swelling with obstructed defecation. D) 65-year-old woman with recurrent TGC, 32 years after sacrococcygec-
tomy. Two lesions locally presacral (not shown) and in the left ischio-rectal space (arrow). Note intermediate to 
low SI of the lesion, including debris. All images T2W TSE in the mid-sagittal (A-C) and left paramedian (D) plane. 
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See table 2 for imaging findings. Only one lesion was found with erosion of the sacrococyy-
geal bone. Management: 12 patients (15 lesions) had undergone surgery. One patient was 
managed conservatively with follow up MRI. Clinical follow up for all lesions ranged 1 to 6 
years: two patients had a local recurrence after surgery. Patient with conservative manage-
ment (n=1) demonstrated unchanged lesion at 3 years follow up MRI. 
Epidermoid and dermoid cysts
There were 5 patients (18%) with epidermoid cysts; 4 cases were incidental findings on 
previous imaging and one case was referred with a recurrent lesion 4 years after surgi-
cal drainage. Lesion level according to the sacrococcygeal spine was SL 4 - CL (n=1), CL 
(n=4). Four lesions were attached to the presacral fascia and located in the midline above 
the levator ani muscle. One lesion was attached to the distal tip of coccygeal bone with a 
proximal paramedian extension within the mesorectum. All lesions were unilocular with 
heterogeneous SI (Fig 4). Management: 3 patients had undergone surgery and 2 patients 
were managed conservatively. Clinical follow up was 1 to 6 years with no recurrence after 
surgery and unchanged lesions (conservative management).  
Another patient had a recurrent mature cystic dermoid with carcinoid, 10 years after resec-
tion of a pelvic dermoid cyst (Fig 5 A,B). This lesion was detected on screening ultrasound 
with no specific symptoms. The lesion was attached to the presacral fascia, located in the 
midline at SL 1 – SL 4 level. Surgical resection was radical. Five years after surgery a solitary 
liver metastasis was found. Two years after liver metasectomy no recurrence (pelvic or liver) 
and no metastasis were found. 
Figure 4. A, B) 47-year-old man with epidermoid cyst as 
an incidental finding at MRI for local staging of recto-
sigmoid carcinoma (not shown). Note the inhomoge-
neous SI on T2W (A) and T1W (B). C) On the contrast 
enhanced image no obvious internal parts are enhanc-
ing. The lesion was completely resected through the 
ventral approach in the same surgical procedure for the 
recto-sigmoid cancer. 
a b
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Teratoma
We found two patients (7%) with benign mature cystic teratomas. One lesion was initially 
clinically suspected of a presacral abscess (Fig 5 C). The other lesion was an incidental find-
ing at MRI for local staging of rectal carcinoma. Both lesions were surgically resected. Lesion 
level: SL 2 - CL and SL 4 - CL. Both lesions were attached to the presacral fascia and located 
in the midline supralevatoir. Follow up MRI at respectively 2 and 5 years post- surgery re-
vealed no local recurrence. Another patient (4%) presented with a presacral abscess, includ-
ing a recurrent mature cystic teratoma. This patient had undergone resection of a teratoma 
in another hospital 10 years earlier. After successful percutaneous drainage of the current 
abscess, CT- guided targeted biopsies aimed at the wall and solid tissue component fol-
lowed. Patient refused surgery and agreed to biopsy to exclude malignancy. Lesion level: SL 
3 - CL; attached to the presacral fascia and located in the midline supralevatoir. The lesion 
was stable for 7 years when compared with a previous MRI. 
a b
c
Figure 5. A, B) 18-yearold woman with recurrent der-
moid cyst and carcinoid, ten years after resection of 
a dermoid cyst. A) Note the inhomogeneous signal 
intensity (SI), suggestive of keratin. Inhomogenuity of 
the lesion is more clear on the axial T2W fat saturation 
image in B) when compared with the SI of urine in the 
bladder. In the dorsal wall of the lesion a nodular solid 
component (arrow) is clear, including an adjacent exo-
fytic nodular solid lesion (arrowhead). The solid com-
ponents were histopathology confirmed as carcinoid 
within the wall of the dermoid cyst. C) 20-yearold wom-
an with mature cystic teratoma. Axial T2W image dem-
onstrates a complicated cystic lesion with debris and a 
small inclusion cyst. The inclusion cyst has a band like 
solid component (short arrow) at the inner wall. Pathol-
ogy analysis confirmed the solid nature which consists 
of rounded fibrous tissue with differentiated muscle 
tissue and focal bone forming. No malignancy was de-
tected. Note thickened wall, including additional solid 
components at de inner wall on the left (long arrow). 
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Colorectal lesions
We found two patients (7 %) with rectal duplication cyst, one benign and one with muci-
nous adenocarcinoma. Both lesions were incidental findings on previous imaging and were 
located within the mesorectum, with a median orientation at the coccygeal level. Both 
lesions were resected. The benign lesion showed  no recurrence for 2 years. The malignant 
lesion was incompletely resected with additional radiotherapy (50 Gy) on the pelvis (Fig 6). 
Follow up MRI at 6 months interval revealed no local recurrence for 8 years. Another patient 
had a mucinous adenocarcinoma of rectal origin (Fig 7). At screening colonoscopy an as-
ymptomatic ulcerated lesion was found in the lower rectum. Biopsy revealed a mucinous 
adenocarcinoma. MRI demonstrated a retrorectal cystic lesion with substantial growth after 
neo-adjuvant chemo radiotherapy. The lesion was resected with additional intra-operative 
radiotherapy on resected surfaces. Histopathology confirmed a cT3N0M0 mucinous type 
adenocarcinoma of rectal origin. Lesion level: SL 4 – CL with a median orientation. Follow 
up one year after surgery revealed no local recurrence and no distant metastasis. A fourth 
Figure 6. 57years old woman, with adenocarcinoma 
within a rectal duplication cyst. A) Sagittal T2W image 
with a retrorectal cystic lesion, including neck and in-
ternal ostium at the ano-rectal junction posteriorly (ar-
rowheads) which was confirmed at surgery. B) Axial T2W 
image reveals focal areas of low signal intensity which 
are suggestive of solid components. C) Sagittal T1W fat 
saturated image after i.v. Gadolinium administration re-
veals enhancing solid components (arrows). Resection 
via the dorsal approach (coccygectomy) proved a rectal 
duplication cyst with mucinous adenocarcinoma. 
a
b
c
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5.2 patient  had a subperitoneal mucinous adenocarcinoma from colorectal origin (Fig 8). This patient had Hirschsprung’s disease and was operated at the age of 3 years with repeat sur-
gery at age 26 (rectum resection and ano-colic anastomosis). Lesion level: SL 4 – CL, above 
the pelvic floor (supralevatoir) with a rounded orientation. The lesion was incompletely 
resected with no malignancy found. Follow up MRI at16 months demonstrated a grow-
ing recurrence. Re- resection, including frozen section pathology analysis, demonstrated 
a mucinous adenocarcinoma probably originating from the distal colonic stump. Patient 
was referred initially with obstructed defecation (Fig 8A) and died 18 months after repeat 
surgery and palliative treatment.
Figure 7. 59year-old man with a mucinous type adenocarcinoma of the lower rectum. A-C) A, axial T1W image; B, 
axial T1W fat saturation image after i.v. Gadolinium administration; C) Sagittal T2W image. At initial presentation 
the lesion has a cystic aspect with thick enhancing strands (B). D) Sagittal T2W image after 10 months. The lesions 
showed progressive increase in size with involved circumferential resection margins dorsally after neo adjuvant 
chemoradiotherapy.
a b
c D
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Neurogenic lesions
We found one patient  with anterior sacral meningocoele and Curanino syndrome. The le-
sion was an incidental finding. Lesion level: SL 2 – CL, including hemi-aplasia of the sacral 
bone below the S2 level. Curanino Syndrome was clinically confirmed. Clinical follow up 3 
years after MRI revealed no indication for repeat imaging or specific treatment. 
Figure 8. 50-yearold woman with subperitoneal mucinous adenocarcinoma from colorectal origin, after rectum 
resection and colonic-anal anastomosis 25 years ago. A) Barium enema image for evaluation of obstructed de-
feacation reveals an elongated stenotic aspect at the anastomotic level (arrowhead). B) Sagittal T2W MR image 
demonstrates a large multiloculated cystic lesion wrapped around the elongated stenotic anastomosis (arrow-
head), including suggestion of solid nodular component in the dorsal wall of the lesion. C) Axial T1W fat saturated 
image after iv Gadolinium administration reveals the central position of compressed lumen (arrowhead), includ-
ing solid enhancing nodular component in the wall (arrow). D) Axial T2W FSE: Local recurrence with increased 
solid content within the cyst proved a mucinous adenocarcinoma originating from the stump of the colonic-anal 
anastomosis. C: colon (most distal part).
a b
c D
Dedicated MRI of the Lower Pelvis
172 173
5.2
Another patient had differentiating neuroblastoma (Fig 9). This patient presented with acute 
abdominal pain in the lower abdomen at the emergency ward. Initial CT scan and subse-
quent MRI revealed a complicated cystic tumor, including findings suggested of intracystic 
hemorrhage. The lesion was attached to the presacral fascia with a median orientation from 
SL 2 – CL. Surgery followed with marginal resection margins. Two years post- surgery local 
recurrence and  metastases to the lumbosacral spine were evident on MRI. Palliative treat-
ment with chemotherapy and consolidation radiotherapy followed. Five years later mar-
ginal growth of the metastases was seen.   
Figure 9. 40-year-old woman with differentiating 
neuroblastoma. A, B) Note the different signal inten-
sity (SI) on the axial T2W (A) and sagittal T1W images 
(B), including debris and signal inhomogeneity. A 
large solid appearing component ventrally consists 
of a complex of SI including large parts of low SI on 
T2W and high SI on T1W which may be indicative for 
a bloodclot. C, D) Axial T1W image before (C) and 
after (D) i.v. Gadolinium administration. Peripheral 
located solid components show enhancement (ar-
rows) with the larger part of lesion not enhancing. 
On pathology analysis the multilocular cystic nature 
was confirmed with no large solid parts. The fluid 
content consists of different viscosity in different 
compartments, including old blood and necrosis. 
a b
c
Chapter 5.2
173
DIscussIon
In the current literature retrorectal cystic lesions (RCL) are often categorized into congeni-
tal, inflammatory, neurogenic, osseous, and miscellaneous (6,7). The basic clinical problem, 
however, is whether a RCL is to be considered malignant and what are the imaging charac-
teristics that suggest malignancy. Our study tries to answer these questions. We found 18 
% of the patients to present with a malignant lesion. Other studies that evaluated all (solid 
and cystic) primary lesions in the retrorectal space reported 43 % in 120 patients, 48 % in 45 
patients and 50 % in 42 patients to be malignant (1,6,8). These relative high percentages of 
malignancy are obviously due to the contribution of solid lesions. To the best of our knowl-
edge, our study is the first to evaluate exclusively RCL with MRI. Hjermstad et al. found 1 
malignant lesion in 53 patients with tailgut cysts (TGC) (9). Mathis et al. found 4 malignant 
lesions (13 %) in 31 patients with TGC (10). Although in our series no malignancy was found 
in 16 TGC, case reports of malignancy in TGC are consistent with findings of solid tissue 
component in the wall of the lesion on MRI (11-13). 
Key findings on MRI for the differentiation between malignant and benign lesions are de-
scribed in table 3. The most important finding to suggest malignancy is solid tissue com-
ponent. We found solid tissue components in all (100%)  malignant lesions. Only 2 (8%) of 
benign lesions had solid components, both teratomas. Teratoma may exhibit solid com-
ponents, but without malignancy (Fig 5). On the other hand, teratomas are real neoplasms 
and should be considered and approached as malignant lesions (14). Wall thickening was 
found in 2 (40 %) malignant and in 3 (12%) of benign lesions. A thickened wall may also be a 
sign of secondary inflammation and a cause for pain symptoms and not exclusively associ-
ated with malignancy (9). The subgroup from colorectal origin had the highest percentage 
(3 of 4, 75 %) of malignancy. Few case reports of rectal duplication cyst with malignancy 
were found in the literature (15). In addition, we found one case of mucinous adenocarci-
table 3 MRI Findings of Primary cystic lesions of the Retrorectal space subdivided into Malignant and 
benign Lesions
MRI feature malignant (n=5) benign (n=26)
Unilocular 4 (80%) 10 (38%) 
Multilocular 1 (20%) 16 (62%)
Max size (range) 5.5-13.5 cm 2-17 cm
Debris 1 (20%) 4 (15 %)
Septa 2 (40%) 15 (58 %)
Solid component 5 (100 %) 2 (8%)
Wall Thickening (> 5 mm) 2 (40 %) 3 (12 %)
SI T1W/T2W ↓/↑ 4 (80 %) ↓/↑ 15 (58 %)
↑/↑ 1 (20 %) ↑/↑ 7 (27 %) 
↑/↓ 4 (15 %)
SI, signal intensity; ↓, low signal intensity; ↑, high signal intensity
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noma of the rectum, presenting as a retrorectal cystic lesion (Fig 7). This is an extra-ordinary 
presentation of rectal carcinoma of which no separate reports were found in de literature. 
Furthermore, one case of subperitoneal pelvic mucinous adenocarcinoma was found. To 
our knowledge, only one similar case was described in the literature so far of  subperitoneal 
pelvic adenomucinosis (16). Our case, however, is a mucinous adenocarcinoma that was 
confirmed at repeat surgery. The difference in imaging features of the initial and the recur-
rent lesion are striking and may reflect the pathology findings (Fig 8). MR imaging of the 
remaining malignant lesions (dermoid with carcinoid) and differentiating neuroblastoma 
were not reported in the literature to our knowledge. Another point to stress is that malig-
nancy can occur in RCL at relative young age. In  five patients with malignancy, two were 
respectively 18 and 40 years. Most patients in our study group were asymptomatic, this is 
consistent with reports from the literature (5). Symptoms are often due to mechanical prob-
lems from large lesions or secondary infection (7). Treatment of choice is surgery. This can 
be through the ventral, posterior or combined approach. Lusanoff et al. presented a practi-
cal classification of RCL to guide proper surgery (17). The multiplanar capabilities of MRI 
enables the lesion to be demonstrated in relation to the surgical plane. On the other hand, 
surgery of the retrorectal space is prone to complications (8,18). We believe that whenever 
surgery is relatively contraindicated, then regular follow up MRI is the best approach. Evolu-
tion of the lesion with emerging solid tissue component and wall thickening may be a way 
to reconsider treatment.
Our study has some limitations; first because of the retrospective analysis. Second, because 
of the relative small number of patients. We are, however, dealing with rare lesions of which 
some were not previously described in the literature using MRI. Not all patients were im-
aged with a uniform MRI protocol, still we believe that all necessary imaging sequences 
were available, including contrast enhanced series in all but one lesion for a decent mor-
phological analysis. Furthermore, it would be interesting to see whether diffusion weighted 
imaging (DWI) and  apparent diffusion coefficient (ADC) can differentiate between benign 
and malignant lesions. Not all patients in our study group had DWI so this was left out of 
evaluation. DWI and ADC seem especially important to differentiate cystic from non-cystic 
lesions as the SI from RCL may be variable as was indicated in table 2. Future studies may be 
needed to evaluate the added value of DWI and ADC for characterizing RCL. 
In conclusion, retrorectal cystic lesions (RCL) represent a broad diversity of lesions. Our 
study has demonstrated that 18 % of patients with RCL have a malignant lesion with MRI 
findings of solid tissue component indicative of malignancy. 
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suMMaRy & geneRaL DIscussIon  
Studies have shown that preoperative MR imaging revealed important additional informa-
tion compared with surgery alone and better predicts clinical outcome of patients with 
fistula-in-ano than initial surgical exploration (1). Anovaginal fistula is a socially disabling 
disease  in which patients pass gas and feces through the vagina and experience recur-
rent vaginal infections. In our study of 20 patients, anovaginal fistulas were identified on 
T2-weighted MR images as predominantly high-signal-intensity linear abnormalities ex-
tending between the anal canal and the vagina. The internal opening in the anal canal 
was detected in all patients. The internal opening in the vagina was detected in 19 (95%) 
patients. In seven (35%) patients, additional abnormalities were found, including abscesses 
within the rectovaginal septum, additional perianal fistulas and defects of the external anal 
sphincter. History of obstetric trauma, pelvic floor surgery, or Crohn disease was present in 
10 (50%) patients. These patients had more complex fistulas compared with patients with-
out relevant medical history. Previously, other authors stated that obstetric injury and Crohn 
disease are important causes for anovaginal fistula(2, 3). In all patients, the anovaginal fis-
tulas were depicted to their full extent. Complete mapping of the fistula with extensions, 
abscesses, and sphincter damage is important in the preoperative work-up of the patient 
and may improve treatment (1), (4).  
The treatment of cryptoglandular fistulas is mainly surgical, with a number of options. Pres-
ervation of fecal continence is a paramount consideration, and treatment strategies aim to 
preserve the integrity of the external sphincter. Fistulotomy, fistulectomy, drain placement, 
advancement flap closure, and fecal deviating colostomy are common techniques for fis-
tula surgery (5). Perianal fistulas passing through the upper or middle third of the external 
anal sphincter present a challenge to many surgeons. Transanal advancement flap repair 
provides a useful tool in the treatment of these fistulas. It enables the healing of the fis-
tula without damage of the external sphincter and consequent fecal incontinence. Initially, 
the reported healing rates varied between 84 and 100% (6, 7). However, during the past 
decade it has become clear that transanal advancement flap repair fails in 1 of 3 patients 
(8, 9). In our study of 157 patients who had undergone transanal advancement flap repair, 
posterior fistulas were identified in 119 patients (76%). Anterior fistulas were observed in 
23% of the patients. Associated abscesses were found in 47% of the posterior fistulas and 
in 5% of the anterior fistulas. The healing rate of fistulas with a direct course (traversing the 
external anal sphincter in a direct course to the external opening) was significantly lower 
than the healing rate of fistulas with a classic or intersphincteric horseshoe extension. Once 
adequately drained, the abscesses did not affect the outcome of transanal advancement 
flap repair. Concordance between surgical findings and MR images was very high. The most 
striking finding of our study is the poor outcome after flap repair in patients with a high 
transsphincteric fistula, and a direct course to the external opening. This finding is difficult 
to explain and has not been described before. It might be possible that both anterior and 
posterior fistulas with a direct course represent a more aggressive form of perianal fistulous 
disease. Another finding of the present study is the high prevalence of associated abscess-
es, especially in high transsphincteric fistulas with their internal opening at the posterior 
midline. Most of these abscesses could not be detected by physical examination. Although 
some of these abscesses presented a rather complex and bizarre course above the pelvic 
floor, they all could be detected and drained because of preoperative MR imaging. Endo-
anal MR imaging provides a useful tool for the visualization of these abscesses, enabling 
adequate drainage. 
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The efficacy of MRI in the evaluation of chronic anal and perianal pain is shown in the 
identification of suppurative lesions in 27% of all (n=103) patients in our study. This is an 
important finding, and these patients will benefit from surgery. Although we found lesions 
in other locations, most suppurative lesions were located dorsally in the intersphincter-
ic space, which may reflect the higher anatomic prevalence of posterior location of anal 
glands (10). It can be assumed that the internal opening of fistulas and abscesses was ob-
structed, probably by granulation tissue. This may have prohibited drainage of these lesions 
in the anal lumen, explaining their clinically occult status with pain as the only presentation. 
In addition, significantly more abscesses were found in patients with a history of surgery 
for anorectal disease, which may be explained by the more severe iatrogenic infectious 
mechanism. The second most common abnormality encountered at MRI was scarring of 
anal sphincter muscles. In addition, the diagnosis of unspecified functional anorectal pain 
can be made with considerable certainty when no abnormalities can be established with 
either clinical workup or MRI. Using MRI, we were able to identify lesions in 39% of patients 
with chronic anal and perianal pain, for whom a standard clinical workup had failed to 
reveal abnormalities. MRI is therefore a recommended constituent of the workup of these 
patients before their symptoms are considered part of a functional gastrointestinal disorder.
Dedicated MRI tailored to patient symptoms and clinical findings has the potential to map 
morphologic alterations and facilitate appropriate treatment in female patients with lower 
urinary tract symptoms (LUTS). In our cohort of 60 clinical patients with LUTS, 20 patients 
(33%) had urethral diverticula and 28 (47%) had an alternative diagnosis, of which 13 (46%) 
were visualized with MRI. In the remaining 12 patients (20%) no abnormalities were found. 
Other studies reported urethral diverticula in 10% of patients examined with endorectal coil 
MRI. The rigid endoluminal coil, that was used in our study, can be inserted into the vagina 
by the patient herself, and there is no need for administration of glucagon or butylbromide 
to prevent rectal spasm, which could be the case when using the inflatable endoluminal 
coil (11). Few studies have focused on the differential diagnosis of patients with urethral di-
verticula. In the differential diagnosis, one should also consider other regional cystic lesions. 
Visualization of communication between the lesion and the urethra confirms urethral di-
verticula (12). The differentiation between a communicating or non- communicating cystic 
lesion with the urethra is important because the surgical approach for the two entities dif-
fers. Both lesions are resected; however, a diverticulum may require urethral reconstruction 
procedures (12-14). To our knowledge, our study is the first to identify the ostium of urethral 
diverticula in the majority of cases (85%) on MRI with improved confidence using the rigid 
endoluminal coil rather than the pelvic phased-array coil. In our study, MRI showed the final 
diagnosis (urethral diverticula or alternative diagnosis) in 33 of 60 patients (55%). Based 
on  MRI, clinical workup, including functional urodynamic studies, and clinical data, 80% 
of patients were diagnosed with an abnormality that was responsible for their complaints. 
According to these findings, in the diagnostic workup of women with suspicion of urethral 
diverticula, both MRI and urodynamic studies, should be considered. 
In our study of 47 patients with locally recurrent rectal cancer (LRRC), a total of 51 lesions 
were evaluated. The results show that contrast enhanced  MRI (CEMRI) is a valuable supple-
ment in the MRI protocol for diagnosis and pre- operative evaluation of LRRC. LRRC has 
typical CEMRI findings of arterial and persistent enhancement (100%), dominant periph-
eral rim- or heterogeneous mosaic enhancement pattern (80%), and is more consistent for 
evaluation of tumor dimension than T2W MRI. For surgical outcome, tumor fixation to pelvic 
walls or presacral fascia will result in incomplete resection margins in 64% of cases, whereas 
non fixed tumors will be completely resected in 87%.  It should be noted that immature 
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fibrosis and inflammation may demonstrate high signal intensity on T2W, and may demon-
strate contrast enhancement (15). However, the CEMRI characteristics found in our study 
may be supportive to diagnose LRRC and differentiate from fibrosis. To our knowledge, our 
study is the first to assess a combination of typical CEMRI characteristics. Another potential 
for CEMRI in the management of LRRC is monitoring of local image guided therapies like 
radio frequency ablation. In our experience CEMRI is less effected by post procedural effects 
than T2W and DWI to confidently demonstrate local residual or recurrent disease. Future 
studies are needed to present evidence for this. Our results show that tumor fixation to the 
pelvic walls or presacral fascia is of importance to predict surgical outcome, with an incom-
plete resection margin in the majority of cases (64%), in contrary to non-fixed lesions (13%). 
To our knowledge, our study is the first MRI based study for LRRC that endorses these clini-
cal results. In our center intra-operative radiotherapy will be applied on the resected surface 
in case of tumor fixation to the pelvic walls or presacral fascia (16, 17). 
We evaluated  28 patients with 31 retrorectal cystic lesions (RCL). Lesions were subdivided 
into 5 groups: tailgut cyst,  epidermoid and dermoid cyst, teratoma, colorectal origin, neu-
rogenic origin. Tailgut cyst was the most prevalent (16/31, 52 %) lesion. Five patients had 
malignancy (18%); on lesion level 5 out of 31 were malignant (16%) with MRI findings of 
solid tissue components (100 %) most suggestive of malignancy. To the best of our knowl-
edge, our study is the first to evaluate RCL as a separate group of lesions with MRI. We found 
solid tissue components in all (100%) of malignant lesions. Only 2 (8%) of benign lesions had 
solid tissue components, both teratomas. Teratoma may exhibit solid tissue components, but 
without malignancy. On the other hand, teratoma are real neoplasms and should be consid-
ered and approached as a malignant lesion (18). Wall thickening was found in 2 (40 %) ma-
lignant lesions. A thickened wall may also be a sign of secondary inflammation and  a cause 
for pain symptoms (19). Another point to stress is that malignancy can occur in RCL at rela-
tive young age. In the five patients with malignancy, two were respectively 18 and 40 years. 
Most patients in our study group were asymptomatic, this is consistent with reports from 
the literature (20). Symptoms are often due to mechanical problems from large lesions or 
secondary infection (21). The treatment of choice is surgery. This can be through the ventral, 
posterior or combined approach. The multiplanar capabilities of MRI enables the lesion to be 
demonstrated in relation to the surgical plane. On the other hand, surgery of the retrorectal 
space is prone to complications (22, 23). We believe that whenever surgery is relatively con-
tra- indicated, then regular follow up MRI is the best approach. Evolution of the lesion with 
emerging solid tissue component and wall thickening may be a way to reconsider treatment.
Future perspective
In theory, a further increase in SNR of the current endoluminal coil applied in some of stud-
ies may be achieved by applying four loops rather than two of the current generation of 
the endoluminal pelvic coil. By arranging the four elements two by two in series the SNR 
could be increased without suffering loss of field homogeneity in the radial direction. Less 
decrease in SNR at increasing distance from the coil could also be expected when com-
pared to the dual loop configuration. Currently a version is being studied for endorectal 
application, including use of flexible material to adjust for  the anorectal angle. Coupling of 
the endoluminal coil to an external receiver coil array may further increases the volume to 
be imaged. For this configuration proper matching and tuning of all components (endolu-
minal-, external coil  and MR system) is required. For prostate imaging this configuration, us-
ing a single loop coil, resulted in significant improvement of anatomic details, extracapsular 
extension accuracy and specificity (24). We believe that stepwise technical improvements 
should be pursued  based on clinical need.  
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With the emergence of novel surgical treatments for perianal fistula disease like MRI-guided 
surgery, laser, and adhesive treatments, MR imaging is a mainstay for preprocedural and 
intraoperative evaluation to ensure the adequacy of the procedure. The use of laser ablation 
or fibrin glue to treat fistula seems attractive, especially in more complex fistulas (25, 26). 
There are promising reports of human granulocyte colony-stimulating factor, as an alterna-
tive to fibrin glue in the treatment of perianal Crohn’s fistula (27). MRI-guided surgery for 
anal fistula is feasible. Pre-procedural and intraoperative MRI techniques can be used to 
identify the extent of the fistula tracts and septic foci and to ensure the adequacy of the 
surgical procedure.
Dedicated MRI of the pelvis and pelvic floor should play an important role in the work up 
of patents with clinical occult pelvic pain. Currently, eligible patients undergo an adapted 
MRI protocol based on clinical presentation and findings and are discussed within the insti-
tutional board for Diseases of the Pelvis and Pelvic Floor. In addition, new developments in 
functional and molecular imaging are promising to identify specific biomarkers of pain and 
may indicate the precise focus and possible cause for pain. A joint effort with collaborating 
clinical partners should lead to a build- up of expertise and insights in pelvic pain and guide 
proper management. 
Conclusion
This thesis demonstrates the value of dedicated MRI, mostly with application of a rigid 
endoluminal coil, for these complex, often  disabling and difficult to diagnose diseases. 
Dedicated MRI of the pelvis and pelvic floor will facilitate accurate diagnosis, map lesions 
in relation to anatomic structures and guide appropriate treatment. In case of surgery, MRI 
is therefore a recommended tool for pre- surgical planning and prevention of recurring 
disease.
Dedicated MRI of the Lower Pelvis
186 187
7
ReFeRences
1. Lunniss PJ, Armstrong P, Barker PG, Reznek RH, Phillips RK. Magnetic resonance imaging of anal fistulae. Lan-
cet 1992; 340:394-396.
2. Hull TL, Fazio VW. Surgical approaches to low anovaginal fistula in Crohn's disease. Am J Surg 1997; 173:95-98.
3. Senatore PJ, Jr. Anovaginal fistulae. Surg Clin North Am 1994; 74:1361-1375.
4. Beets-Tan RG, Beets GL, van der Hoop AG, et al. Preoperative MR imaging of anal fistulas: Does it really help 
the surgeon? Radiology 2001; 218:75-84.
5. Seow C, Phillips RK. Insights gained from the management of problematical anal fistulae at St. Mark's Hospi-
tal, 1984-88. Br J Surg 1991; 78:539-541.
6. Wedell J, Meier zu Eissen P, Banzhaf G, Kleine L. Sliding flap advancement for the treatment of high level 
fistulae. Br J Surg 1987; 74:390-391.
7. Aguilar PS, Plasencia G, Hardy TG, Jr., Hartmann RF, Stewart WR. Mucosal advancement in the treatment of 
anal fistula. Dis Colon Rectum 1985; 28:496-498.
8. van Koperen PJ, Wind J, Bemelman WA, Bakx R, Reitsma JB, Slors JF. Long-term functional outcome and risk 
factors for recurrence after surgical treatment for low and high perianal fistulas of cryptoglandular origin. Dis 
Colon Rectum 2008; 51:1475-1481.
9. Zimmerman DD, Delemarre JB, Gosselink MP, Hop WC, Briel JW, Schouten WR. Smoking affects the outcome 
of transanal mucosal advancement flap repair of trans-sphincteric fistulas. Br J Surg 2003; 90:351-354.
10. Gupta PJ. A study of suppurative pathologies associated with chronic anal fissures. Tech Coloproctol 2005; 
9:104-107.
11. Lorenzo AJ, Zimmern P, Lemack GE, Nurenberg P. Endorectal coil magnetic resonance imaging for diagnosis 
of urethral and periurethral pathologic findings in women. Urology 2003; 61:1129-1133; discussion 1133-
1124.
12. Hahn WY, Israel GM, Lee VS. MRI of female urethral and periurethral disorders. AJR Am J Roentgenol 2004; 
182:677-682.
13. Rovner ES, Wein AJ. Diagnosis and reconstruction of the dorsal or circumferential urethral diverticulum. J Urol 
2003; 170:82-86; discussion 86.
14. Fortunato P, Schettini M, Gallucci M. Diagnosis and therapy of the female urethral diverticula. Int Urogynecol 
J Pelvic Floor Dysfunct 2001; 12:51-57.
15. Lavini C, de Jonge MC, van de Sande MG, Tak PP, Nederveen AJ, Maas M. Pixel-by-pixel analysis of DCE MRI 
curve patterns and an illustration of its application to the imaging of the musculoskeletal system. Magn Re-
son Imaging 2007; 25:604-612.
16. Ferenschild FT, Vermaas M, Nuyttens JJ, et al. Value of intraoperative radiotherapy in locally advanced rectal 
cancer. Dis Colon Rectum 2006; 49:1257-1265.
17. Rodriguez-Bigas MA, Chang GJ, Skibber JM. Multidisciplinary approach to recurrent/unresectable rectal can-
cer: how to prepare for the extent of resection. Surg Oncol Clin N Am 2010; 19:847-859.
18. Miles RM, Stewart GS, Jr. Sacrococcygeal teratomas in adult. Ann Surg 1974; 179:676-683.
19. Hjermstad BM, Helwig EB. Tailgut cysts. Report of 53 cases. Am J Clin Pathol 1988; 89:139-147.
20. Bullard Dunn K. Retrorectal tumors. Surg Clin North Am 2010; 90:163-171, Table of Contents.
21. Singer MA, Cintron JR, Martz JE, Schoetz DJ, Abcarian H. Retrorectal cyst: a rare tumor frequently misdiag-
nosed. J Am Coll Surg 2003; 196:880-886.
22. Bohm B, Milsom JW, Fazio VW, Lavery IC, Church JM, Oakley JR. Our approach to the management of congeni-
tal presacral tumors in adults. Int J Colorectal Dis 1993; 8:134-138.
23. Wang JY, Hsu CH, Changchien CR, et al. Presacral tumor: a review of forty-five cases. Am Surg 1995; 61:310-
315.
24. Futterer JJ, Engelbrecht MR, Jager GJ, et al. Prostate cancer: comparison of local staging accuracy of pelvic 
phased-array coil alone versus integrated endorectal-pelvic phased-array coils. Local staging accuracy of 
prostate cancer using endorectal coil MR imaging. Eur Radiol 2007; 17:1055-1065.
Chapter 7
187
25. Bodzin JH. Laser ablation of complex perianal fistulas preserves continence and is a rectum-sparing alterna-
tive in Crohn's disease patients. Am Surg 1998; 64:627-631; discussion 632.
26. Lindsey I, Smilgin-Humphreys MM, Cunningham C, Mortensen NJ, George BD. A randomized, controlled trial 
of fibrin glue vs. conventional treatment for anal fistula. Dis Colon Rectum 2002; 45:1608-1615.
27. Vaughan D, Drumm B. Treatment of fistulas with granulocyte colony-stimulating factor in a patient with 
Crohn's disease. N Engl J Med 1999; 340:239-240.
Dedicated MRI of the Lower Pelvis
188 189
7
saMenvattIng
MRI spoelen in het kleine bekken 
Er zijn 2 soorten MRI signaal ontvang spoelen voor het klein bekken; de uitwendige spoel 
(phased array) en de inwendige (endoluminale) spoel. De endoluminale type kent een op-
blaasbare en een rigide variant. In ons centrum gebruiken we de rigide variant naar tevre-
denheid. Deze wordt toegepast in de anus of in de vagina. Deze spoel heeft een techni-
sche verbetering ondergaan door het “dual loop” concept. De vorige generatie inwendige 
spoelen waren gebaseerd op het “single loop” concept. De nieuwe versie heeft een betere 
signal-ruis-verhouding dan de vorige generatie en kan aldus scherpere afbeeldingen ma-
ken zonder dat de duur van het onderzoek verlengd wordt. Dit betekent een winst voor de 
diagnostiek in ons vak.  
MRI onderzoek van fistelgangen  
en pijn rond de anus
Bij fistelgangen blijkt MRI van grote waarde en laat meer afwijkingen zien dan de chirurg 
zou vermoeden op basis van het klinische onderzoek alleen. Dit is dan van groot belang 
voor de chirurgische behandeling.  Anovaginale fistels zijn fistels tussen de anus en vagina 
die  verlies van faeces via de vagina en steeds terugkerende ontstekingen van de vagina 
kan veroorzaken. In een analyse van 20 patienten liet MRI alle anovaginale fistels zien en 
additionele afwijkingen z.a. abcessen, fistelgangen op andere locaties en defecten van het 
sphincter complex (steunende spierweefsel) van de anus. De opening van fistelgangen in 
de anus werd aangetoond in alle gevallen en de opening in de vagina werd gezien in 19 
gevallen. De helft van de patienten had een onderliggende aandoening of eerdere operatie 
in het bekkenbodem gebied ondergaan wat indirect geleid heeft tot deze fistels. In deze 
patienten werd vaker complexe anovaginale fistels met abcessen aangetroffen bij vergelij-
king met patienten die geen duidelijke onderliggende oorzaak voor de fistels hadden. 
De behandeling van fistels is voornamelijk chirurgisch. Hiervoor zijn een aantal technieken 
beschikbaar. Een specifieke operatie techniek die veel toegepast wordt voor lange fistels 
die hoog in de anus communiceren is de “advancement flap closure”.  Deze techniek is 
gebaseerd op behoud van het continentie mechanisme na de operatie. We hebben 157 
patienten geevalueerd die deze operatie techniek hebben ondergaan. Het blijkt dat de ge-
nezing van fistels die behandeld zijn met deze operatie minder gunstig is wanneer de fistels 
een rechtlijnige  verloop hebben. Bovendien werden vaker abcessen bij de fistels gevonden 
wanneer deze aan de achterkant van de anus gelegen waren. Deze abcessen konden al-
leen met de MRI goed worden vastgesteld en indien goed gedraineerd, hadden deze geen 
verdere invloed op de operatie. Er was een hoge mate van overeenkomst tussen de MRI 
beelden en de bevindingen tijdens de operatie
Aanhoudende langdurige pijn de anus komt niet zelden voor. Wanneer het klinische on-
derzoek door de behandelende arts geen duidelijke oorzaak laat zien is afbeeldend onder-
zoek belangrijk. MRI liet bij 103 patienten die verwezen waren naar een gespecialiseerde 
centrum, in 27 % verborgen fistels en/of abcessen zien. Deze patienten hebben baat bij 
een operatieve behandeling van de fistels met afname van hun pijnklachten. Een tweede 
afwijking die redelijk vaak gezien wordt is verlittekening van de anus. MRI is aldus een be-
langrijke gereedschap in de diagnostiek bij deze patienten en dient overwogen te worden 
voordat de klacht als ‘psychisch’ wordt afgedaan.  
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MRI op maat bij de vrouw met afwijkingen  
van de plasbuis en omgeving 
MRI kan een belangrijke rol spelen bij het onderzoek van vrouwen met chronische blaas- en 
plas klachten. In een groep van 60 vrouwelijke patienten die MRI ondergingen met der-
gelijke klachten, werd door de MRI in 20 patienten (33%) een uitstulping van de plasbuis 
(divertikel van de urethra) vastgesteld. In 28 patienten werd een andere diagnose uiteinde-
lijk vastgesteld waarvan 13 gevallen (46 %) door de MRI werd ontdekt. De MRI werd in de 
meeste gevallen uitgevoerd met een MRI spoel in de vagina. Deze spoel ontvangt de MRI 
signalen van de plasbuis en directe omgeving en kan aldus hele scherpe afbeeldingen ma-
ken. Deze spoel is een rigide spoel die door de patient zelf wordt ingebracht in de vagina. 
Door de haarscherpe afbeeldingen komen belangrijke detailles van de afwijking goed in 
beeld. Bijvoorbeeld het vaststellen van de positie van de interne opening van het divertikel 
naar is plasbuis wordt in 85 % van de gevallen duidelijk. Dit is niet eerder met andere afbeel-
dingstechnieken gelukt. Dit kan van belang zijn bij de chirurgische behandeling. 
MRI van het achterste compartiment  
in het kleine bekken.
Het recidief rectum (endeldarm) carcinoom. 
Het recidief rectum carcinoom wordt in 5- 10 % gezien en veelal binnen 2 jaar na opera-
tie van het eerste rectum carcinoom. Complete chirurgische verwijdering van het recidief 
biedt de beste kans op genezing. We hebben de MRI kenmerken van het local recidief 
rectum carcinoom (LRRC) onderzocht in  47 patienten met in totaal 51 tumoren en tevens 
gekeken naar bevindingen op MRI die belangrijk zijn voor de uitkomst van de chirurgische 
behandeling (compleet verwijderd of microscopische tumor rest achter latend). We heb-
ben aangetoond dat het LRRC typische kenmerken heeft op MRI na toediening van MRI 
contrast middel (gadolinium). Deze zijn vroege en aanhoudende aankleuring (100%) met 
een ringvormige of heterogene mozaiek patroon  (80%).  Voor de uitkomst van de chirurgie 
is van belang dat de meeste tumoren die gefixeerd zijn aan de bekkenwand niet volle-
dig verwijderd kunnen worden met achterlating van een microscopische tumor rest (64%). 
Niet- gefixeerde tumoren worden in de meeste gevallen compleet verwijderd (87 %).  
Vochthoudende gezwellen van het achterste compartiment in het kleine bekken.  
Vochthoudende gezwellen van het achterste compartiment in het kleine bekken (Retro-
rectal cystic lesions (RCL)) zijn zeldzaam in de volwassen leeftijd en met weinig literatuur 
hierover. Vaak is de grote vraag of een dergelijke gezwel gerekend moet worden tot de 
kwaadaardige of goedaardige gezwellen.  We hebben een analyse gedaan van 28 patien-
ten met in totaal 31 soortgelijke vochthoudende gezwellen. De afwijkingen werden in 5 
subgroepen verdeeld met de “Tailgut cyst” als groep met de meeste gezwellen (16/31, 52 
%). In 5 patienten betrof  het kwaadaardige gezwel (18%) of (5/31, 16% van alle gezwellen). 
We vonden dat vast weefsel component in het gezwel (100%) een belangrijke aanwijzing is 
voor een kwaadaardige gezwel. Een andere bevinding die kan wijzen op een kwaadaardig 
gezwel is een verdikte wand welke in 40 % van de kwaadaardige gezwellen werd gevon-
den. Van belang is verder te weten dat de kwaardige gezwellen ook op relatieve jonge 
leeftijd kunnen voorkomen en dat de meeste afwijkingen geen specifieke klachten geven, 
maar vaak per toeval ontdekt worden bij onderzoek van de patient om andere redenen.  
Dedicated MRI of the Lower Pelvis
190 191
7
Toekomst perspectief 
Verdere technische verbetering van de bestaande inwendige MRI spoelen is mogelijk. Denk 
aan extra (4) loops in plaats van de huidige dual (2) loops. Andere voorbeelden zijn het 
technisch koppelen van de inwendige spoel met de uitwendige spoel voor het scherp af-
beelden van een ruimer gebied. Studies hebben laten zien dat dit veelbelovend en haal-
baar is. We zijn van mening dat de technische verbeteringen stapsgewijs moet geschieden 
naar gelang de noodzaak voor betere afbeeldingen. 
Nieuwe behandeltechnieken, z.a. gebruik van laser, voor fistels rond de anus zijn in ontwik-
keling. MRI is hierbij van belang voor de planning en begeleiding van de procedure. De 
operatie vindt plaats in de MRI kamer in een speciale “open MRI” apparaat door de chirurg 
en radioloog. De eerste rapportages zijn veelbelovend en laten zien dat een d.g. opstelling 
haalbaar. 
Nieuwe ontwikkelingen in beeldvormende technieken kunnen een belangrijke rol spelen 
in de diagnostiek en behandeling bij patiënten met klinisch onbegrepen en vaak invalide-
rende pijnen in het kleine bekken gebied.
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ESMRMB 2003 (European Society for Magnetic Resonance in Medicine and Biology) 
20th Annual Scientific Meeting
September 18 - 21, Rotterdam, The Netherlands Invited Speaker, Advanced MR Imaging of 
the Abdomen, 
"MR Imaging of the Anorectal Diseases"
ESMRMB 2004 (European Society for Magnetic Resonance in Medicine and Biology) 
21st Annual Scientific Meeting
September 9 - 12, Copenhagen, Denmark
Invited Speaker, Teaching Session, "MR imaging of the anorectum"
Moderator "MRI and MRS of abdomen and pelvis"
ESGAR 2005 (European Society for GastroIntestinal and Abdominal Radiology) 
16-th annual scientific meeting
May 28-31, Florence, Italy
Invited Speaker, Teaching Session and workshop
“MRI of the anorectum, fistula disease and pelvic sepsis”
ESMRMB 2006 (European Society for Magnetic Resonance in Medicine and Biology) 
23-rd annual scientific meeting
September 21-23, Warsaw, Poland
Invited Speaker, School of MRI, Teaching Session, “MRI of the anorectum”. 
Externe Refereeravond 2011, afdeling Urologie, Erasmus MC
March 7, Rotterdam. 
Invited Speaker,  “State of the art MRI bij diagnostiek van uretrale en peri-uretrale pathologie 
in symptomatische vrouwelijke patiënten”
ISMRM 2013 (The International Society for Magnetic Resonance in Medicine)
21-st Annual Meeting & Exhibition 
April 20-26, Salt lake City, UT/USA
Invited Speaker, Body MRI educational program
“MR Imaging of Anal Pain and Perianal Fistula Disease”
Externe Refereeravond 2015, afdeling Radiologie, Erasmus MC
April 23, 2015, Rotterdam 
“Dedicated MRI of the Lower Pelvis: Do We Need an Endoluminal Coil ?”
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Selected (Inter)national Conferences, Seminars, Workshops,
including scientific and teaching presentations
Radiological Society of North America (RSNA), Chicago, USA
Annual Scientific Meeting: 2001, 2002, 2003, 2004, 2007, 2008, 2009, 2011, 2012, 2013, 2014
2009, scientific podium presentation.
R.S. Dwarkasing, W. Dinkelaar, W. Hop, G. Dohle, GP. Krestin. 
MRI evaluation of urethral diverticula and differential diagnosis in female patients with 
chronic lower urinary tract symptoms.
2011, scientific poster presentation.
R.S. Dwarkasing, T. Geeraerdts,  W. Hop, R. Schouten, GP Krestin. 
MRI Evaluation of Patients with Anal and Perianal Pain Referred to a Tertiary Colorectal Surgi-
cal Department. 
2011, teaching exhibit poster presentation.
R.S. Dwarkasing, S. Verschuuren, G.R. Dohle, G.P. Krestin. 
MR Imaging and Urodynamic Findings in Female Patients with Chronic Lower Urinary Tract 
Symptoms (LUTS).
2012,  scientific podium presentation.
R. Elias, K. Biermann, G. P. Krestin, R.S. Dwarkasing. 
Can Inflammatory Myofibroblastic Tumor of the Hepatobiliary System be Differentiated 
from Cholangiocarcinoma on Imaging?
2012, scientific poster presentation.
R. Dikkers, R. Devos, G. P. Krestin, R.S. Dwarkasing. 
Pediatric Primary Liver Tumors: Imaging Appearances and Pathologic Correlation. 
2012, teaching exhibit poster presentation.
R. Elias, F. Willemssen, K. Biermann, G.P. Krestin, R.S. Dwarkasing. 
Inflammatory Myofibroblastic Tumor of the Hepatobiliary System: Imaging Characteristics 
with Histopathology Correlation and Differential Diagnosis.
 
2012, teaching exhibit poster presentation.
S. Verschuuren, R.S. Dwarkasing, G. van Leenders, R.W. Schouten, G.P. Krestin. 
MRI of Primary Cystic Lesions of the Retrorectal Space.   
2013, teaching exhibit poster presentation.
R.S. Dwarkasing, H. Flick, G. Kotek, G.P. Krestin. 
Endoluminal Receiver Coil for Endoanal and Intravaginal Application on 1.5 and 3.0 T MRI 
Systems. Design, technical Aspects and Clinical Application. Proposal for a New Rigid En-
dorectal Coil Design For Dedicated Prostate Imaging.
2015, scientific podium presentation.
K. Ramsaransing, R.S. Dwarkasing, F. Willemssen, M. de Vries. 
Is Contrast-Enhanced Ultrasound Comparable to MRI with Liver-Specific Contrast Agent for 
Diagnosis of Focal Nodular Hyperplasia and Hepatocellular Adenoma? 
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2015, scientific poster presentation.
R.S. Dwarkasing, R. van Waardhuizen, W.J. Alberda, M. Doukas, M. de Vries, C. Verhoef, F. 
Willemssen. 
Value of MRI for Diagnosis and Local Staging of Recurrent Rectal Cancer: Correlation with 
Surgery and Histopathology of Resected Specimen. 
2015, teaching exhibit poster presentation.
M.L. Dijkshoorn, F. Willemssen, D. van der Velden, M. van Straten, R.S. Dwarkasing. 
State-of-the-art CT Imaging Techniques of the Abdomen with 3rd Generation Dual Source 
CT. 
2015, teaching exhibit poster presentation.
R.S. Dwarkasing, R.N. Boxhoorn, G.P. Krestin, C.H. van Eijck. 
Dedicated Imaging of Inguino-femoral and Lower Abdominal Wall Hernias. 
2015, teaching exhibit poster presentation.
V. Lai Nguyen, M. Rossius, P. Wielopolsky, G. Dohle, G.P. Krestin, R.S. Dwarkasing.
Magnetic Resonance Imaging of Penile Diseases.
European Society for Magnetic Resonance in Medicine and Biology (ESMRMB)
Annual Scientific Meeting 
2002, August 22-25, Cannes, France. 
2003, September 18 - 21, Rotterdam, The Netherlands.
2004, September 9 - 12, Copenhagen, Denmark.
2006, September 21-23, Warsaw, Poland.
European Society of Gastrointestinal and Abdominal radiology (ESGAR)
Annual Scientific Meeting 
2005, May 28-31, Florence, Italy
2012, June 12–15, Edinburgh, UK. 
2014, June 18 – 21, Salzburg, Austria.
2015, June 9-12, Paris, France.
European Society of Radiology (ECR)
Annual Scientific Meeting.
2010, March 4-8, Vienna, Austria
2010, scientific poster presentation.
F. Willemssen, R.S. Dwarkasing. 
Imaging Features of Hepatobiliary Cystadenoma.
2015, scientific podium presentation.
R.S. Dwarkasing, S. Verschuuren, G. van Leenders, L.M.M. Braun, W.R. Schouten, G.P. Krestin. 
Primary Cystic Lesions of the Retrorectal Space: MRI evaluation, Histopathology Confirma-
tion and Clinical Assessment
2015, scientific podium presentation.
M.G. Thomeer, F. Willemssen, K. Biermann, R. de Man, J. IJzermans, R.S. Dwarkasing. 
MRI features of inflammatory hepatocellular adenomas on hepatocyte phase imaging with 
liver-specific contrast agents.
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2015, educational poster presentation.
F. Willemssen, R.S. Dwarkasing. 
Practical Guide to Differentiate Cystic Lesions of the Liver
International Diagnostic Course in Davos (IDKD).
Abdominal and Pelvic Imaging.
2006, April 1-7, Switzerland.
ESOR, European School of Radiology, Brussles, Belgium 
Advanced Untrasound and Contrast Enhanced Ultrasound 
2011, May 12-13.  
The International Society for Magnetic Resonance in Medicine (ISMRM)
Annual Scientific Meeting 
2013, April 20-26, Salt Lake City, USA
Radiologen Dagen, The Netherlands
2007, 2008, 2009, 2012, 2013
2007, scientific podium presentation.
M. Kekelidze, R. Dwarkasing, M. Dijkshoorn, P. Verhagen, G.P. Krestin. 
Optimizing MDCT of Kidneys and Urinary Tract with Triple - bolus Contrast Injection 
Technique.
2009, scientific podium presentation.
R.S. Dwarkasing, S.I. Verschuuren, W. Dinkelaar, W. Hop, G. Dohle, G.P. Krestin. 
MRI evaluation of Urethral Diverticula and differential Diagnosis in Female Patients with 
Chronic Lower Urinary Tract Symptoms.
2010, scientific podium presentation.
T.E.A. Geeraedts, R.S. Dwarkasing, W. Hop, R. Schouten, G.P. Krestin. 
MRI Evaluation of Patients with anal and perianal pain referred to a tertiary colorectal surgi-
cal department
2012, scientific podium presentation.
R. Elias, K. Biermann, G.P. Krestin, R.S. Dwarkasing. Can Inflammatory Myofibroblastic Tumor 
of the Hepatobiliary System Be Differentiated from Cholangiocarcinoma on Imaging?
2012, educational podium presentation. 
R. Dikkers, A. Devos, G.P. Krestin, R.S. Dwarkasing. Pediatric Primary Liver Tumors: Imaging 
Appearances and Pathologic Correlation.
2012, educational podium presentation.
S.I. Verschuuren, R. S. Dwarkasing, G. J.L.H. van Leenders, G. R. Dohle, G. P. Krestin. 
MR Imaging and Urodynamic Findings in Female Patients with Chronic Lower Urinary Tract 
Symptoms (LUTS).
2012, educational podium presentation
S.I. Verschuuren, R. S. Dwarkasing, G. J.L.H. van Leenders, W. R. Schouten, G.P. Krestin. 
MRI of Primary Cystic Lesions of the Retrorectal Space
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2013, scientific podium presentation 
I.J.S.M.L Vanhooymissen, R. Atzei, R.S. Dwarkasing, F.E.J.A. Willemssen. 
Validity of One Stop Triple-Bolus Multidetector CT Urography in Detecting renal and uro-
thelial malignancy
2013, educational podium presentation
M. de Vries, M.G.J. Thomeer, R.S. Dwarkasing. 
Adenomen in de Lever: Alles wat een Radioloog moet weten. 
2014, scientific podium presentation; Winner Travel Grant Award
R.M. van Waardhuizen, R.S. Dwarkasing, W.J. Alberda, M. Doekas, M.A.J. de Ridder, J.J.M.E. 
Nuyttens, C. Verhoef, F.E.J.A. Willemssen. 
Value of Dynamic Contrast Enhanced MRI and Fusion with T2-weighted Imaging for Local 
Staging of Recurrent Rectal Cancer: Correlation with Surgery and Histopathology of Re-
sected Specimen. 
2015, educational podium presentation
V. Lai Nguyen, M. Rossius, P. Wielopolsky, G. Dohle, G.P. Krestin, R.S. Dwarkasing. 
Dedicated Magnetic Resonance Imaging of Penile Disorders.
2015, educational podium presentation
R.N. Boxhoorn, R.S. Dwarkasing, C. van Eijck, G.P. Krestin. 
Dedicated Imaging of Inguino-femoral and lower abdominal wall hernias.
2015, scientific podium presentation.
L.M.M. Braun R.S. Dwarkasing, S. Verschuuren, G. van Leenders, W. Schouten, G. Krestin. 
Primary Cystic Lesions of the Retrorectal Space: MRI evaluation, Histopathology Confirma-
tion and Clinical Assessment.
Others 
2006, Recht in de Medische Praktijk, 29 mei, Pfizer partners in Practice.
2007, Teach the Teacher, Erasmus MC, Rotterdam.
2008, Invited Lecture, Cursus Klinische Hepatologie 29-30 mei 2008, Nederlandse Vereni-
ging voor Hepatologie. “Beeldvorming van focale leverhaarden, MRI en CT”.
2008, October 9, Moderator, Scientific Session, Abdominal Oncology Imaging, Radiologen 
Dagen, Rotterdam, The Netherlands.
2010, October 12-15, Moderator, NVvR Sandwichcursus Abdomen, Ede.
2010, April 26, Training: Implementatie Modernisering Medische Vervolgopleidingen voor 
Medische Specialisten en Arts Assistenten in Opleiding tot Medisch Specialist. Desiderius 
School, Erasmus MC, OORZWN.
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2011, Persoonlijk Leiderschapsprogramma. Sector Organisatie Advies en – Ontwikkeling, 
EMC, Rotterdam. 
2011, Organisor, Landelijke Sectiedag Abdomen, NVvR, April 27, de Euromast, Rotterdam.
2014, February 6, Roadshow Wetenschappelijke Integriteit, Erasmus MC, Rotterdam. 
2014, March 25, Workshop Postdoc Network Erasmus MC Meeting: Presenting yourself and 
your work. 
2016, June 8,9. Course leader, SWC Abdomen, NVvR. 
2017, February 7-10. Course leader, Teaching In Holland, AIRP, SWC Abdomen, NVvR. 
Teaching 
Supervisor Master Research, Medical Faculty, Erasmus MC
Completion of the following projects
2011, E.C. Boer, C.P Raaijmakers. CT imaging of Complications Related to Major Abdominal 
Surgery. 
2011, F. Dahbi, J. Makhkash. Contrast Enhanced MRI in the surveillance, therapy and moni-
toring of Therapeutic Effects in Patients with Recurrent Rectal Carcinoma.
2012, N. Haverkamp. The value of CT in the Detection or Confirmation of Acute Pyelone-
phritis.
2013, H. Fares. Clinical aspects and Imaging of Primary Malignant Liver Tumors in Children.
2013, R.M. van Waardhuizen. The value of T2-weighted, Dynamic Contrast Enhanced (DCE) 
MRI and Fusion Imaging for Pre-operative Assessment of Local Recurrent Rectal Carcinoma, 
Correlation with Histopathology Analysis of Resected Specimen.
2014, K. Ramsaransing. Is Contrast- Enhanced Ultrasound Equivalent to MRI with Liver-
specific Contrast Agent for the Diagnosis of Hepatocellular Adenoma and Focal Nodular 
Hyperplasia?
Work in progress
C. Spanjer. Imaging and Clinical Aspects of Uncommon Primary Liver Lesions, Analysis of 
Cases Referred to a Tertiary Referral Center for Hepatobiliary Diseases.
S. Tajjiou. Atypical and Suspect- Symptomatic Liver Hemangiomas: Cross-sectional Imaging 
with Pathology Confirmation and Surgical Outcome.
Reviewer radiology journals
Reviewer for European Radiology, 2009 – current. 
Referee for papers on “Hepatobiliary Imaging” and “Pelvic Imaging”
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